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Abstract 
Silicon Nanoparticles (SiNPs) are non-toxic materials particularly suitable for various 
biomedical applications. They exhibit unique optical properties for use in bioimaging and 
diagnostic applications. To exploit these aspects, this thesis explores the synthesis, 
characterisation and biological activity of SiNPs functionalised by anticancer compounds.  
Thiourea-based compounds have been shown to represent one of the most promising classes 
of anticancer agents due to their strong inhibitory activity against Epidermal Growth Factor 
Receptor (EGFR), overexpression of which is observed in common types of cancer cells. 
Conjugation of thiourea compounds in nanosystems presents one potential approach to target 
such cells. In this thesis, successful synthesis of novel thiourea-functionalised SiNPs was 
undertaken and their physiochemical properties were investigated by photoluminescence 
emission and elemental analysis. In vitro cytotoxicity assay was employed to evaluate the effect 
of SiNPs. Confocal microscopy images demonstrate SiNP internalisation and flow cytometry 
data confirms receptor-mediated targeting in cancer cells.  
Isothiocyanates (ITCs) can prevent the onset of carcinogenesis and act as chemopreventive 
compounds. ITC-functionalised SiNPs were synthesised using two different methods, initiated 
from two different types of SiNPs. The surface chemistry of these particles were characterised 
and their optical properties examined to assess both synthesis approaches. The samples 
produced from the precursor Br SiNPs exhibit strong photoluminescence and therefore are 
suitable for uptake studies. The cytotoxicity of ITC SiNPs was evaluated by MTT and their 
internalisation confirmed using confocal microscopy and flow cytometry assay. 
Synchrotron-based FTIR microspectroscopy was used as a novel approach to investigate 
ITC SiNP cell internalisation. Spectral comparison between treated and control cells shows the 
effect of ITCs, leading to an increase both in protein level in the nuclei, and also in the chance 
of apoptosis, which increases phospholipid contents. 
Considering the obtained results, such multifunctional nanosystems have the potential to be 
applied for further diagnostic and therapeutic applications.  
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1. General Background and Concepts 
In common conversation, things that are small are synonymous with concepts such as the 
‘head of a pin’. Reality however, requires imagination orders of magnitude greater, as there are 
1,000,000 nm within this minute space. ‘Nanometre’ is derived from the Greek nano meaning 
‘dwarf’, and denotes a factor of 10-9; thus, a nanometre is one billionth of a metre. In this 
standard unit, the thickness of a human hair is approximately 80,000 nm, while a red blood cell 
is approximately 7000 nm. Having one or more dimensions of the order of 100 nm or less is 
considered nanoscale according to British Standards Institution (BSI).1 The science of 
materials that possess at least one dimension in the nanoscale is called nanoscience. More 
precisely, nanoscience is the study of phenomena and manipulation of materials at atomic, 
molecular and macromolecular scales, where material properties differ significantly from those 
at a larger scale. Nanoscience is a highly multidisciplinary field which is known to be at the 
interference between chemistry and physics; between molecules and solids; between quantum 
mechanics and classical physics and chemistry.2, 3  
In 1959, Richard Feynman gave a lecture to the American Physical Society which is 
considered as a first source of inspiration towards the conceptual understanding of nanoscience. 
His talk was entitled “There is plenty of room at the bottom” in which he laid out some of the 
consequences of measuring and manipulating materials at nanoscale. Initially he attempted to 
visualise this by explaining the idea of being able to write the entire 24 volumes of the 
Encyclopaedia Britannica on the head of a needle; each letter would be 8 nm in diameter, 
around 32 atoms across.4 His contribution opened up to a wider audience the concept of the 
science of the miniature, in a similar way as Einstein in his popularisation of macro-scale 
physics.  
The term "nanotechnology" was itself coined by Tokyo Science University Professor, Norio 
Taniguchi at a 1974 conference. His original statement remains as the standard definition 
today: “Nanotechnology mainly consists of the processing of separation, consolidation and 
deformation of materials by one atom or one molecule”.5 In modern applications the standard 
definition has expanded to the design, characterisation, production and application of 
structures, devices and systems by controlling shape and size at nanometre scale.2 
Nanochemistry is then the utilisation of chemistry to make nanoscale building blocks of 
different size, shape, composition and surface structure, charge and functionality.6 
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According to historical evidence there exist several remarkable examples of what we would 
now call nanoscience and nanotechnology. One of the earliest cases of this can be observed in 
“The Roman Lycurgus Cup” related to the 4th century presently in the British Museum (Figure 
1.1). The glass of this cup shows unusual optical effects which appears pea-green in daylight 
(reflected light), whilst appearing wine-red coloured when illuminated with transmitted light 
from the inside of the vessel. The chemical analysis of the glass of the cup attributed this 
dichronic colouring to the surface plasmon resonance of the nanocrystals of an alloy of gold 
and silver and probably copper which are dispersed throughout the glassy matrix of the cup.7   
 
 
Figure 1.1. The Lycurgus Cup under the reflected (left) and transmitted (right) light, Department 
of Prehistory and Europe, The British Museum.8 
 
9th century Abbasid lustre ceramics similarly have a coating that forms a nano-grating which 
produces a multi-coloured iridescence (Figure 1.2 (a)).9 Carbon nanotubes were also used 
unwittingly by 10th century Muslim sword-smiths in their though Damascus blades (Figure 1.2 
(b)).10 Another example is the use of colloidal metal nanoparticles in stained glass windows of 
ancient European cathedrals. In the Middle Ages, colloidal gold was used to produce bright red 
and purple colours by artisans.  Figure 1.3 (a) shows a stained glass window made by Niccolo 
da Varallo between 1480 and 1486 in Milan Cathedral. This contains gold nanoparticles which 
appear red in diameters from 10-100 nm.11 Moreover, the red and purple colours appear in the 
Rose window of the Cathedral of Notre Dame (Figure 1.3 (b)) are as a result of the presence of 
colloidal gold in the window.12  
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(a) (b) 
    
Figure 1.2. A Pottery containing silver and copper nanoclusters excavated from Fustat, Cairo, 
Egypt (a)9 and a Damascus sword with the nanotube structure (b).13  
 
      (a)             (b) 
 
Figure 1.3. The stained Glass window by Niccolo da Varallo at Duomo of Milan (a)11 and the Gothic 
stained glass rose window of Notre-Dame de Paris (b) the red colour is due to colloidal gold 
nanoparticles.14  
 
 Although the incidental use of nanoscience and nanotechnology is present in historical 
artefacts, the awareness and the importance of them only existed since the late 1950s. 
Significant breakthroughs have been made however since the invention of the Scanning 
Tunnelling Microscope (STM) by Gerd Binnig and Heinrich Rohrer at IBM Zurich in the early 
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1980s.15, 16 This innovation allowed the direct observation of nanostructures, previously 
impossible, and since then nanomaterials have come to be at the forefront of scientific research 
with potential applications in a wide range of fields from biomedicine to engineering.17-21 
 
1.1. Nanomaterials 
Nanoscience and nanotechnologies are concerned with producing new or enhanced 
materials with at least one dimension in nanoscale. These nanomaterials appear in a variety of 
forms. Some materials such as films or coating surfaces of computer chips are nanoscale in 
only one dimension and the other two are macroscopic. Nanotubes and nanowires are 
considered as two-dimensional nanostructures with nanometre scale.22 Sometimes they might 
show three dimensions in nanoscale such as nanoparticles and colloids. In some other cases, it 
is possible to find bulk material which are nanocrystalline materials made of nanometre-size 
grains such as nanoporous materials which contain features at nanometre.23 
The surface reactivity and electrical characteristics are fundamental properties of materials 
which are size dependent and this behaviour is dependent on the ratio of surface atoms to the 
total number of atoms within the material. For a microstructure material this ratio is zero 
whereas it is different for nanomaterials. For example, a particle with size of 30 nm has 5% of 
atoms on its surface, a particle with 10 nm size has 20% of atoms on the surface, and this 
relationship continues to the situation where half of all atoms are on the surface for a particle 
with 3 nm size.24 As a result of the reduced dimensions of nanocrystals, the increase in the 
surface area per unit mass occurs and thus the chemical and physical properties of 
nanomaterials is different from those of bulk materials. For example, nanomaterials show much 
lower melting points and sintering temperatures and they exhibit different catalytic properties 
and thermal stabilities due to the large fractions of surface atoms and surface energy. The 
mechanical strength of nanomaterials is normally higher than their bulk counterparts which 
occurs because of the reduction of crystal defects.25 Therefore, nanoscale materials exhibit 
unique optical, electrical, photonic and catalytic properties and as a result they are ideal for use 
in various applications in nanotechnology.26 
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1.2. Semiconductor Nanoparticles 
A nanoparticle (NP) is a cluster of atoms or molecules with three dimensions in nanoscale.  
There are several sub-categories of NP depending on the nature of the material. For instance, 
for crystalline materials this is called a nanocrystal and if the material is a semiconductor with 
three nanoscale dimensions, where the dimensions are of a similar magnitude to the exciton 
Bohr radius of the material, this is called a quantum dot (QD).2  
Semiconductor NPs or QDs are of particular interest to the scientific community due to their 
unique optical, electronic and physical properties which are size dependent. Depending on the 
material, the size range could be between 2 to 20 nm. In addition to the large surface area to 
volume ratio and the dominant role of the surface, there is another factor responsible for these 
unique properties and that is the well-known quantum confinement effect.27, 28 This has given 
rise to many potential applications such as optical, electronics, catalysis, and optoelectronics. 
Therefore by selecting the appropriate synthesis method used to produce QDs it is possible to 
obtain particles with the desired size, which is the dominant factor determining the underling 
material properties.29-31  
 
1.2.1. Quantum Confinement Effect 
The size dependent property of QDs is generally described as the quantum confinement 
effect, which is considered to be their most significant characteristic feature.32 This effect is 
essentially as a result of direct influence of the ultra-small length-scale on the energy band 
structure. The term "confinement" refers to the motion of electrons moving randomly as this 
path is restricted in specific energy levels and the word "quantum" refers to the atomic 
dominion of particles. A simple explanation of this effect uses a model called "The electron in 
the box" or "potential well".33 Based on this, the reduction of the size of the box in three 
dimensions gives rise to discrete energy levels instead of a continues band as in bulk materials. 
As the particle size decreases, the energy gap between the valence and conduction bands 
increases (Figure 1.4).34, 35 
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Figure 1.4. Schematic of energy diagrams illustrating the difference between the energy electronic   
states of bulk semiconductor, semiconductor QDs and molecules, reproduced from O’Farrell et al.27 
 
This phenomenon can be discussed by the relationship between the position and energy of 
an electron in both free and confined space. In a bulk semiconductor, the energy or crystal 
momentum of an electron can be precisely defined whereas the position cannot be defined. 
However, in a semiconductor NP, as we decrease the size of the particle, we increase the 
certainty of where the electrons are while the momentum is no longer well defined. In the bulk 
semiconductor, series of nearby transitions occur with slightly different energies while in the 
QD the transitions are compressed into a single and intense transition as a result of the quantum 
confinement. This therefore causes discrete absorption bands and fluorescence in terms of the 
optical properties of QDs.34 The electron-hole pair produced as a result of the absorption of a 
photon, is then delocalised over the interior of the NP and then recombination of the electron 
and hole leads to the emission of a photon which caused fluorescence. This is only efficient 
when the size of the QD is smaller than the exciton Bohr radius.36 
 
1.3. Silicon Nanoparticles 
Among the different types of semiconductor NPs, silicon is a well-known semiconductor 
material and is of particular interest. SiNPs are heavy metal free in nature and exhibit visible 
photoluminescence as a result of the quantum confinement effect.37-40 The size tuneable 
emission,41-43 high brightness44 and high photostability compared to organic dyes,45 have made 
SiNPs attractive materials as fluorescent cellular markers. In addition, silicon is abundant and 
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economical46 but more importantly silicon has low inherent toxicity which conveniently leads 
to several applications in the biomedical field. Studies report silicon to be almost ten times 
safer than cadmium-based counterparts for use in biomedical and bioimaging applications.47 
Unlike other semiconductors, silicon has an indirect band gap that provides significant optical 
properties due to their very small size (about 4 nm), which is close to the bulk Bohr radius.43, 
48  
The silicon atom that exists on the surface of SiNPs has a different geometry than the bulk 
lattice structure, due to surface reconstruction. This influences the properties of NPs 
particularly those with very small size down to 1-2 nm.49 The surface termination can also 
impact the photophysical properties of NPs significantly. Considering the monohydride 
termination, each surface atom has three Si-Si “back-bonds” and one Si-H bond which provides 
a different set of bonding constrains compared to dihydride termination.50, 51 SiNPs can 
therefore be functionalised with different groups which can change the chemical and electronic 
properties, tailored for specific applications. 
 
1.3.1 Synthetic Strategies for Silicon Nanoparticles 
Strategies to synthesise SiNPs, utilising different apparatus and chemical compositions, 
have advanced significantly during the past 50 years. Through repeated experimentation, two 
important factors have been understood to control key properties of SiNPs: particle size and 
surface functionalisation. Both of these can be modified by number of different synthetic 
strategic methods and preparative conditions applied in the synthesis approach. Several reports 
(detailed in the following sections) have focussed on developing synthetic strategies to produce 
stable SiNPs along the lines suggested in the synthesis of SiNPs by Health et al. in 1992.52 This 
study reported a liquid solution phase techniques for the production of micrometre and 
submicrometre-sized silicon crystals. The synthesis was based on a reduction of SiCl4 and 
RSiCl3 in a nonpolar organic solvent.  
There are numerous synthesis methods for producing silicon nanocrystals featuring desired 
characteristics, and are described as either ‘top down’ or ‘bottom up’ techniques. Top down 
techniques are based on the bulk reduction of silicon which produces very small structures 
from larger material pieces. SiNPs are produced by this method from crystalline silicon by 
applying an etching procedure to reduce the size of bulk silicon to nanometre sized particles. 
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These physical processes generally produce limited yields of pure products but can remove 
contaminants originating from by-products. Using bottom up techniques on the other hand, 
SiNPs can be constructed by assembly methods; atom by atom, one silicon atom at a time. Self-
assembly is one way of achieving this whereby the atoms of molecules arrange themselves into 
a structure as a result of their specific natural properties. Chemical synthesis of large molecules 
provides an example of self-assembly. Chemical routes tend to scale up the yields and complete 
further functionalisation of the surface synchronously, however, they are plagued by impure 
products.53 Another bottom up approach is to use tools to move each atom or molecule 
individually as a positional assembly, however, this method is currently laborious and not 
suitable for industrial applications despite the fact that it offers great control over construction.2 
The synthesised SiNPs are initially either hydrogen or halogen terminated and thus require 
further surface passivation in order to prevent oxidation on the surface. This is crucial because 
oxidation can alter the optical properties of SiNPs as well as increase toxicity levels in 
biological environments.54, 55 All of these methods have advantages and disadvantages relating 
to the surface chemistry, monodispersity, shape, stability and optical properties on SiNPs.  
 
1.3.1.1. Top Down Methods 
1.3.1.1.1. Electrochemical Etching 
For the first time Canham et al. reported that porous silicon can show photoluminescence at 
room temperature in 1990.56 They produced mesoporous silicon layers with high porosity and 
visible red luminescence using the electrochemical and chemical dissolution techniques. 
Perhaps the most reliable way to produce hydrogen terminated SiNPs is electrochemical 
etching.57 This produces SiNPs by breaking up the porous silicon. Utilising the HF in this 
synthesis method produces a hydrogen terminated surface with very low levels of oxide. Porous 
silicon can be produced first via electrochemical etching and followed by a fracturing process 
in a dry solvent, producing hydrogen terminated SiNPs. This method was originally reported 
by Heinrich et al. in 1992.58 They reported the synthesis of porous silicon by electrochemically 
etching of n-type or p-type silicon wafers. This was achieved by soaking in a (1:1) solution of 
HF:EtOH using an electrical potential. This approach was later followed by ultra-sonication of 
the material to remove the nanostructured silicon from the surface of the wafer. The resultant 
SiNPs were polydispersed with irregular shapes and showed a visible red luminescence. This 
method was later optimised by Bley et al. in 1996; the sensitivity of the synthesis method was 
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studied by his research group by investigating factors including the current density, etching 
time, sonication time and more importantly the effect of HF on the synthesis. They reported 
how the optical and physical properties of SiNPs can be affected by these parameters.59 In 1999 
Wolkin et al. produced SiNPs by electrochemical etching followed by photo-assisted stain 
etching of p-type Si wafers.60 Using this method they showed that the photoluminescence of 
these SiNPs can be tuned from near infrared to ultraviolet by changing the size of NPs. 
Belomoin et al. in 2002 showed that further optimisation of the photoluminescence can be 
achieved through an improved control on the size of SiNPs. In this study, they optimised the 
current density and the etching time to obtain SiNPs with different diameters (1.0, 1.67, 2.15 
and 2.9 nm) resulting in different colours of luminescence (ultra-bright blue, green, yellow and 
red) for each specific size.61 An improved optimisation of this method was reported by Lie et 
al. in 2002 and Chao et al. in 2007 showing that a low etching time with high current density 
can produce SiNPs in a range of 2 to 10 nm.62-64 This was done by using a 1:1 mixture of 48% 
aqueous HF and ethanol acting as etching solution and a current density of 210–550 mAcm-2 
which passed through a silicon wafer in a PTFE cell. The silicon wafers needed to be dry in 
vacuo and later the ultrasonication in a dry solvent produced hydrogen terminated SiNPs. 
According to this well-established procedure, many factors including electrolyte 
composition, silicon dopant type, dopant concentration and etching time may adversely affect 
the surface morphology and properties of the PSi thin film.65 The role of EtOH is used to 
prevent bubbles, which occur during the etching process, from splitting and also to overcome 
the strong hydrophobic nature of the silicon surface to ensure that pores continue propagating 
on the surface.66 As a result, more uniform hydrogen-terminated SiNPs can be generated. 
  
1.3.1.1.2. Reactive Sputtering 
In 1998 Furukawa et al. reported the use of a reactive sputtering technique to synthesise 
hydrogen terminate SiNPs. In this method they used a low substrate temperature of 
approximately 100K and produced SiNPs with a wide optical band gap up to 2.4 eV.67 
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1.3.1.1.3. Annealing of SiO Powders 
In 2005 Liu et al. showed a new method which involves annealing SiO powders at 
approximately 700K under ambient conditions. The annealed powder was later etched with 
10% HF and the resulting particles were functionalised via hydrosilylation. Although this 
method is economical, the synthesised SiNPs were rather polydisperse and showed significant 
amount of oxide on the surface.68  
 
1.3.1.1.4. Ball Milling 
High energy ball milling is a mechanical technique which is straightforward and industrially 
scalable.69 Using this method, silicon particles can be ground down into smaller particles. The 
size of synthesised nanoparticles produced is rather large in a range of 40 to 800 nm. Therefore, 
these particles do not show the properties which are normally associated with quantum 
confinement effects such as photoluminescence. In 2000, Lam et al. produced SiNPs with 
dimensions of about 5 nm by pure mechanical attrition of solid graphite with SiO2 in a planetary 
ball miller for 7–10 days followed by annealing at 150 oC. The resulting NPs were capped with 
an amorphous oxide layer of silicon about 1 nm in thickness and featured a multi-peak PL 
spectrum, due to the broad range of particle sizes. Besides the wide size distribution, 
aggregation was also a serious issue because this led to a complex and uneven shape. As a 
result of these drawbacks, ball milling methods are rarely used in place of other physical 
synthetic strategies, despite its convenience and inexpensive nature.70 
In 2007 Heinz et al. showed the synthesis of alkyl-capped SiNPs by this method which 
exhibited quantum size effects.71 The obtained crystalline SiNPs showed a PL at 450 nm. 
Nevertheless, the functionalisation was carried out via oxygen atoms. Therefore, this would 
affect their optical properties and long term stability for further application. 
 
1.3.1.1.5. Laser Ablation 
In 2001, Hata et al. reported the use of a self-assembled monolayer of hexanethiol on 
epitaxial Au (111) surfaces to deposit SiNPs by laser ablation. According to the data obtained 
from SEM and AFM observations and PL measurements, SiNPs had a round shape structure 
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and remained stable for at least a couple of months. They found control over the NP size could 
be obtained by changing the argon ambient pressure.72 
In 2008, Umezu et al. demonstrated the use of laser ablation to synthesise SiNPs. The 
synthesis was performed by pulsing a laser on a Si single crystal under an inert atmosphere. 
The crystallinity of particles was shown to be improved by increasing the pressure of inert 
gas.73  
A year later Shiharata et al. demonstrated the one-pot synthesis of a silicon wafer by the 
same method using 1-octene to functionalise the resultant SiNPs and produce octyl-teriminated 
SiNPs. The diameter of the particles was between 1 to 10 nm and the maximum PL emission 
was centred at 375 nm.74 
Many researchers prefer to use laser ablation to prepare SiNPs since the particle size is easily 
adjusted by controlling experimental parameters without requiring additional chemicals. It is 
straightforward and clean as it is carried out on a bare silicon wafer or immersed in water or 
polar solvents. However, low production efficiency in this method cannot be ignored. 
 
1.3.1.2. Bottom Up Methods 
1.3.1.2.1. Solution Synthesis and Micelle Reduction 
Another synthesis method which is chemical based is micelle reduction. This method uses 
a reducing agent such as LiAlH4 or Mg2Si for the reduction of silicon based micelles 
(anhydrous compounds e.g. SiX4; X = Cl, Br or I). This technique gives more control over the 
size of the synthesised SiNPs to obtain a narrow size distribution. In 1999 Wilcoxon et al. 
introduced the synthesis of hydrogen terminated SiNPs which retained their crystallite 
structures down to 4 nm and had a PL in the range of 700–350 nm.75 This synthesis method 
was later optimised to functionalise the surface and introduce Si-C mainly via hydrosilylation.76  
Another type of product which can be obtained by micelle reduction is halide-terminated 
SiNPs with the use of non-hydride reducing. This field was established by the Kauzlarich et al. 
group in 1996.77-80 They used various reducing agents such as Mg2Si, KSi and sodium 
naphthalide to reduce micelles of SiCl4 in 1, 2-dimethoxyethane and produce chloride-
terminated SiNPs. This type of NPs can be used as a reactive template for further 
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functionalization. For example, they can undergo nucleophillic substitutions with reagents such 
as primary alcohols and organometallic nucleophiles. 
Amine-functionalised SiNPs have been synthesised using micelle reduction by several 
different research groups. In 2009, Rosso-Vasic et al. produced biocompatible NPs which were 
used for bioimaging in BV2 cells and were quite stable in a range of different pH values and 
high temperatures up to 120 oC.81 Wang et al. reported another recent method with facile 
conditions in 2013.82 This involved using sodium ascorbate as a reducing agent to reduce 3-
aminopropyl trimethoxysilane (APTES) in water at ambient conditions to obtain water soluble 
amine-functionalised SiNPs which had an average diameter of 1.5 nm. 
 
1.3.1.2.2. Thermolysis and Pyrolysis  
A synthesis method involving the decomposition of salines was introduced by Littau et al. 
in 1993 in which they used a high temperature aerosol apparatus to produce small size surface-
oxidised SiNPs. These particles were prepared by homogeneous gas-phase nucleation 
following pyrolysis of dilute disilane in helium. They showed a red photoluminescence and 
had a crystalline silicon core with 1.2 nm silicon oxide sell around.83 
A year later Fojtil et al. reported a similar synthesis method which was followed by etching 
the particles in acyclohexane/propan-2-ol suspension with HF. They showed the effect of the 
solvent polarity on the PL of the particles, since the polar solvents such as alcohol and 
chloroform partially quenched the PL of the nanoparticle suspension, whereas they did not 
observed the quenching effect with non-polar solvents such as CCl4.
84 
Another method for the synthesis of SiNPs involves the decomposition of a liquid precursor 
and high temperatures (500 oC), which was reported by Korgl et al. in 2001.85 They 
demonstrated the decomposition of diphenylsilane using the thermal decomposition to produce 
SiNPs. Even though the size control was achieved using this technique, the susceptibility of 
the particle surface to react with solvent borne impurities was considered as a drawback of 
using the liquid precursor.  
The decomposition of both liquid and gas precursors is an attractive method to prepare 
SiNPs. However the decomposition of gas phase precursors has been more successful.86 One 
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of the major drawbacks of using liquid precursors is their high decomposition temperature and 
the possibility of the particle surface to react with other solvent impurities. 
In 2003 Li et al. reported the synthesis of SiNPs using a CO2 laser-induced decomposition 
of silane as a gaseous precursor molecule.87 Large quantities of nanoparticles were produced 
via this method with an average diameter of 5 nm. The PL emission was later established by 
using HNO3 leading to chemical oxidation. Later, Swihart et al. modified this method to control 
the size of NPs.87 They reported that the flow rates and the laser power can affect the size of 
NPs. This size was further optimised by etching with HF/HNO3 in water to produce smaller 
size particles. However, the resultant particles showed some degree of surface oxidation a non-
homogeneous surface; thus, the PL was not stable. To remedy this drawback, SiNPs were 
further etched with 5% HF and thermally hydrosilylated with a series of alkyl- and ester-
termination which resulted in a much more stable PL for particles.88 
Solid precursors have also been reported to be used for the decomposition to prepare SiNPs 
by Belomoin et al. in 2002.89 Nanoparticles can be synthesised from the pyrolytic 
decomposition of hydrogen silsesquioxane or other silicon rich oxides by heating at 1000 oC 
in an atmosphere containing 5% H2 and 95% N2. Afterward, HF etching must be undertaken to 
remove silicon oxide.89, 90 
 
1.3.2. Strengths and Weaknesses 
To summarise, size control of SiNPs prepared by physical methods is simple without 
requiring the use of chemical reagents. However, it cannot trivially realise scalable production 
and the obtained NPs require further modification to become stabilised. Using chemical 
procedures, on the other hand, allows simultaneous control under mild conditions of the 
synthesis, surface modification as well as the NP diameter. Nevertheless, contamination of 
residual by-products, such as the reducing agents, can be a complicating factor.  
Porous silicon, produced by the electrochemical procedure under certain conditions, is 
always regarded as the primary material for SiNPs.91 However, the lack of capability to control 
particle size, shape and size distribution is a noticeable drawback of etching, which needs a 
further separation process. 
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1.3.3. Functionalisation of Silicon Nanoparticles 
Hydrogen terminated SiNPs or halogen terminated SiNPs are highly reactive and therefore 
prone to oxidation under ambient conditions.92 As surface oxides can alter the optical properties 
considerably, these types of nanoparticle require further functionalisation in order to passivate 
the surface, and thus avoid oxidation and agglomeration.  
There are different types of surface functionalisation for SiNPs ranging from alkylation 
reactions by hydrosilylation to radical halogenation. In some cases it is possible to determine 
the surface passivation prior to the particle synthesis by choosing the specific surfactants in 
some micelle reduction methods.   
Hydrosilylation has been known as one of the most common methods of functionalisation 
for hydrogen terminated SiNPs. Due to the specific coordination of surface atoms in SiNPs, 
the covalent Si-C linkage can stabilise the particle surface and avoid oxidation. Hydrosilylation 
can be undertaken on planar or porous silicon surfaces as one of the methods which can add 
C=C bonding to the surface of hydrogen or halogen terminated SiNPs. This Si-C linkage can 
be introduced using different methods such as thermal initiation,62, 93 photo initiation (with 
UV94, or visible light)95, 96 or using a radical initiator (benzoyl peroxide)97 and applying 
different catalysts (EtAlCl2 or H2PtCl6)
76. The resultant NPs will in fact be protected from the 
surrounding environment by the new functional group which provides electronic stabilisation 
of the surface. In addition to the improved stability of nanoparticles, hydrosilylation can also 
alter the solubility of NPs according to polarity of the specific functional group present on the 
surface of the adding ligand.98, 99 One of the other advantages of hydrosilylation is that it does 
not break the Si-Si bond while adding the Si-C on the surface; therefore, the optical properties 
remain unchanged.100  
When using a radical initiator for hydrosilylation, normally a source such as heat or light is 
used to generate radicals for the reaction. This can form a radical site on the silicon surface 
after reacting with the hydrogen. This radical site will then directly react with an alkene and 
this trend will terminate by picking up hydrogen from the neighbouring silicon atom (Scheme 
1.1).101 The thermal hydrosilylation is also assumed to follow a similar mechanism as the 
radical based mechanism. This method normally is done by refluxing for several hours in a 
solvent containing the desired ligand and hydrogen terminated SiNPs.62, 63, 78 
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Scheme 1.1. Mechanism of radical-based hydrosilylation.101 
 
 
Another type of hydrosilylation uses the metal catalysis (e.g. H2PtCl6 (Speier’s catalysts)) 
to functionalises SiNPs.102 The proposed mechanism in this case is known to be the Chalk- 
Harrod mechanism and is shown in Scheme 1.2.103 The mechanism can be divided into two 
steps. First, the oxidative addition of a hydrosilane gives a hydridosilyl complex which is 
coordinated with the functional ligand. This complex then undergoes migratory insertion of the 
ligand into the Pt-H bond (hydrometallation) to give a new species. Reductive elimination of 
this species at the end will form the final hydrosilylation product.  
 
 
Scheme 1.2. Metal complex catalysed hydrosilylation of SiNPs using Speier’s catalysts. 
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1.4. Biomedical Applications of Semiconductor Quantum Dots 
Semiconductor QDs exhibit unique optical and electronic properties such as high quantum 
yield, size dependent and tuneable fluorescence emission42, 43, 89 and stability against 
photobleaching as well as against chemical degradation.45, 76 These NPs have been investigated 
for various biomedical applications not only because of their unique optical properties but also 
owing to their dimensional similarities with biological macromolecules such as proteins and 
nucleic acids.27, 104 These characteristics allow them to be used for bioimaging applications as 
well as drug delivery detection systems. They have several advantages over their organic 
counterparts in the field of bioimaging. First of all they possess very narrow emission spectra 
which decreases the chance of spectral overlap and thus increases the possibility of 
distinguishing multiple fluorophores simultaneously. Moreover, QDs show a very broad 
excitation spectra which enables the use of single excitation wavelength to excite QDs with 
different colours.27 In addition, there is large separation between the excitation and emission 
wavelength of QDs (the Stokes’ shift) which allows the whole emission spectra to be 
collected.105 QDs are also brighter than the conventional dyes due to their larger extinction 
coefficients.106 They are also more stable to photobleaching for several hours, allowing the 
collection of images with high contrast and is useful for 3D imaging too where bleaching of 
fluorophores during the acquisition of successive z-sections is problematic.106 
Until now, various types of fluorescent QDs with elements of groups II–IV such as CdSe 
and CdS (with tuneable wavelength emission) have been used as biological probes. However, 
the use of these materials for biological applications is challenging due to their toxicity. Thus, 
less toxic or non-toxic materials such as silicon can be suitable candidates to replace cadmium 
based QDs for biomedical applications.107  
 Silicon has been considered as an extremely biocompatible material due to its low level 
toxicity. Their applications in drug delivery, cancer cell diagnostics and therapeutics are active 
fields and of considerable attention of research over recent years.106, 108, 109  
 
1.4.1. Cytotoxicity 
Toxicity is a critical factor to consider when evaluating the use of nanomaterials for 
biomedical purposes, especially in vivo applications, and as such research into nanotoxicology 
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is gaining more attention. Exposure to NPs for medical purposes involves intentional contact 
or administration; thus understanding the properties of nanoparticles and their effect on the 
body is crucial before any clinical trials or use can occur. 
Cytotoxicity is known to be dependent on a number of factors such as the particle size, 
capping ligand, shape, surface charge and chemistry, dose of NPs, coating bioactivity and 
processing parameters.110 Even if NPs do not induce significant alterations in cell physiology, 
they can produce subtle alterations of function which may affect the quality of data derived 
from their use. Free radical formation, and interaction of QDs with intracellular components 
are considered as some of the potential mechanisms responsible for NP cytotoxicity.111, 112 If 
NPs show aggregation or morphological variations in the biological media, this can affect the 
overall cytotoxicity and therefore it is important to check the stability of NPs in biological 
environments by assessing different parameters such as the hydrodynamic size and the zeta 
potential of NPs. In this regard, Lin et al. investigated the aggregation state in the cell culture 
media. They studied NPs with two different sizes (15 nm and 46 nm) and observed no 
difference in terms of the cytotoxic behaviour due to the fact that both NPs reached a similar 
size after aggregation in the culture medium.113  
Surface charge is one of the factors which plays a significant role in cytotoxicity. Cationic 
surfaces have shown to be more cytotoxic than anionic and neutral surfaces.114 This could be 
because of the affinity of cationic NPs to the cellular membrane which is negatively charged. 
Thus, adding a coating to render the surface charge of NPs can greatly affect their toxicity. In 
addition, the cytotoxicity of NPs is also cell dependent as the conditions of each cell line can 
be completely different and they can show different interactions with nanomaterials.115           
Therefore, it is crucial to determine the cytotoxicity of each type of NPs for the various 
potential environments that they may be exposed to before taking any step further towards their 
actual applications.  
One simple cytotoxicity test involves visual inspection of the cells with bright-field 
microscopy for changes in cellular or nuclear morphology before and after the treatment with 
NPs.116 Fiorito et al. used this technique to evaluate the cytotoxicity of single-walled carbon 
nanotubes.117 However, the majority of cytotoxicity assays used in this field measure cell death 
using colorimetric techniques. These colorimetric methods can be further categorised into 
assays that measure mitochondrial activity and plasma membrane integrity.116 MTT (3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay is considered as one of the most 
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widely used methods which measures the activity of the mitochondrial dehydrogenase 
enzyme.118 This enzyme cleaves the tetrazolium ring, which only occurs in living cells.119 MTT 
salt is pale yellow in solution but produces an insoluble purple formazan product within live 
cells. Another common method is Trypan blue dye exclusion assay which provides information 
of cell death by showing dye staining on ruptured cells, whilst live cells remain colourless. The 
amount of cell death can be determined via light microscopy.120 
One potential cause of NP toxicity is the occurrence of internal heavy metals (such as Cd 
and Se) which can gradually leak in the biological environments.121 As the toxicity of heavy 
metal ions are known, the release rate and environmental conditions can being measured. 
Kondoh et al. reported that Cd induces apoptosis in HL-60 cells via caspase-9 activation.122 
Furthermore, Shen et al. found sodium-selenite induced oxidative stress and apoptosis in 
HepG2 cells.123 These findings confirmed the toxicity of both bulk cadmium and selenium in 
vitro. In another work, Derfus et al. published data regarding the toxicity of CdSe NPs in 
hepatocytes as a liver model.124 They further suggested functionalisation of these QDs with 
mercaptoacetic acid (MAA) which can make them water soluble and remove cytotoxic 
effects.125  In addition, the cellular viability decreased when NPs were initially subjected into 
air and then functionalised with mercaptoacetic acid which was dose dependent. These findings 
indicated that oxygen in the air induced the CdSe NPs oxidisation and the consequential release 
of Cd2+ ions which induce cytotoxicity in cells. Cd-induced hepatotoxicity can be explained 
either by direct or indirect cytotoxic pathways. The direct pathway occurs when Cd2+ binds to 
sulfhydryl groups on the mitochondrial molecules, leading to damage of the mitochondria. The 
indirect pathway, on the other hand, is assumed to occur via activation of Kupffer cells.126  
Although, there has been significant breakthroughs published on the cytotoxicity of group 
II–VI semiconductor NPs, research into the cytotoxicity of SiNPs has not progressed as far. 
Chin et al. investigated the effect of porous silicon on primary hepatocytes under various 
culture conditions.127 The viability of cells in all conditions and in the long-term was 
considerable suggesting no obvious cytotoxicity from porous silicon on cells.  
NPs used for imaging and drug delivery applications are often purposely coated with 
bioconjugates such as DNA, proteins, and antibodies to target specific cells. Despite the fact 
much of the function of NPs is due to their core structure, the surface coating defines much of 
their activity in the biological environments.116 For many types of NPs to be more effective in 
biological applications, the addition of some type of surface coating is required. This coating 
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can alter the potential toxicity of the whole system. Since these NPs are intentionally designed 
to interact with cells, it is vital to ensure that these enhancements are not causing any adverse 
effects. More specifically, information should be obtained about whether naked or 
functionalised NPs will undergo any biodegradation in the cellular environment and what 
cellular responses those degraded NPs might induce. For instance, biodegraded NPs may 
accumulate within cells and lead to intracellular changes such as disruption of organelle 
integrity or gene alterations.116  
Several in vitro and in vivo studies have demonstrated the low level of toxicity for SiNPs.128-
130 The main factors affecting the toxicity of SiNPs are surface ligands and the NP diameter. 
The surface functionality of SiNPs on lung and skin cell viability was investigated by Shiohara 
et al.131 They reported that highly reactive surface groups, like epoxides, were twice as toxic 
to lung epithelial cells compared with amine or diol surface groups due to the epoxide’s ability 
to cause oxidative stress within the cell. In addition, smaller SiNPs (1.6 nm) have been found 
to be more toxic than larger NPs (3.9 nm) due to an increased surface area per unit volume.55 
Alsharif et al. examined the cytotoxicity of alkyl-capped SiNPs and the intracellular 
internalisation in human neoplastic and normal primary cells. No clear evidence of cytotoxicity 
was observed in vitro based on their data.132 Poly acrylic acid and amine coatings on SiNPs are 
other examples of functionalisation which have been also shown to have not any serious 
cytotoxic effect up to 200 μg/mL NPs in HepG2 cells.99, 133 However, this reported data could 
be time and cell line dependent. Therefore, the nature of the functionalised group can strongly 
determine the cytotoxic behaviour. 
In vivo toxicity studies by Swihart et al. performed on two animal models of mice and 
monkeys, showed that a large dose of SiNPs of up to 200 mg/kg had no adverse effects in terms 
of blood chemistry, behaviour, and weight.128 However, pathology work did show a difference 
between the two animal models, with mice showing adverse effects in the liver.  
In order to understand the excretion pathway of SiNPs, Tu et al. carried out in vivo positron 
emission tomogorpahy (PET) studies on mice.129 The data showed that SiNPs are largely 
removed via renal filtration within minutes to hours after injection, with a very small population 
residing within the liver for up to several weeks.  
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1.4.2. Biomedical Applications of Silicon Nanoparticles 
Bioimaging applications require nanomaterials with good biocompatibility, low cytotoxicity 
and stable photoluminescence emission.134 The stability plays a key role for biomedical 
applications, and this could be achieved by improving the solubility in water and biological 
environment in order to avoid the aggregation.76 Aggregation and precipitation of NPs can 
interrupt the cell internalisation and also cause cytotoxicity. Moreover, labelling NPs with 
targeting molecules not only can lead the particles to specific cells for specific purposes but 
also can make them more hydrophilic and stable and therefore this functionalisation for specific 
biomedical applications has high utility.76  
In 2002, Perez et al. synthesised nanometric particles from porous silicon film to investigate 
the growth behaviour of B. subtilis and K. pneumoniae bacterial strains.135 The different 
behaviour that each bacterium presents (grown in a medium containing SiNPs) suggests the 
idea that these particles can be used as a bacteriological sensor. 
Fluorescent SiNPs are regarded as an ideal biological probe due to their low toxicity, 
substantial quantum yields and photostability.136 However, most surface ligands of SiNPs (e.g. 
styrene, alkyl, and octene) are hydrophobic, resulting in poor dispersibility in aqueous media 
and thus have limited bioapplications as a result. Tremendous effort has been made to address 
this issue. For example, in 2004, Ruckenstein et al. reported the use of red emitting poly (acrylic 
acid) SiNPs to image CHO cells.96 These NPs showed strong luminescence after 24 h exposure 
to UV light whereas a series of organic dyes lost emission after 20 min exposure. Swihart et 
al. also showed that red emitting SiNPs encapsulated within PEG phospholipid micelles could 
be used for imaging applications in panc-1 cells.137 The photoluminescence from these NPs 
was still visible after 2 month and showed good pH stability.  
The first use of blue emission for the imaging of HeLa cells was reported by Yamamoto et 
al. in 2005.76 Blue emitting SiNPs had strong luminescence after 60 min of UV exposure 
compared to the organic dye which significantly decreased in luminescence over the same time 
period. Confocal images confirmed that blue emitting SiNPs retained their fluorescence in 
MCF-7 cells after a 24 h incubation, showing that they are suitable candidates for longer term 
biological fluorescence imaging.138 
In 2010, Prasad at al. showed the in vivo multi-colour imaging of SiNPs conjugate to a 
protein in mice models with emission ranging from red to NIR.139 They also developed a class 
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of red and blue emitting SiNPs conjugated to proteins that allowed immunofluorescent cell 
imaging of HeLa cells.  
 
1.5. Thiourea as an Epidermal Growth Factor Receptor Inhibitor 
1.5.1. EGFR and Its Inhibition in Cancer Therapy 
Receptor protein tyrosine kinases play a crucial role in signal transduction pathways which 
control cell division and differentiation. These receptors exist as inactive monomers which can 
be dimerised upon binding to their specific extracellular growth factors. After the ligand 
binding, the tyrosine kinase intercellular domain of the receptor is activated leading to the 
autophosphorylation of the intracellular domain. This initiates a cascade of downstream 
signalling events.140 Many of the growth factor receptor proteins have intracellular domains 
that function as tyrosine kinases, and thus can effect signalling. The interaction between growth 
factors and these receptors is a necessary event in normal regulation of cell growth. However, 
under certain conditions, as a result of overexpression or mutation of the ligand and the 
receptor, these receptors can become hyper-activated leading to the uncontrolled cell 
proliferation.141  
Among various growth factor receptor kinases that have been identified as being important 
in cancer is the epidermal growth factor receptor (EGFR) kinase, also known as erb-B1 or 
HER-1. It was discovered by Stanley Cohen from Vanderbilt University, for which he received 
the 1986 Nobel Prize in Medicine, shared with Rita Levi-Montalcini for their discovery of 
growth factors.142, 143 EGFR signalling is important for cell proliferation. It also contributes to 
multiple processes involve in cancer progression such as angiogenesis, metastatic spread, and 
the inhibition of apoptosis.144, 145 EGFR overexpression has been reported in a wide variety of 
solid human cancers, including lung, colorectal carcinomas, breast, gastric, bladder, ovarian, 
prostate, head and neck and glioblastomas in which it is generally associated with advanced 
disease and poor prognosis.146-148 Over-expression of EGFR has also been linked to other 
factors such as hormonal therapy, cytotoxic agents and radiotherapy.148-151 
The critical role of the EGFR in cancer growth has led to an extensive search to find and 
synthesise potential compounds to inhibit the EGFR signalling pathway; successful targeting 
the EGFR could represent a significant contribution to cancer therapy. A variety of different 
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methods are currently being used to target the EGFR. Some of the most promising approaches 
include monoclonal antibodies in order to prevent the ligand binding and also small molecule 
inhibitors of the tyrosine kinase enzymatic activity to inhibit autophosphorylation and 
downstream intracellular signalling. However, the therapeutic efficiency of the existing 
inhibitors is limited. Hence, identifying new molecules which can through novel strategies 
inhibit the EGFR, as a prime target for cancer therapy, is an exciting avenue in the development 
of targeted cancer therapy research.152 
Zeneca Pharmaceuticals has reported the discovery and optimisation of novel quinazoline-
based compounds as anticancer agents.153, 154 Anilinoquinazoline is a synthetic molecule with 
low-molecular weight which effectively inhibited EGFR tyrosine kinase in vitro and also 
inhibited the growth of EGF-stimulated KB oral carcinoma cells. Further experiments showed 
inhibition of autophosphorylation of EGFR in a number of tumour cell lines such as A549 
(lung), DU145 (prostate) and HT29 (colorectal).155, 156 
Other EGFR inhibitors have been reported by Pfizer which are also a quinazoline 
derivative.157 This compound showed behaviour that inhibits EGFR tyrosine kinase and also 
autophosphorylation in DiFi human colon tumour cell line. The inhibitor has indicated 
selectivity for EGFR, as opposed to other tyrosine kinases studied. The compound can block 
the cell cycle in phase G1 with significant accumulations of underphosphorylated 
retinoblastoma protein and the cell cycle inhibitor p27KIP1. This compound has also showed 
activity against various human tumour xenografts in vivo.158  
An antibody (C225) inhibiting the binding of ligand to EGFR has been shown to 
significantly inhibit the growth of A431 vulval carcinoma xenografts.159 It also inhibited EGF-
induced receptor activation in prostate carcinoma cells and alone or in conjunction with 
doxorubicin, inhibited progression of DU145 and PC-3 prostate carcinoma xenografts.160  
One interesting development has been the conjugation of recombinant human EGF to 
genistein, a soybean-derived tyrosine kinase inhibitor, giving an EGFR-targeted cytotoxic 
agent with tyrosine kinase inhibitory activity. This new conjugated compound was 100-fold 
more potent with EGFR inhibitory activity than unconjugated genistein. This agent initiated 
rapid apoptosis in MDAMB-231 and BT-20 breast cancer cells at nanomolar concentrations.161  
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1.5.2. EGFR Overexpression in Colorectal Cancer  
The role of EGFR has been most thoroughly studied in breast cancer, where it is 
overexpressed in approximately 25–30% of cases and is associated with a poor prognosis.142 
However, the enhanced activity of EGFR has been found to be associated with tumour 
progression in several other malignancies including colon. It has been shown that the 
overexpression of EGFR in colon cancer may be correlated to an advanced stage of the disease 
or might be a sign of a potential metastatic risk.162, 163 However, the influence of EGFR 
expression on survival is controversial and it is not uniformly related to an unfavourable 
prognosis. According to immunohistochemical methods, used for the detection of EGFR in 
colorectal cancer, the EGFR overexpression ranges from 25% to 82%163-167 and this level of 
expression in colorectal cancer tissue is higher than in surrounding mucosa.163, 164, 168 In primary 
cultures of human colorectal carcinomas, EGFR overexpression has also been observed during 
the tumour progression suggesting an increased sensitivity of colon cancer cells to a mitogenic 
stimulation.169 
 
1.5.3. EGFR Signalling Pathways 
The HER/ERBB family consists of four transmembrane receptors, including EGFR 
(HER1/erbB-1), HER2 (erbB-2/neu), HER3 (erbB-3) and HER4 (erbB-4). The EGFR 
(HER1/erbB-1) is a protein comprising three major functional domains: an extracellular ligand-
binding domain, a short hydrophobic transmembrane domain and an intracellular tyrosine 
kinase domain.170  
EGFR signalling is a well-conserved pathway which controls key cellular programmes 
including survival, proliferation and differentiation both during development and 
postnatally.171 The enactment of these diverse cellular programmes requires that receptor 
signals with adequate strength and duration are generated to produce responses that are either 
binary, such as cell proliferation, or graded such as cell motility.164 
Under physiological conditions, specific soluble ligands selectively bind to the extracellular 
domains of EGFR. Seven genetically distinct ligands have been shown to be capable of binding 
with EGFR including EGF, transforming growth factor-α (TGF-α), heparin-binding EGF, 
amphiregulin, betacellulin, epiregulin and neuregulin G2b.170, 172 The ligand binding to the 
receptor induces a conformational change of the receptor ectodomain that is followed by 
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receptor dimerisation as a homodimer or as a heterodimer (with other members). EGFR 
dimerisation stimulates its intrinsic intracellular protein-tyrosine kinase activity. As a result, 
autophosphorylation of several tyrosine residues within the COOH-terminal tail of the 
receptors occurs in the cytoplasm.173, 174 The autophosphorylation stimulates downstream 
activation and signalling by several other cytoplasmic proteins that associate with the 
phosphorylated tyrosines through their own phosphotyrosine-binding SH2 domains. These 
downstream signalling proteins initiate a cascade of intracellular signalling transduction 
pathways which lead to DNA synthesis and cell proliferation. The specificity and potency of 
each intracellular signalling cascades are determined by several factors: 
 The specific composition of the activating ligand 
 Expression of positive and negative regulators 
 Receptor dimer constituents 
 Array of proteins that associate with the tyrosine phosphorylated domain of the 
receptors 
 
1.5.3.1. Ras/Raf/mitogen-activated Protein Kinase Pathway 
This pathway is a critically important route which regulates cell proliferation and survival. 
Following EGFR phosphorylation, the complex formed by proteins Grb2 and Sos binds either 
directly or through association with the adaptor molecule Shc to specific docking sites on the 
receptor (Figure 1.5).175 This interaction leads to a conformational modification of Sos which 
causes Ras activation (Ras-GDP changes to Ras-GTP). Ras-GTP activates Raf-1 that 
phosphorylates the mitogen-activated protein kinases (MAPK).176 Activated MAPKs are 
imported into the nucleus where they phosphorylate specific transcription factors involved in 
cell proliferation.177  
 
1.5.3.2. Phosphatidylinositol 3-kinase Pathway 
This pathway is mainly involved in cell growth, apoptosis resistance, invasion and 
migration. Phosphatidylinositol 3-kinase (PI3K) is an enzyme composed of a p85 subunit 
(regulatory), which is responsible for binding to erbB receptor specific docking sites (Figure 
1.5). The docking sites for p85 are absent on EGFR, whereas on HER-3 receptors they are 
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abundant. Instead, the p85 subunit can interact with EGFR through the docking protein Gab-
1.174, 178  
 
1.5.3.3. Phospholipase Cγ Pathway 
Phospholipase Cγ (PLCγ) interacts directly with activated EGFR and hydrolyses 
phosphatidylinositol 4,5-diphosphate to form inositol 1,3,5-triphosphate (IP3) and 1,2-
diacylglycerol (DAG) as depicted in Figure 1.5. IP3 is important for intracellular calcium 
release and while DAG serves as a direct activator of protein kinase C. Protein kinase C (PKC) 
activation can result in MAPK and NH2-terminal kinase activation.
174 
 
1.5.3.4. Signal Transducers and Activators of the Transcription Pathway 
Signal transducers and activators of transcription (STAT) proteins interact with 
phosphotyrosine docking residues on the EGFR via their SH2 domain. Upon dimerisation, they 
translocate to the nucleus and induce the expression of specific target genes (Figure 1.5).179  
 
1.5.3.5. Src Kinase Pathways  
Src plays a critical role in cell proliferation, migration, adhesion, angiogenesis, and immune 
function.180 Src is located in the cytosol and activates a series of other proteins including PI3K, 
and STAT proteins as shown in Figure 1.5.180 Src serves as a signal transducer and an enhancer 
of EGFR activation.181 However, it may also be involved in resistance to EGFR therapies 
through independent activation or association with other receptors.174  
 
1.5.4. Mechanism of Action of EGFR Inhibitors 
The most clinically advanced approaches to inhibit EGFR include the use of monoclonal 
antibodies which act at the EGFR extracellular ligand-binding site of the receptor, and the use 
of small molecule tyrosine kinase inhibitors (TKIs) which function at the intracellular tyrosine 
kinase domain of the EGFR. TKIs bind to the intracellular domain, which prevents the tyrosine 
kinase activation and phosphorylation by competing for the intracellular ATP-binding sites, 
therefore, this leads to inhibition of EGFR signalling pathways.182 Gefitinib (Iressa) and 
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erlotinib (Tarceva) are some of the well-known ATP-competitive EGFR TKIs.174, 178 In 
addition to these mentioned clinically approved strategies, other approaches suggest using 
antisense oligonucleotides and ribozymes in order to block receptor translation.183 
 
 
Figure 1.5. Schematic representation of major EGFR signalling pathways.178, 184, 185  
 
1.5.5. Thiourea Derivatives as Inhibitors of EGFR 
The cytotoxicity and genotoxicity of anticancer drugs for normal cells are major concerns 
in cancer therapy and increases the risk of inducing secondary malignancy.186 A sufficient dose 
of anticancer drug in order to kill cancer cells is normally toxic to normal tissues and cells and 
leads to several side effects, which limits the efficacy of treatment. In recent years, there has 
been a concerted effort to discover and develop novel selective antitumour agents, in order to 
avoid the undesirable side effects of conventional anticancer compounds. In the search to 
develop drugs with such capabilities, many different aspects of cancer biology have to be taken 
into consideration.  
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Among the anticancer drugs discovered in recent years, thiourea derivatives possess potent 
anticancer properties. Thiourea-based compounds represent one of the most promising classes 
of anticancer agents which have been shown a wide range of biological activities.187 These 
compounds contain a central hydrophilic component and two hydrophobic moieties forming a 
butterfly-like conformation. The presence of the thiocarbonyl functional group may alter the 
properties of the compound exposed to it. For example, the hydrophilicity or hydrophobicity 
as well as electronic properties have the potential to be changed.188 Thiourea derivatives have 
demonstrated potential antitumour activity as a result of their inhibitory activity against 
receptor tyrosine kinases (RTKs), protein tyrosine kinases (PTKs) and nicotinamide adenine 
dinucleotide phosphate hydrogen (NADH) oxidase.142, 189 
 
Scheme 1.3. Chemical structure of thiourea derivatives. 
 
In the past two decades many reports have been published on the synthesis of thiourea 
derivatives and their evaluation as anticancer compounds, mechanism of action as well as the 
structural activity relationships.190, 191 In these reports PTKs such as EGFR have been identified 
as the prime targets of thiourea based chemotherapeutics. Several research groups such as Liu 
and Jiang et al. focused on the antitumour activity of a series of N-substituted-thiourea 
derivatives which acted as EGFR inhibitors.192, 193 They reported on the optimisation of 
anticancer activity through the EGFR role in angiogenesis. Out of the library of forty newly 
synthesised and bioassayed compounds, four compounds with a pyridine ring in the side chain 
showed promising inhibitory activity toward human lung adenocarcinoma cell line SPAC1. 
Two compounds with amine moiety in the side chain showed the most potent tumour anticancer 
activity toward SPAC1. 
Another series of novel N-substituted-N′-phenylthiourea derivative as potential 
antiproliferative agents have also been reported.142 By comparison with positive control 
erlotinib, the compounds showed potent antiproliferative activity for autophosphorylation of 
EGFR. Assays of different synthesized thiourea compounds against MCF-7 revealed that these 
thiourea derivatives exhibit significant antiproliferative activity against MCF-7. The 
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replacement of terminal aryl group with an alkyl group caused a decrease in EGFR inhibitory 
activity, probably due to a less effective interaction of the alkyl group with the hydrophobic 
regions. The molecular docking of the most potent thiourea inhibitors into the ATP binding 
site of EGFR kinase on the binding model was also performed, which demonstrated that 
thiourea compounds bind effectively to the region with the N–H groups toward the side chain 
carbonyl group of Leu 768 (amino acid). From this, the external N–H formed a more optimal 
H-bond interaction, and the hydroxyl group formed a hydrogen bond with amino hydrogen of 
Gln767.142 
Zhu et al. reported the synthesis of novel thiourea derivatives containing the pyrazole moiety 
as potent antiproliferative agents for the MCF-7 cell line.189 Thiourea compounds also 
displayed a similar characteristic against the MCF-7 breast cancer cell line with IC50 values 
ranging from 0.08 to 0.71μM. Additionally, these compounds showed inhibited 
autophosphorylation of EGFR kinases which had IC50 values ranging from 0.07 to 1.36μM. 
This data was comparable to the positive control erlotinib with IC50 of 0.03 μM. 
The important interaction between the thiourea compounds and EGFR can happen through 
the formation of hydrogen bonds between the thiourea and the carbonyl group of amino acids 
in the ATP binding site of EGFR.189, 194 Furthermore, thiourea compounds exhibit several other 
properties such as antiviral,195 antibacterial,187 antimalarial,196 anti-inflammatory197 and 
antifungal (plant growth regulator)198 properties and thus attract great attention in 
pharmaceutical industry. Thiourea derivatives have also attracted the attention of synthetic 
medicinal chemists for developing synthetic methods for the synthesis of these entities with 
enhanced anticancer activity. Therefore, a thorough detailed investigation into the synthesis 
more potent thiourea derivatives with EGFR inhibitory properties, as well as their stability 
under biological conditions, is highly desirable. The importance of such work lies in the 
possibility that the next generation of thiourea compounds might be more efficacious as 
anticancer agents when combined with other diagnostic agents. 
 
1.6. Isothiocyanate Compounds for Cancer Therapy  
Isothiocyanates (ITCs) are naturally occurring molecules which are formed from 
glucosinolate (β-thioglucoside N-hydroxysulfates) (GSH) precursors in cruciferous 
vegetables.199 GSHs exist as a N-hydroxysulfate with a sulphur linked β–glucose and a variable 
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side chain containing an alkyl, alkenyl, aromatic, indolyl, or perhaps other moieties (Scheme 
1.4).200 GSHs are usually broken down through hydrolysis catalysed by myrosinase, an enzyme 
which is released by physical stress such as chewing or chopping of the plant. ITCs are also 
known as mustard oils and abundant in cruciferous vegetables such as broccoli, Brussel sprouts, 
watercress, cabbage, horseradish, mustard and cauliflower. ITCs are responsible for the 
pungent odour and acrid and bitter flavour of condiments such as mustard and horseradish and 
the biting taste that develops when some cruciferous vegetables are eaten. The term "mustard 
oil" originates from the flavour of mustard seeds which is mainly due to the presence of 
abundant quantities of allyl isothiocyanate (AITC).  
 
 
Scheme 1.4. Conversion of glucosinolates to their corresponding isothiocyanates reproduced from 
Fahey et al.200 
 
ITCs are reactive compounds with the structure R-N=C=S, where R is an alkyl or aryl group. 
Their reactivity is contributed particularly with respect to nucleophilic attack at the electron-
deficient central carbon atom. Nucleophilic attack of ITCs by thiols forms dithiocarbamates R-
N(=S)-SR′ which are unstable under physiological conditions and undergo a reverse reaction, 
which results in the establishment of an equilibrium as follow:201, 202  
 
R-N=C=S + R′SH ⇌ RNHC(=S)-SR′ 
 
In addition to their characteristic flavours and odours, ITCs have a variety of other important 
properties such as antibacterial, antifungal, and antiprotozoal actions; the ability to attract or 
repel insects, the induction of chromosome abnormalities and the inhibition of chemical 
carcinogenesis. Many of ITCs significantly contribute to the cancer chemopreventive activity 
of cruciferous vegetables since they reduce activation of carcinogens and increase their 
detoxification. Some ITCs derived from cruciferous vegetables, such as AITC, sulforaphane 
(SFN), phenethyl isothiocyanate (PEITC) and benzyl isothiocyanate (BITC), shown in Scheme 
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1.4, are greatly effective in preventing or reducing the risk of cancer induced by carcinogens 
in animal models. They have also been recognised to inhibit the growth of various types of 
cancer cells.203, 204 The antitumour activity of ITCs happens due to affecting several pathways 
such as apoptosis, oxidative stress, and cell cycle progression.201 
 
Scheme 1.5. Chemical structures of some ITCs. 
 
 
1.6.1. Chemopreventive Effects of Isothiocyanates  
ITCs can profoundly affect carcinogen metabolism. The ability of ITCs to inhibit chemical 
carcinogenesis was first documented more than 30 years ago with α-naphthyl isothiocyanate.205 
Interest in these compounds arose from its ability to produce profound proliferative damage in 
the liver tissue. In long-term feeding experiments this ITC considerably reduced the formation 
of liver tumours in male Wistar rats in a dose-dependent manner.206, 207 These findings laid the 
groundwork for various subsequent studies on the tumour blocking activities of ITCs. 
 
1.6.1.1. Phase II Enzyme Induction  
 Approximately 20 natural and synthetic ITCs have been shown to block chemically induced 
carcinogenesis since that time. The anticarcinogenic activities of ITCs have been tested in 
animal models using various chemical carcinogens such as polycyclic aromatic hydrocarbons 
and several nitrosamines. Protection is observed in multiple target organs including the lungs, 
liver, forestomach, small intestine, colon and bladder.205, 208 The cellular and molecular events 
affected or regulated by these chemopreventive ITCs include inhibition of Phase I enzymes 
(e.g. cytochrome P450 enzymes (CYP)), which are involved in the bioactivation of 
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carcinogens, and induction of Phase II enzymes (e.g. glutathione S-transferases (GST)), 
responsible in carcinogen detoxification.209, 210 These enzymes play a critical role in cellular 
defence against chemical carcinogens and oxidants. Therefore, deficiencies of them lead to 
increased DNA damage and cancer risk, whereas increased expression of these enzymes, on 
the other hand, suppresses cancer development.211 Since ITCs increase the activity of Phase II 
enzymes but not that of Phase I enzymes, they are referred to as monofunctional inducers.212 
Enhanced expression of most of Phase II genes by ITCs is mediated through the antioxidant 
responsive element (ARE). Nuclear factor E2-related factor 2 (Nrf2) is a member of the family 
of transcriptional factors which dimerises and binds to the ARE, resulting in the transcriptional 
activation of a battery of detoxification and antioxidant proteins.213 Nrf2 which is sequestered 
by cytoskeleton-anchored Keap1 protein in the cytoplasm, exists as an inactive form.214 
Following exposure to the extracellular stimuli such as ITCs, Nrf2 is dissociated from Keap1 
protein, translocates into the nucleus and binds to the ARE and this leads to the induction of 
Phase II enzymes (Figure 1.6). 
  
        
Figure 1.6. Model of the signalling pathways involved in activation of Nrf2 by ITCs to induce Phase 
II enzymes; reproduced from Keum et al.208 
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1.6.1.2. Apoptosis Induction 
Apoptosis or programmed cell death is an active process in which dysfunctional cells are 
removed in order to maintain normal functioning of the tissues. Apoptosis plays an important 
role as a protective mechanism by eliminating genetically damaged or excess cells that have 
been improperly induced to divide.208 
Many reports have demonstrated the induction of apoptosis by ITCs; they exhibit antitumor 
activity at the post-initiation phase suggesting their additional role in cancer prevention.205 
Mitochondria are damaged by ITC’s intracellular metabolites that can accumulate in the cells, 
and thus mitochondrial damage induced by ITCs leads to apoptosis. Specifically, AITCs are 
known to inhibit TNF, a protein involved in a type of apoptosis known as extrinsic apoptosis.215 
Another hypothesis in this regard is that, oxidative stress by depletion of intracellular GSH may 
contribute to subsequent signalling events leading to apoptosis.208 For instance, depletion of 
intracellular GSH caused by the treatment with some ITCs such as SFN may play a significant 
role in the induction of Phase II enzymes as well as apoptotic responses in HepG2 cells.216 
However, this is highly dependent on the amount of SFN added. When the cells are treated 
with SFN, ARE reporter expression was maximal while no apoptotic responses were observed; 
however, when the concentration of SFN was increased ARE reporter activity was totally 
abolished while apoptosis was significantly increased.216 
 
1.6.1.3. Induction of Cell Cycle Arrest  
When DNA is damaged, cell cycle arrest occurs by activating cellular checkpoints including 
G1/S or G2/M phase until errors are corrected in the DNA. However, if DNA damage is 
substantial and irreparable, apoptosis is initiated instead of cell cycle arrest. Therefore, both 
cell cycle arrest and apoptosis are closely coupled as cellular protective mechanisms which are 
promising avenues to develop chemopreventive strategies. ITCs have been reported to induce 
cell cycle arrest possibly by transcriptionally inhibiting cyclin D1 expression in cells, which is 
a protein required for progression through the G1 phase of the cell cycle.208 
In general, ITC compounds have many favourable properties that make them attractive for 
further development as chemopreventive agents for human cancer.217  
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1.6.2. Metabolism of Isothiocyanates  
ITCs are metabolised in vivo through the mercapturic acid pathway. Initial conjugation of 
the –N=C=S group with the cysteine thiol of glutathione forms the corresponding conjugates 
(dithiocarbamates) which are then metabolised sequentially to the cysteinylglycine, cysteine 
and N-acetylcysteine (NAC) conjugates. These compounds are then excreted and concentrated 
in the urine.218 
 
1.7. Endocytosis Mechanisms 
In order to communicate with the biological environment, all different types of cells in the 
body use the endocytosis process. This process controls the lipid and protein composition of 
the plasma membrane and is energy-dependant which allows the cell internalisation of ions and 
biomolecules.219 More specifically, the internalisation of nutrients and signalling molecules 
occurs to obtain energy and interact with other cells respectively. In addition, endocytosis is 
known as the major route in nanomedicine to transport across the cellular membrane. The 
endocytosis pathways are generally classified into phagocytosis and pinocytosis. 
 
1.7.1. Phagocytosis 
Phagocytosis is a special endocytic pathway which is actin-dependent and mainly restricted 
to professional phagocytes such as macrophages. When phagocytic cells internalise foreign 
materials (particles larger than 0.5 µm) the phagocytosis pathway is most likely used.220, 221 
NPs which adopt this way of entry into cells need to be recognised by the opsonin firstly, such 
as immunoglobulin and blood serum proteins. Afterwards, the opsonised NPs bind to the cell 
surface and interact with the receptor, which will induce the formation of a cup-shaped 
membrane extension as depicted in Figure1.7.222 The membrane extensions enclose the NPs 
and internalise them, which will form phagosomes that have a diameter of 0.5 to 10 µm. At the 
final stage, the phagosomes move to fuse with lysosomes223 and the cargo within the 
phagosomes will be destroyed by acidification and enzymolysis in the lysosomes. Thus, in 
order to produce desired effects for NPs, they must bypass this route to avoid degradation.222 
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1.7.2. Pinocytosis 
Pinocytosis is a major route for the cells to drink fluid and suspensions containing small 
particles. Based on the proteins involved in the pathways, it is classified to clathrin-dependent 
endocytosis, caveolae-dependent endocytosis, macropinocytosis and clathrin- and caveolae-
independent endocytosis.222, 224 
 
1.7.3. Clathrin-dependent Endocytosis 
Clathrin-dependent endocytosis is receptor mediated and present in all types of mammalian 
cells. This type of endocytosis is considered as an important part in cellular entry. Many types 
of cells use this pathway in order to internalise materials at nanoscale.221, 225 After NPs interact 
with receptors on the cell membrane, a kind of cytosolic protein called clathrin-1 polymerises 
on the cytosolic side of the plasma where the cargo is internalised.224 After wrapping the NPs 
inside the cells, the vesicle is pinched off by dynamin (an enzyme responsible for endocytosis) 
and forms clathrin coated vesicles (CCV) around the internalised material as illustrated in 
Figure 1.7.226 CCVs move further inside the cells by using the energy supplied by actin,227 and 
the clathrin coat is shed off in the cytosol. The destination of the vesicles is associated with the 
receptor that NPs’ ligands interact with. They can either be transferred to lysosomes for 
degradation, such as the interaction between low-density lipoprotein particles and LDL 
receptor, or recycled back to the cell surface, such as when iron-loaded transferrin interact with 
transferrin receptor.228  
 
1.7.4. Caveolae-dependent Endocytosis 
Caveolae-dependent endocytosis is another common cellular entry pathway that is receptor 
mediated. As this pathway could bypass lysosomes, many pathogens including viruses and 
bacteria select this way to avoid lysosomal degradation.228 For the same reason, this route is 
considered to be beneficial for improving both targeting and therapeutic effects. Caveolin is a 
protein which exists in most cells and plays a dominant role. There are three types of caveolin 
in mammalian cells: caveolin-3 is muscle specific, while caveolin-1 and -2 are in most non-
muscle cells such as endothelial cells and fibroblasts and absent in neurons and leukocytes.228 
NPs or pathogens can bind to the receptors on the plasma membrane and interact with them to 
Chapter 1                                                                                                                                            Introduction  
36 
induce the formation of the flask-shaped vesicles, which are then cut off from the membrane 
by dynamin. Caveolar vesicles require actin to move and transmit within the cell, similar to 
clathrin-dependent endocytosis. The caveolae vesicles transmit to combine with caveosomes 
or multivesicular bodies (MTV) which have a neutral pH (Figure 1.7).229 MTVs containing 
NPs move along with microtubules towards the endoplasmic reticulum,230 from which they 
then can penetrate into the cytosol, and then enter the nuclear envelope via the nuclear pore 
complex.222 
Compared to clathrin-dependent endocytosis, this pathway has smaller vesicles and the 
process takes longer time. The NPs which undertake caveolae-dependent endocytosis, can 
avoid degradation and enhance the delivery to a target organelle such as endoplasmic reticulum 
or nucleus, which is significant in terms of the improvement of therapeutic delivery systems.222 
 
1.7.5. Macropinocytosis 
Macropinocytosis is a non-specific process for the internalisation of surrounding fluids and 
particles into large vacuoles228 and commonly defined as a transient clathrin- and caveolin-
independent or growth factor-induced endocytosis. This pathway can be found in almost all 
cells, with few exceptions for example brain microvessel endothelial cells, and is generally 
begins with external stimulations. The activation of receptor mediates a signalling cascade that 
causes the formation of membrane ruffles (Figure 1.7). Based on the form of the ruffles, there 
are different mechanisms of the macropinosomes which get pinched off from the membrane. 
For example, circular ruffles are cut off by dynamin whereas lamellipodial macropinosomes 
separated from the membrane is free of dynamin. Depending on the cell type, after separating 
from the membrane, macropinosomes either move into the cytosol and fuse with lysosomes or 
travel back to the cell surface of the membrane and release the contents to the extracellular 
space.231 
 
1.7.6. Clathrin- and Caveolae-independent Endocytosis 
Clathrin- and caveolae-independent endocytosis is a distinct pathway, which relies on 
cholesterol and requires specific lipid compositions. Although this pathway is not well 
understood, dynamins play a dominant role.  
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When NPs are systemically administered into the body, they are confronted with different 
types of cells. It is believed that the efficiency of NP endocytosis is dependent on several 
parameters such as physiochemical properties of NP including size, shape and surface charge 
and chemistry, as well as cell-specific parameters such as cell type or cell cycle phase.232 Since 
NPs have emerged as drug carriers for the treatment of complex diseases, it has become crucial 
to understand endocytosis mechanisms they overtake. 
 
 
Figure 1.7. NPs internalisation pathways in mammalian cells reproduced from He et al.222 
 
1.8. Motivation, Aims and Objectives of the Study  
 
Although significant advances have been made in nanomedicine in recent years, one of the 
remaining key challenges is defining the optimal targeting agents to selectively deliver nano-
compounds to cancer tissues. Identifying tumour specific antigens, such as cell surface protein 
receptors, is the current focus of many research projects, further advancing methods which can 
recognise cancerous cells among thousands of other normal cells. Therapeutic treatments have 
been developed to target some of these proteins, and receptor expression is sometimes used as 
a prognostic indicator. Therefore, compounds such as thiourea derivatives which are known to 
specifically target these receptors and inhibit their activity can be exploited to improve the 
targeting properties of therapeutic systems. Moreover, integrating these compounds on the 
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surface of NPs can increase the functionality of the system. It is well known that SiNPs have a 
high potential for bioimaging, and thus are known to offer exciting opportunities for design of 
high performance silicon based nano-agents. This can play a vital role in the efficiency of cell 
internalisation since the targeting molecule can enhance specific NP–cell surface interactions 
and increase endocytosis of the NPs. As a result, successful internalisation of NP drug delivery 
systems, through better targeting, has shown improvements in therapeutic effect.233-235 
In this thesis, for the first time we report the synthesis of two types of functionalised SiNPs 
as new multifunctional nanoscale systems. By developing such hybrid NPs, we can exploit the 
unique optical properties of SiNPs whilst introducing the targeting and therapeutic 
characteristics of the functional ligands for diagnostic applications. The aims of this thesis are 
as follows: 
 To develop methods of synthesising SiNPs with biologically active ligands. 
 To develop functionalised SiNPs with targeting capability on cancerous cells for 
diagnostic purposes. 
 To determine the therapeutic properties of SiNPs functionalised with known anticancer 
drugs. 
 To utilise a range of characterisation methods to evaluate the physiochemical properties 
of synthesised SiNPs. 
To achieve these aims, the following objectives are undertaken: 
 To carry out prospective research on the development of hybrid SiNPs, integrating 
thiourea compounds to develop a diagnostic approach with efficient targeting of cancer 
cells. 
 To explore potential therapeutic properties of functionalised SiNPs, isothiocyanate 
compounds are conjugated and the resulting effect on cancerous cells evaluated. 
 To study and employ the process of hydrosilylation for the synthesis of SiNPs. 
 Investigating the structure and physiochemical properties of the synthesised SiNPs 
using various characterisation techniques and analysis. 
 Determining the stabilisation and compatibility of the obtained SiNPs as well as the 
effect of different synthetic procedures for biomedical applications. 
 In vitro evaluation of synthesised SiNPs to investigate their potential for further 
biomedical applications. 
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 Using a synchrotron FTIR microspectroscopy as a novel technique to investigate the 
cell internalisation of functionalised SiNPs. 
 
1.9. Thesis Overview 
This thesis comprises six chapters dealing with the development and optimisation of 
methods for the synthesis of stable functionalised SiNPs and their detailed characterisation. 
The study aims to examine the potential of these synthesised SiNPs for further biomedical 
applications. A brief description of each chapter is summarised below: 
Chapter 1 covers the general introduction for the overall project with the basic concepts 
and terminology related to nanomaterials, nanoparticles and semiconductor quantum dots. A 
variety of methods to synthesise SiNPs will be discussed as well as the description of the origin 
of SiNP luminescence. The concerns and considerations about the cytotoxicity of SiNPs will 
be explained and a brief overview regarding the biomedical applications of SiNPs. The 
chemopreventive properties of thiourea and isothiocyanates, used as functional ligands in this 
project, will be described.  
Chapter 2 describes the synthetic procedures for the production of different functionalised 
SiNPs. Various chemical and physical characterisation techniques used to analyse 
nanomaterials are discussed. Later on in this chapter, methods for in vitro evaluation of the 
biomedical studies of synthesised SiNPs are discussed. 
Chapter 3 describes the preparation of thiourea-functionalised SiNPs using allylamine and 
sulforaphane, an important anticancer drug, followed by a hydrosilylation reaction on the 
surface of hydrogen terminated SiNPs. The physiochemical properties of SiNPs were 
investigated using photoluminescence emission, FTIR, and elemental analysis. The size of NPs 
was measured by TEM and DLS techniques. The MTT assay was employed to evaluate in vitro 
toxicity in Caco-2 and CCD-841 cells. Confocal microscopy was performed on cells before 
and after the treatment with NPs to evaluate the cell internalisation and flow cytometry was 
used to confirm the interaction of synthesised NPs with EGFR on the surfaces of cancer cells. 
The two different methods, top down and bottom up, were used to synthesise amine-
functionalised SiNPs as less cytotoxic nanomaterials to be used as control in biological 
experiments. 
A portion of this chapter has appeared in the following publication: 
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Behray M, Webster C A, Pereira S, Ghosh P, Krishnamurthy A, Al-Jamal W and Chao Y, 
Synthesis of Diagnostic Silicon Nanoparticles for Targeted Delivery of Thiourea to Epidermal 
Growth Factor Receptor-Expressing Cancer Cells, ACS Applied Materials and Interfaces 2016, 
DOI: 10.1021/acsami.5b12283 
Chapter 4 discusses the synthesis of isothiocyanate-functionalised SiNPs obtained from 
two different precursors using bromine-functionalised SiNPs and amine-functionalised SiNPs. 
All types of NPs were characterised using FTIR and elemental analysis. The size measurement 
was performed using TEM and DLS and their optical properties were evaluated by PL and UV-
vis spectroscopy. The cytotoxicity of ITC SiNPs was evaluated by MTT and their 
internalisation was examined using the confocal microscopy and flow cytometry assay.  
Chapter 5 demonstrates the use of synchrotron-based FTIR microspectroscopy as a novel 
approach to investigate the cell internalisation of isothiocyanate-functionalised SiNPs in Caco-
2 and CCD-841 cell lines. The spectral comparison of cells treated with NPs and control cells 
is presented showing the individual spectra from both nuclei and cytoplasm of cells and the 
variations in the protein and phospholipid contents of cells are monitored. The response of cells 
to changes in their chemical environment was evaluated using the infrared chemical images 
obtained from the FPA detector.  
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2.1. Materials 
 
The following chapter describes the synthesis methods, experimental apparatus and 
chemicals used in the work presented in the thesis. This includes an overview of the preparation 
methods used in the synthesis of silicon nanoparticles conjugated by allylamine, allyl bromide, 
thiourea and isothiocyanate functional groups. Following this, the characterisation techniques, 
such as chemical analysis, optical and size measurements, and biological methods are provided.  
All chemicals were employed without further purification unless specified.  The following 
materials, reagents and solvents have been used in the following work. 
 
Table 2.1. List of chemicals and materials. 
Substance Source Description 
Acetone Sigma Aldrich 99.5% 
Dichloromethane        
(DCM) 
Sigma Aldrich 99% 
Dimethylsulfoxide  
(DMSO) 
Fisher Scientific ≥99.9% 
Ethanol 
 (EtOH) 
Sigma Aldrich 99.8 % 
Ethyl Acetate  
(EtOAc) 
Fisher Scientific 99.9% 
Hexane Fisher Scientific 99.9% 
Iso-Propanol Sigma Aldrich ≥99.7% 
Tetrahydrofuran                
(THF) 
Fisher Scientific 
99.5%, dried by reflux over sodium 
and benzophenone and collected by 
distillation 
Toluene Fisher Scientific 
99.9 %, dried by reflux over molten 
sodium and collected by distillation. 
 
Allyl Isothiocyanate 
(AITC) 
 
Sigma Aldrich 
94%, stabilized with 0.01% alpha-
tocopherol 
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3-Amino-1-propene 
(Allylamine) 
Sigma Aldrich >99% 
3-aminopropyl 
trimethoxysilane  
 (APTES) 
Sigma Aldrich 97% 
3-Bromo-1-propene  
(Allyl Bromide) 
Sigma Aldrich 99% 
Ascorbate Sodium  
(AS) 
Sigma Aldrich ≥98% 
Carbon Disulphide  
(CS2) 
Sigma Aldrich ≥99.9% 
Chloroplatinic Acid 
(H2PtCl6) 
Sigma Aldrich 
8 wt. % in H2O 
0.05M 
Dicyandiamide Sigma Aldrich 99% 
Hydrofluoric Acid          
(HF) 
Argos Organics 48% in water 
L-Sulforaphane Toronto Research Chemicals ≥95% 
Magnesium Sulphate 
(MgSO4) 
Sigma Aldrich 97% 
Potassium Thiocyanate      
(KSCN) 
Sigma Aldrich ≥99% 
Triethylamine                
(Et3N) 
Sigma Aldrich ≥99% 
Anti-EGFR Antibody Abcam 
Primary Antibody 
0.2 mg/ml, 1:1000 
Anti-rabbit IgG, HRP-linked 
Antibody 
Abcam 
Secondary Antibody 
2 mg/ml BSA, 1:1000 
Ammonium Chloride 
(NH4Cl) 
Sigma Aldrich 50 mM 
3-(4,5-dimethylthiazol-yl)- 
2,5 diphenyltetrazolium 
bromide  
(MTT) 
Sigma Aldrich _____ 
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Fetal Bovine Serum  
(FBS) 
Fisher Scientific _____ 
Hoechst 33342 Sigma Aldrich 2 µg/mL 
Hydrogen Peroxide  
(H2O2) 
TMB stop solution 
Fisher Scientific Peroxide Solution 
Hydromount 
Vectashield hard, Vector 
Labs 
Non-fluorescing Mounting Media 
Janus Green Whole Stain Fisher Scientific _____ 
L-Glutamine Fisher Scientific 1% , 200mM 
Paraformaldehyde  
(PFA) 
Sigma-Aldrich 4% (v/v) 
Penicillin/ Streptomycin          
(P/S) 
Fisher Scientific 5000u 
Permeabilization buffer Fisher Scientific 0.5 % Triton X-100 in PBS 
Phosphate Buffered Saline                    
(PBS) 
Fisher Scientific _____ 
Roswell Park Memorial 
Institute medium              
(RPMI) 
Fisher Scientific _____ 
Sodium Chloride  
(NaCl) 
Sigma Aldrich 0.9 % 
3,3’,5,5’-Tetramethyl 
benzidine 
(TMB substrate) 
Fisher Scientific Peroxidase Substrate 
Texas Red-X Phalloidin Life Technologies 6.6 µM 
Trypsin/EDTA Fisher Scientific 0.25% 
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Silicon Wafer Compart Technology Ltd Thickness: 500 µm, one side polished 
Calcium Fluoride  
(CaF2) substrates 
Crystran Limited 
13 mm diameter × 1 mm polished 
window        
10 mm diameter × 1 mm polished 
window 
Potassium Bromide  
(KBr) substrates 
Crystran Limited 13 mm diameter × 1 mm polished 
window 
 
 
2.2. Synthetic Procedures 
As mentioned earlier in the Chapter 1, there are two major methods to synthesise silicon 
nanoparticles: bulk reduction (top down) and self-assembly (bottom up). The final silicon 
nanoparticles synthesised throughout this work were mainly based on the top down method 
and derived from the nanometre-sized structures found within the surface layers of porous 
silicon. In this project, porous silicon was obtained by electrochemical etching (anodisation) of 
crystalline silicon. A bottom up method, although not utilised in the biomedical applications 
presented in this thesis, is also given to show how large-scale synthesis could be undertaken.  
 
2.2.1. Top Down Synthesis of Silicon Nanoparticles  
2.2.1.1. Synthesis of Porous Silicon 
Electrochemical etching was carried out in a PTFE (Teflon) cell as previously described by 
Chao et al.1 The boron-doped p-Si (100) wafer (10 Ωcm resistivity, Compart Technology, 
Peterborough, UK) was cut into square chips (1.25 × 1.25 cm) by a diamond-tipped scribe to 
adopt the anodisation cell which is circular in cross-section. The silicon chips were rinsed in 
absolute ethanol and distilled water in order to eliminate the surface impurities and dried under 
nitrogen flow. Silicon chips were later dipped briefly in 48 wt.% HF to remove the native oxide 
layer from the surface followed by rinsing with distilled water and then dried under the nitrogen 
flow. The silicon chip was positioned between the upper and lower plates of the cell chamber 
while the polished side of the chip was exposed to the electrolyte solution. The silicon chip 
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was placed on a platinum foil to improve the conductivity. The upper plate contains an open 
cavity in the centre in order to hold the electrolyte solution and is fitted with a VitonTM O-ring 
(Polymax LT) to prevent the etching solution from leaking. The cell was later filled with the 
electrolyte solution that was 1:1 98 wt.% ethanol to 48 wt.% hydrofluoric acid. The silicon chip 
acts as anode and HF-resistant electrode serves as a cathode. The addition of the ethanol to the 
electrolyte solution increases the silicon wafer wettability, improving pore penetration and 
therefore making the porous silicon layer more homogeneous. Furthermore, ethanol assists in 
the removal of hydrogen gas evolved in the dissolution reaction from the silicon surface and 
maintain more uniform current density. The cathode was a piece of tungsten wire (0.5 mm in 
diameter, Goodfellow UK) coiled into a loop to improve the uniformity of the current 
distribution and the etching was carried out using a constant current source (Keithley Source 
Meter 2601). The silicon chip was etched at a current density 400 mAcm-2 for 5 min. After 
etching, the H-terminated porous silicon chip was dried under vacuum for at least 2 h to remove 
residual hydrofluoric acid and was stored under nitrogen flow until use.2 
 
 
Figure 2.1. Schematic diagram of the synthesis of porous silicon through electrochemical 
etching. Top right shows the two-electrode electrochemical cell used for etching. Enlarged cross 
section of porous silicon is shown on bottom right. 
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                     𝑺𝒊 + 𝟒𝑯𝑭𝟐
− + 𝟐𝑯+ →  𝑺𝒊𝑭𝟔
𝟐− + 𝟐𝑯𝑭 + 𝟐𝑯𝟐                       (Equation 2.1) 
 
2.2.1.2. Synthesis of Amine-functionalised Silicon Nanoparticles 
Amine-functionalised silicon nanoparticles were synthesised from H-terminated porous 
silicon through the hydrosilylation reaction as previously described by Ahire et al3 with some 
modifications.  
Hydrosilylation has been shown as one of the methods to introduce C=C of alkenes to H-
terminated silicon surface in order to form Si-C bonding.4-6 This can be induced through 
different approaches such as photochemical,7-9 thermal,10   UV irradiation11 and by employing 
catalysts (normally EtAlCl2 or H2PtCl6).
12-14 In this work, the conventional hydrosilylation of 
alkenes by chloroplatinic acid as catalyst has been applied on the surface of H-terminated 
silicon nanoparticles.  
Amine-functionalised SiNPs were synthesised through a two-step reaction. The first step is 
the breakup of the nanostructured porous silicon layer to release the silicon nanoparticles and 
the second step is the functionalisation of the surface of nanoparticles by covalently bonded 
propylamine.  
H-terminated porous silicon, produced from the etching of four chips, was dried in a Schlenk 
flask under vacuum for 2 h. Chloroplatinic acid solution (H2PtCl6 8 wt. % in H2O, 160 μL, 
0.948 mmol, 0.05M) was added to the porous silicon in the presence of iso-propanol (10 mL) 
as solvent under nitrogen flow. Then allylamine (2 mL, 26.725 mmol) was added to the Schlenk 
flask followed by 20 min of sonication at room temperature (RT). The reaction mixture was 
filtered to remove the silicon chips and dried under reduced pressure at 60 oC. Heating up to 
this temperature would evaporate the unreacted allylamine from the product. The product was 
washed with CH2Cl2 (3 × 10 mL) and extracted in water (3 × 5 mL) to remove any by-products 
as well as the Pt catalyst and then dried under reduced pressure.     
Although the amount of the product obtained from the top down methods is batch dependent, 
the average of 30 mg water soluble amine-functionalised silicon nanoparticles were produced 
from each reaction.  
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2.2.1.3. Synthesis of Thiourea-functionalised Silicon Nanoparticles 
H-terminated SiNPs were synthesised by galvanostatic anodization of porous silicon layer 
as reported previously in Section 2.2.1.1.  
Thiourea chain was obtained after 6 hrs refluxing of sulforaphane (4 μl, 0.0225 mmol) with 
2 equivalent of allylamine (3.37 μl, 0.45 mmol) at RT in dry acetone (5 mL) under N2. The 
reaction mixture was dried under reduced pressure. 
The product was reacted with dry H-terminated SiNPs obtained from etching of 4 silicon 
chips for extra 24 hours in ethanol at 35 oC. The mixture solution was centrifuged and the 
solvent was evaporated under the reduced pressure at 60 oC. The average of 20 mg of thiourea-
functionalized SiNPs was obtained from each batch. 
 
2.2.1.4. Synthesis of Bromine-functionalised Silicon Nanoparticles 
H-terminated porous silicon, from etching four chips, were synthesised and dried in vacou. 
Dry toluene (10 mL) was introduce to the reaction mixture followed by sonication for 5 min to 
dissolve all SiNPs in the solvent. Silicon chips were filtered from the solvent and allyl bromide 
(2 mL, 23.142 mmol) was added to the reaction mixture. Bromine-functionalised SiNPs were 
synthesised after refluxing overnight at 65 oC. The average of 26 mg bromine-functionalised 
SiNPs were obtained from each batch.  
 
2.2.1.5. Synthesis of Isothiocyanate-functionalised Silicon Nanoparticles 
Two different approaches have been investigated to synthesise isothiocyanate-
functionalised SiNPs in this project. 
 
2.2.1.5.1. Use of Amine-functionalised Silicon Nanoparticles as the Precursor 
To a mixture of amine-functionalised SiNPs (30 mg) in dry THF (10 mL), CS2 (2.7 mL, 
44.681 mmol) was added dropwise over a period of 20 min while the reaction mixture was 
cooled with an ice bath. This was followed by stirring the reaction for 3 h.  Dicyandiamide (1.5 
g, 17.84 mmol) was added followed by more dry THF (10 mL). Next, Et3N (3 drops) was added 
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followed by 3 hours stirring at 40 oC. The solvent was removed and then the compound was 
extracted in ethyl acetate (3 × 5 mL) and washed with water (3 × 10 mL). The organic layer 
was dried over magnesium sulphate, filtered and the solvent was removed in vacuo.  A resultant 
28 mg ITC SiNPs was obtained from this procedure. 
 
2.2.1.5.2. Use of Bromine-functionalised Silicon Nanoparticles as the Precursor 
A mixture of bromine-functionalised SiNPs (30 mg), Potassium thiocyanate (KSCN) (18 
mg, 0.185 mmol) and dry ethanol (10 mL) were placed in a flask, stirred and refluxed at 65 oC 
overnight. On completion of the reaction, the mixture was allowed to cool and then the solvent 
was removed under the reduced pressure. The mixture was extracted into diethyl ether (3 × 10 
mL). The organic layer was washed with water (3 × 12 mL), dried over magnesium sulphate 
and filtered. The filtrate was subjected to a vacuum and produced ~25 mg of the desired 
isothiocyanate-functionalised SiNPs.  
 
2.2.2. Bottom Up Synthesis of Silicon Nanoparticles  
Amine-functionalised SiNPs were synthesised by a method adapted from Wang et al.15 
APTES (1 mL, 4.273 mmol) was added to water (4 mL) while stirring. Next, Ascorbate Sodium 
(AS) (1.25 mL, 10.663 mmol, 0.1 M) was added to the mixture followed by stirring for 20 min. 
The average of 500 mg water soluble NPs were produced from each reaction.  
 
2.3. Characterisation Techniques 
In order to have a better understanding about the characteristics of the synthesised silicon 
nanoparticles, a variety of experimental techniques were used to explore their properties. This 
is done to assess the behaviour of these materials for biomedical applications and also allow 
for the identification of any necessary modifications to the nanocompounds. Furthermore, it is 
essential to confirm the validity of the synthetic procedures used to prepare nanoparticles 
through use of different characterisation techniques. 
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2.3.1. Chemical Analysis 
2.3.1.1. Fourier Transform Infrared Spectroscopy (FTIR) 
Fourier Transform Infrared Spectroscopy (FTIR) deals with the infrared radiation region of 
the electromagnetic spectrum which is normally from 4500 cm-1 to 500 cm-1. It is a very 
sensitive instrument for identifying different types of chemical bonds in molecules by 
producing an infrared absorption spectrum. Each functional group absorbs the radiation at 
specific frequencies and therefore produces structural information.  This is normally unique for 
each type of molecule and therefore is considered as a molecular fingerprint.  
FTIR was used for the identification of specific functionalisation on the surface of SiNPs to 
confirm the presence of ligands. As nanoparticles that were dispersed in solvents gave weaker 
signals, all spectra in this work were recorded from powder samples using Attenuated Total 
Reflection (ATR) FTIR spectroscopy. FTIR Measurements were carried out using a Perkin-
Elmer ATR-FTIR spectrometer from the solid sample of SiNPs. The spectra were recorded 
after 16 scans by correcting the background.  
 
2.3.1.2. X-ray Photoelectron Spectroscopy (XPS) 
X-ray photoelectron spectroscopy (XPS) is a quantitative surface analytical technique which 
is used for chemical analysis. More specifically, XPS measures the elemental composition, 
empirical formula, chemical and electronic states of the elements that exist within a material. 
Apart from the surface chemical composition of materials, this method is used to determine the 
local chemical environment of a given atom. 
XPS spectra are obtained by bombarding a material with a beam of X-ray photons under 
vacuum while simultaneously measuring the kinetic energy and the number of electrons that 
escape from the top 1 to 10 nm of the material. After the incident X-ray photons interact with 
the sample, they exchange energy with the inner orbital electrons near the surface of a material 
and this thus causes ejection of electrons. All electrons, whose binding energy is less than that 
of the incident X-rays, are ejected from the atom and get detected. This relies on the 
photoelectric effect. The ejected core electrons have a specific kinetic energy (Ek) that is 
determined by the following equation: 
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                                              𝑬𝒌 = 𝒉𝝂 − 𝑬𝒃 −  Ф                                  (Equation 2.2) 
 
Where Ek is related to the energy of the exciting electron (hν) where h represents the Planck 
constant and ν is the frequency of a photon. The characteristic work function of the material is 
represented by Ф which is the minimum energy needed to remove an electron from solid and 
(Eb) is the binding energy of the electron to the atom.
16  
There is a characteristic binding energy for each element that is associated with each core 
atomic orbital. Thus, each element will give rise to a characteristic set of peaks in the 
photoelectron spectrum at specific kinetic energies determined by the photon energy and the 
respective binding energies. Figure 2.2 illustrates the schematic representation of the X-ray 
photoelectron process. 
 
Figure 2.2. Schematic representation of an X-ray photoelectron spectrometer equipped with an X-
ray source and a hemispherical analyser showing the basic components of the system and the process 
occurring during XPS. 
  
XPS measurements were performed on a K-Alpha XPS instrument (Thermo Scientific, East 
Grinstead, UK) at NEXUS nanolab. A few drops of the concentrated dispersion of SiNPs were 
drop-cast onto a cleaned gold substrate (10 mm × 10 mm). The film was introduced into a load-
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lock attached to an ultra-high vacuum (UHV) chamber in which the typical pressure was 
maintained below 5 × 10−9 mbar. All spectra were acquired at normal emission with AlKα 
radiation at 1486.6 eV and a spot size of 400 µm. A pass energy of 200 eV and step size of 0.4 
eV was used for the survey spectra and a pass energy of 40 eV and step size of 0.1 eV was used 
for high resolution spectra. In all photoemission spectra, binding energies (BEs) were referred 
to the Au 4f7/2 line measured on a gold foil in direct electrical contact with the sample which 
was found at binding energy of 84 eV. XPS data analysis and peak fitting was performed using 
CasaXPS software version 2.3. 
 
2.3.1.3. Energy Dispersive X-ray Spectroscopy (EDX) 
Energy dispersive X-ray Spectroscopy (EDX) is an analytical technique used in conjugation 
with Scanning Electron Microscopy (SEM). EDX is used for the elemental analysis or chemical 
characterisation of a sample. This technique relies on the fundamental principle that each 
element has a unique atomic structure producing a characteristic set of peaks on a X-ray 
emission spectrum. Therefore, EDX is based on the interaction of a source of X-ray excitation 
and the sample analysed. A high-energy beam of charged particles such as electrons or photons, 
or a beam of X-rays, is focused onto the sample and this will stimulate the emission of X-rays. 
When the sample is bombarded by the incident beam, electrons are ejected from the inner 
energy levels of the sample’s surface atoms. The resulting electron holes are filled by electrons 
from a higher-energy state and an X-ray is emitted to balance the energy difference between 
the two electron states. The energy of the X-rays emitted is characteristic of the energy 
difference between the two levels and also of the unique atomic structure of the element.  
Therefore, the elemental composition can be estimated. However, the data obtained from this 
technique is generally indicative and not particularly sensitive to atomic ratios.16   
Chapter 2                                                                                                                           Methods and Materials 
 
71 
                             
Figure 2.3. Schematic diagram of the process occurring with energy and electrons during EDX. 
 
In this work, the samples were analysed using an EDX sensor attached to a JEOL Scanning 
Electron Microscope (SEM). Samples in powder form were coated with gold (Au) which was 
used as the reference. This allowed conduction away from the structure of material when 
observed under the SEM. Points of interest on the material were identified by SEM and then 
an individual spectrum was produced for each in turn.  
 
2.3.2. Size and Dispersity Measurement and Surface Charge 
2.3.2.1. Transmission Electron Microscopy (TEM) 
Transmission electron microscopy (TEM) is an electron based technique used to study 
materials. TEM is capable of much higher magnifications and has a greater resolution than a 
light microscope as it can probe the internal structure of the samples providing information 
about the fine morphological structure details.  
 In order to avoid the scattering of electrons from the air molecules, the instrument is 
operated under a high level of vacuum.  A beam of electrons transmits through a thin sample 
and is detected on the other side to form an image. As electrons strongly interact with matter, 
this gives rise to the ability to use contrast for detection. Dark areas in the images represent 
regions where electrons do not transmit through, while lighter regions are more electron 
transparent.17 
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Figure 2.4. Schematic representation of a light and transmission electron microscope with 
different components showing the optical path through a light microscope and electron beam path 
through a TEM. 
 
TEM results were used to measure the core particle size in this work as well as to visualise 
their morphology. Particle size plays a key role in the properties observed in SiNPs. Therefore, 
it is important to measure the particle size and size distribution of SiNPs. In addition, TEM is 
able to identify the crystalline structure of the silicon core.  
Studies were performed with the JEOL, JEM 2100 microscope running a LaB6 (lanthanum 
hexaboride crystal) emitter at voltage 200 kV. TEM samples were prepared by drop-casting a 
dilute suspension of the sample dispersed in an appropriate solvent (according to their 
solubility) onto a 200 mesh carbon-coated copper grid (Agar Scientific). The grids were dried 
before the measurement. TEM micrographs were taken at different spots of grids from at least 
100 particles from each sample. ImageJ was used to view and analyse the micrographs.  
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2.3.2.2. Dynamic Light Scattering (DLS) 
Dynamic Light Scattering (DLS), which is also known as Photon Correlation Spectroscopy 
(PCS), is another technique to characterise the size of the nanoparticles typically in the sub-
micron region. This technique is capable of particle sizing down to 1 nm diameter. The 
diameter that is measured in DLS is related to a value that shows how a particle diffuses within 
a solution and therefore is referred to as a hydrodynamic diameter. 
DLS measures the light scattered from a monochromatic light beam such as a laser that 
passes through a colloidal solution and by analysing the modulation of the scattered light 
intensity as a function of time. By doing this the hydrodynamic size of particles and particle 
agglomerates can be determined. DLS works based on the Brownian motions of the particles 
and relates this to their size. Brownian motion is the movement of particles due to the random 
collision with the molecules of the liquid that surrounds the particle. An important feature of 
Brownian motion for DLS is that small particles move quickly and large particles move more 
slowly. In other words, the larger particles will diffuse slower than smaller particles and the 
DLS instrument measures the time dependence of the scattered light to generate a correlation 
function and this can be mathematically linked to a particle size. The velocity of the Brownian 
motions is defined by the translational diffusion coefficient. Thus, the size of the particle can 
be calculated by the Stokes- Einstein equation as follow: 
 
                                                𝑫𝒉 =  
𝒌𝑩 𝑻
𝟑𝝅𝜼𝑫𝒕
                        (Equation 2.3) 
                                                                                                                                                                             
Where Dh is the hydrodynamic diameter, Dt is the translational diffusion coefficient, kB is 
Boltzmann’s constant, T is absolute temperature and η is the dynamic viscosity.   
When DLS sizing data is compared to Transmission Electron Microscopy data, the 
aggregation state of the particles can be determined. In an unagglomerated suspension, the 
diameter measured will be similar or slightly larger than the TEM size. If the particles are 
agglomerated, the DLS measurement is often much larger than the TEM size and can have a 
high polydispersity index (PdI) which shows the variability in the particle size. 
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PdI is a measure of the width of the particle size distribution. Polydispersity indices less 
than 0.1 are typically referred to as monodisperse and can be related to the particle size as the 
following formula: 
                                                         𝑷𝒅𝑰 = (
𝝈
𝒅
)𝟐                                            (Equation 2.4) 
 
Where σ is the standard deviation and d represents the mean diameter.  
The hydrodynamic diameter of SiNPs and polydispersity index were determined by DLS 
measurement with Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) at room 
temperature, equilibrating samples for 120 seconds prior to the measurement.  
 
 
Figure 2.5. Schematic demonstration of a DLS instrument showing different components.18 
 
1 mg/mL of SiNP solution was measured in a variety of solvents according to their solubility 
to assess the stability of the SiNPs under normal and in vitro conditions.  Size measurements 
were performed in triplicates and, in order to obtain the diameter of SiNPs as close as possible 
to real size, ultrasonication and filtration were applied before any measurement. The scattered 
photons were detected under an angle of 173° and the relative intensity distribution was 
obtained.  
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2.3.2.3. Zeta Potential 
Zeta potential is a physical property which is displayed by particles in suspension. It can be 
used to optimise the formulations of suspensions and emulsions. The zeta potential can be used 
to estimate the long-term stability of compounds, which is necessary for use in biomedical 
applications. 
In an ionic solution, nanoparticles with a certain net charge will have a layer of ions with 
the corresponding opposite charge which is strongly bound to the surface. This layer is known 
as the Stern layer. A second layer, called a diffuse outer layer, is comprised of loosely 
associated ions. These two layers are collectively called the electrical double layer. As the 
particle moves in the solution, described by Brownian motions or an applied force, a distinction 
is produced between ions in the diffuse layer that move with the nanoparticle and ions that 
remain with the bulk dispersant. The electrostatic potential at this “slipping plane” boundary is 
related to the surface charge of the NP and this is what the zeta potential refers to. 
In zeta potential measurements, an electrical field is applied across the sample and the 
movement of the NPs (electrophoretic mobility) is measured by laser doppler velocimetry 
(LDV).  
In order to calculate the zeta potential, the Henry equation is then used: 
 
                                                 𝑼𝒆 =  
𝟐 𝜺 𝒛 𝒇(𝒌𝒂)
𝟑𝜼
                                          (Equation 2.5) 
  
Where, Ue is the electrophoretic mobility, ε is the dielectric constant, 𝒛 is the zeta potential, 
f(ka) is the Henry function, a is the particle radius, ka is the ratio of particle radius to double 
layer thickness (the Debye length) and η represents the absolute zero-shear viscosity of the 
medium.19  
Zeta potential of SiNPs was measured using the Zetasizer Nano ZS (Malvern Instruments, 
Malvern, UK) in water and the measurements were performed in triplicates. Prior to the 
measurement, ultrasonication and filtration were applied on samples. 
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2.3.3. Optical Measurements 
2.3.3.1. Ultraviolet-Visible Spectroscopy (UV-Vis) 
Ultraviolet–visible spectroscopy (UV-Vis) refers to the absorption spectroscopy in the 
ultraviolet-visible region of electromagnetic spectrum. This technique uses the light in the 
visible and adjacent (near-UV and near-infrared) ranges. The absorption in the visible range 
normally affects the colour of the chemicals involved in the sample being analysed.  In this 
spectral region, molecules undergo electronic transitions and the absorption measures 
transitions from the ground state to the excited state.20 
A beam of light from a visible or/and UV light source is separated into its component 
wavelengths by a prism or diffraction grating. Each monochromatic beam is split into two equal 
intensity beams by a half-mirrored device.  The sample beam passes through a cuvette 
containing the sample being analysed and the other beam, which is the reference, passes 
through another cuvette containing only the dispersing solvent. The intensity of these beams is 
measured by electronic detectors and then compared to each other. The ultraviolet region 
scanned is normally from 200 to 400 nm and the visible regions from 400 to 800 nm.  
 
          
Figure 2.6. A diagram of a typical UV-Vis spectrometer with different components. The sample beam 
(in green) passes through a cuvette containing the sample dispersed in a solvent and the reference 
beam (in blue) passes through an identical cuvette containing only the dispersing solvent.21 
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The absorbance of UV-Vis light is related to the concentration of the sample based on the 
Beer-Lambert Law as follows:                        
                                                        𝐴 =  𝓔 𝒍 𝒄                                               (Equation 2.6) 
 
Where A represents the absorbance, 𝓔 is the molar absorptivity, l is the path length of the 
sample and c is the concentration of the sample.  
UV-Vis spectroscopy was used to identify the maximum absorbance of SiNPs. In SiNPs, 
this is normally seen as a shoulder on the spectrum since SiNPs scatter shorter wavelengths. 
Therefore, as the spectrum moves towards 200 nm, the absorbance increases due to greater 
scattering. 
The measurement was performed on SiNPs dispersed in suitable solvents. The UV-Vis 
absorption spectra were recorded by a Perkin-Elmer 35 UV-Vis double-beam spectrometer in 
a quartz cuvette (10×10 mm). The scan range was over a 200 to 700 nm at a rate of 900 nm/min 
and the spectra were corrected by subtracting the background contribution from the dispersing 
solvent. 
 
2.3.3.2. Photoluminescence Spectroscopy (PL) 
Photoluminescence spectroscopy (PL) is a method for probing the electronic structure of 
materials and is considered to be non-contact and non-destructive. Light is directed onto a 
sample, where it is absorbed and where a process called photo-excitation can occur. The photo-
excitation process causes the electrons in a material to jump to a higher electronic state. As it 
relaxes, the electrons return to a lower energy level through the release of energy in the form 
of photons. The emission of light or luminescence through this process is photoluminescence 
or PL. 
Photoluminescence is a key property of quantum dots such as SiNPs. This technique can be 
used to measure the emission wavelength of SiNPs and the optimum excitation wavelength. 
This data is useful in terms of designing the imaging experiments using these NPs.  
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Figure 2.7. Schematic representation of an energy diagram known as Jablonski diagram explaining 
the fluorescence process. Green circles represent the normal energy level of the fluorophore and red 
circles depict the maximum energy level.22 
 
The PL spectra were collected using a Perkin Elmer LS55 spectrometer for SiNPs dissolved 
in a suitable solvent in a quartz cuvette (10×10 mm). The excitation and emission slit widths 
set at 10 nm. The emission spectra were corrected by the background spectra which was from 
the pure solvent emission under the same condition. 
 
2.3.3.3. Quantum Yield (QY) 
The fluorescence QY is the ratio of the number of photons absorbed to the number of photos 
emitted through fluorescence. In other words, the QY shows the probability of the excited state 
being deactivated by fluorescence rather than by other, non-radiative mechanisms. 
There are two different approaches to calculate the QY: absolute and relative. The 
measurements of the absolute QY require sophisticated instrumentation. It is easier, therefore, 
to determine the relative QY of a fluorophore by comparison to a reference fluorophore with a 
well-known QY. 
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There are two different methods for assessing relative QYs: a single-point and a comparative 
method.23 Single-point uses only one emission value for the sample and one for the standard to 
calculate the QY of the unknown sample. By using this method, the QY is calculated using the 
integrated emission intensities from a single sample and reference pair with identical 
concentrations. The QY is calculated as in Equation 2.7. 
                                                      𝑸 = 𝑸𝑹
𝑰
𝑰𝑹
𝑨𝑹
𝑨
𝜼𝟐
𝜼𝑹
𝟐                                      (Equation 2.7) 
Where Q is the quantum yield, I represents the integrated intensity, η is the refractive index 
of the solvent and A is the absorbance. The subscript R refers to the standard fluorophore with 
a known quantum yield. 
Even though measuring the QY using this method is fast, it is not always reliable due to the 
inaccurate measurement of the fluorophore’s absorbance. A more reliable method for recording 
QY is the comparative method of Williams et al.24 which involves the use of multiple well-
characterised standard samples with known QY values. Solutions of the standard and test 
samples with identical absorbance can be assumed to be absorbing the same number of photons 
at the same excitation wavelength. Thus, a simple ratio of the integrated fluorescence intensities 
of the two solutions, under identical conditions, will yield the ratio of the QY values. As QY 
for the standard sample is known, QY for the test sample can be calculated. 
In this work, QY was calculated to estimate the quantum efficiency of SiNPs which is 
particularly important for imaging applications. Solutions with absorbance between 0.1 and 
0.01 were prepared and the QY obtained by calculating the gradient of the line generated by 
plotting the integrated fluorescence intensity against the absorption for various concentrations 
of fluorophore. The QY can be calculated using Equation 2.8. 
                                                   𝑸 =  𝑸𝑹 (
𝑮𝒓𝒂𝒅
𝑮𝒓𝒂𝒅𝑹
)(
𝜼𝟐
𝜼𝑹
𝟐)                           (Equation 2.8) 
Where Q is the quantum yield, and η is the refractive index of the solvent. Grad is the 
gradient from the plot of integrated fluorescence intensity vs. absorbance. The subscript R 
refers to the reference fluorophore of a known QY. In this study Quinine sulphate (QR =0.546 
in 0.5M H2SO4) was used as reference. 
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2.3.4. Thermal Gravimetric Analysis (TGA) and Differential Scanning Calorimetry 
(DSC) 
Thermal gravimetric analysis (TGA) and differential scanning calorimetry (DSC) are useful 
techniques to measure the thermal stability of materials in addition to the ligand coverage of 
SiNPs.  
TGA is a technique that can show the weight change caused by the chemical of physical 
processes as a function of temperature or time in a controlled atmosphere. The weight change 
of materials can happen due to the decomposition, oxidation or dehydration of samples.  
DSC provides an indication of the nature of the process under observation. This technique 
shows the typical transitions and phase changes when a material is subjected to continuous 
heating. 
TGA and DSC analysis was performed using a Mettler-Toledo TGA-DSC1. The powder 
sample of SiNPs (approx. 1.5 mg) was placed in a 40 µL aluminium pan and measurements 
were taken while heating the sample between the specified temperature limits. The background 
measurements were performed from heating an empty pan within the same temperature range.  
 
2.4. Biological Studies 
2.4.1. Culture of Cell Lines 
Two mammalian cell lines including Caco-2 (human colorectal adenocarcinoma) and CCD-
841 (human normal colon epithelial) were used in this study. Both cell lines were a kind gift 
from Dr Yongping Bao (Norwich Medical School, UK).  
Cell lines were cultured in Roswell Park Memorial Institute medium (RPMI) supplemented 
with 10% Fetal Bovine Serum (FBS). The media contained 1% Penicillin/ Streptomycin (P/S, 
5000u) and 1% L-Glutamine (200mM). 
Both cell lines are adherent cell lines which grow in vitro until they have covered the 
available surface area or the medium nutrients are depleted. At this point the cells should be 
subcultured in order to prevent cell death. When cells reached 70-80% confluence, the old 
medium was removed and cells were washed three times by pre-warmed Phosphate Buffered 
Saline (PBS). Cells were detached from the culture flask surface by adding 2mL 
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Trypsin/EDTA (0.25%) and incubated at 37 oC for 5-10 min. Trypsin was then neutralised by 
adding 5 mL fresh medium. Later, cells were centrifuged and re-suspended in a fresh medium. 
Cells were maintained at 37 oC in a humidified atmosphere containing 5% CO2. The medium 
was changed every two-three days and cells were checked under microscope.  
 
2.4.2. In Vitro Cytotoxicity Studies by Colourimetric MTT Assay 
In vitro cytotoxicity of synthesised SiNPs was assessed by standard MTT [3-(4,5-
dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide] bioassay in cancerous and normal 
cells.25 This can evaluate the influence of samples on cell proliferation. MTT measures the 
mitochondrial activity of cells using tetrazolium salts which act as mitochondrial 
dehydrogenase enzymes and cleave the tetrazolium ring. This only occurs in living cells. 
Initially, Caco-2 and CCD-841 cells were seeded in a 96-well culture plate (Applied 
Biosystems) at a seeding density of 4.5×104 cells per well and allowed to attach overnight at 
37 oC. After which the media was removed and replaced with a range of different 
concentrations of SiNPs suspension in media for various time points according to the table 2.2. 
At the end of these periods, the medium was removed and 10 μL of MTT (Sigma-Aldrich) 
solution (5mg/mL in sterile water) mixed with 100 μL fresh medium was added to each well 
including controls for determination of living cells.  
After four hours incubation at 37 oC, the medium was removed and formazan was 
solubilised in dimethylsulfoxide (DMSO). The absorbance was recorded by a microplate reader 
(BMG Labtech Polar Star Optima) at the wavelength of 570 nm. The percentage of mean cell 
viability was calculated from a minimum of triplicate wells normalised to untreated control 
cells. All experiments were repeated at least three different occasions and experimental error 
given as a standard deviation. 
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Table 2.2. List of different experimental conditions used for MTT assays.  
 
Chapter 
 
NPs 
 
Concentration (µg/mL) 
 
Incubation 
Time (h) 
 
Cell Line 
 
3 
 
NH2 SiNPs 
(top down) 
 
5, 10, 20, 50, 100 
 
24, 48 
 
Caco-2 
CCD-841 
 
3 
 
NH2 SiNPs 
(bottom up) 
 
5, 10, 20, 50, 100 
 
24, 48 
 
Caco-2 
CCD-841 
 
 
3 
 
Thiourea SiNPs 
NH2 SiNPs 
(top down, control) 
 
 
5, 10, 20, 50,100, 200, 
500, 1000, 1200, 1500 
 
 
24, 72 
 
Caco-2 
CCD-841 
 
 
4 
 
ITC SiNPs 
(P Br SiNPs) 
 
NH2 SiNPs 
(top down, control) 
 
 
 
5, 10, 15, 20, 30, 50, 70 
 
 
24, 48 
 
Caco-2 
CCD-841 
 
 
4 
 
ITC SiNPs 
(P NH2 SiNPs) 
 
NH2 SiNPs 
(top down, control) 
 
 
 
5, 10, 15, 20, 30, 50, 70 
 
 
24, 48 
 
Caco-2 
CCD-841 
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2.4.3. Cellular Uptake Studies 
2.4.3.1. Bioimaging 
2.4.3.1.1. Microscope Slide Preparation and Cell Staining 
Caco-2 cells were seeded on a 12 well plate with a sterile ø 18 mm borosilicate glass cover 
slip at a density of 1×105 cells per well and were allowed to attach overnight at 37 oC. Cells 
were grown on cover slips until approximately 70% confluent. The growth medium was then 
removed and 100 µg/mL of SiNPs were added on top of the cells (Control was also made at 
the same time). Cells were incubated with thiourea functionalised SiNPs for 2 and 4 h and ITC 
SiNPs for 6 and 12 h at 37°C.  
After these time periods, cells were washed three times with PBS and fixed by 4% (v/v) 
paraformaldehyde (PFA) in FBS solution for 20 min at room temperature. After washing three 
times with PBS, 200 µL of NH4Cl (50 mM) was added to each well for 20 min to quench the 
effect of fixing agent. The solution was then removed and the cells were washed three times 
with PBS. Nuclei were stained with Hoechst 33342 (2 µg/mL) in PBS for 5 min. Followed by 
three times PBS washing, Texas Red-X Phalloidin (6.6 µM) was employed for actin staining. 
All cover slips were washed with PBS three times and then with autoclaved water. A drop of 
mounting media (~10 µL) was added on top of the microscope slide. The cover slips were 
turned upside down on top of the mounting media and then sealed with nail varnish. The slide 
was then dried in the fridge for approx. 30 min before use. 
 
2.4.3.1.2. Confocal Laser Scanning Microscopy 
Confocal imaging is an optical imaging technique that produces highly detailed images and 
is used for an increased optical resolution and contrast of images over conventional 
microscopes. This is achieved by adding a spatial pinhole at the confocal plane of the lens to 
eliminate out of focus light.26 In addition to allowing improved observation of fine details, this 
technique enables the reconstruction of three-dimensional (3D) structure of a specimen by 
assembling a series of thin slices taken along the vertical axis.  
Confocal microscopy can overcome the limitations of wide-field fluorescence microscopes. 
In these conventional microscopes, the sample is flooded evenly in light from a source. Thus, 
all parts of the sample being analysed are excited at the same time and the resulting 
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fluorescence is detected. A confocal microscope, on the other hand, uses point illumination and 
a pinhole in an optically conjugate plane in front of the detector in order to eliminate the out of 
focus signal. A spot of a minimum size in the specimen is illuminated and an image formed by 
scanning the specimen. 
Figure 2.8 shows the internal mechanism of a confocal microscope. First, the laser light is 
directed by a dichroic mirror towards a pair of rotating mirrors which scan the light over the x 
and y plane. The light then passes through the microscope objective and excites the sample. 
The fluorescent light from the sample passes back through the objective, followed by the same 
set of rotating mirrors used to scan the sample. After that, the light passes through the dichroic 
mirror through a pinhole placed in the confocal plane of the sample. Next, the pinhole rejects 
all out-of-focus light arriving from the sample. Finally, the light that emerges from the pinhole 
is measured by a detector.27 
 
           
Figure 2.8. Schematic diagram of a conventional confocal microscope reproduce from Prasad et al.27  
The light passes through a diachronic mirror followed by two rotating mirrors in x and y directions. 
Then, the light excites the specimen. The fluorescence light from the sample passes through the same 
components and then directed to the pinhole which lies in the back focal plane of the sample and rejects 
most of out of focus light.  The light that emerges from the pinhole is measured by a detector. The inset 
shows the light from the focal point that reaches the screen is allowed through and the light away from 
the focal point is mostly rejected. 
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Laser scanning confocal microscopy was performed on a Zeiss LSM510 META confocal 
microscope using a 63× oil immersion objective lens for imaging. SiNPs were excited using a 
488 nm laser beams. Hoechst was excited using a 364 nm laser and Phalloidin imaging was 
performed using 543 nm excitation wavelength.  
The same microscope was used to image cells in multi-track mode. Z-series images were 
collected with stepper motor. ImagePro software was used to process the images. 
 
2.4.3.2. Flow Cytometry 
Flow cytometry is a laser-based technology that allows simultaneous multi-parametric 
analysis such as cell counting, cell sorting, biomarker detection and protein engineering. This 
can happen by suspending cells in a stream of fluid and passing them by an electronic detection 
apparatus. This technique is able to measure the light scattering and fluorescence from 
biological cells as well as particles. Individual cells with fluorophore labels can be 
characterised by flow cytometry and provide semi quantitative information about the cellular 
uptake of NPs.28, 29 
The optical system in flow cytometry comprises several lasers which illuminate the particles 
present in the stream as they pass through and scatter light from the laser. Any fluorescent 
molecules on the particle can be detected by various lenses. The light scattered from up to six 
or more fluorescence molecules is determined from two different angles. Optical filters and 
beam splitters then direct the light signals to the relevant detectors, which emit electronic 
signals proportional to the signals that hit them. Data can then be collected on each particle or 
event and the characteristics of those events or particles are determined based on their 
fluorescent and light scattering properties. The size of the cells can be measured using forward 
scatter and the granularity of cells by side scatter (Figure 2.9) 
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Figure 2.9. Schematic representation of a flow cytometer with different lasers. The sample containing 
cells with fluorescence molecules is injected in the middle of a fluid sheeth and funnelled to give a 
single line of ordered cells. The cells are passed through a laser beam that measures the forward 
scatter (FSC) and side scatter (SSC).30 
 
Fluorescence-activated cell sorting (FACS) is a specialised type of flow cytometry which 
provides a method for sorting a heterogeneous mixture of biological cells into two or more 
containers. Each cell is analysed one at a time, based upon their specific light scattering and 
fluorescent characteristics. FACS is a useful scientific instrument since it provides fast, 
objective and quantitative recording of fluorescent signals from individual cells as well as 
physical separation of cells of particular interest. The cell suspension is entrained in the centre 
of a narrow, rapidly flowing stream of liquid. The flow is arranged based on the relative 
diameter of cells so that there is a large separation between cells. A vibrating mechanism causes 
the stream of cells to break into individual droplets. One cell per droplet is analysed by this 
system. The flow passes through a fluorescence measuring station where the fluorescent 
character of each cell of interest is measured. An electrical charging ring is placed where the 
stream breaks into droplets. A charge is placed on the ring based on the immediately prior 
fluorescence intensity measurement, and the opposite charge is trapped on the droplet as it 
breaks from the stream. The charged droplets then fall through an electrostatic deflection 
system that diverts droplets into containers based upon their charge.31 
Caco-2 and CCD-841 cells were seeded on 24 well plates at a density of 5×104 cells per 
well and incubated at 37 oC overnight. The attached cells were subsequently washed with PBS 
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and exposed to a range of different concentrations of SiNPs for various time points according 
to table 2.3. The cells were trypsinised and then washed three times with PBS followed by 
centrifugation at 1200 rpm for 5 min after each washing. Finally, the cells were fixed with 4% 
(v/v) PFA in FBS for 20 min and washed again with PBS. Prior to the flow cytometric 
measurement, the cells were re-suspended in a buffer of 5 % (v/v) FBS in PBS. The uptake of 
NPs was examined in 10,000 gated cells by detecting SiNPs fluorescence using FL1 channel 
detector under the excitation wavelength at 488 nm and a BD FACS Calibur (BD Bioscience). 
Measurements were performed in triplicate (with different sets of NPs) and data was analysed 
with CellQuest Pro® software (BD Biosciences) and presented as median ± SD. 
 
Table 2.3. List of different parameters examined in flow cytometric analysis.  
 
Chapter 
 
NPs 
 
Concentration   
(µg/mL) 
 
Incubation 
time 
 
T (oC) 
 
Cell line 
 
3 
Thiourea 
SiNPs 
10, 20, 50, 100 
 
30 min, 4 h 
 
37 
 
Caco-2 
 
3 
NH2 SiNPs 
(control) 
10, 20, 50, 100 
 
30 min, 4 h 
 
37 
 
Caco-2 
3 
Thiourea 
SiNPs 
 
 
100 30 min,  
1, 4, 6, 8 h 
 
 
37 
 
Caco-2 
 
CCD-841 
3 
NH2 SiNPs   
(control) 
 
 
100 30 min,  
1, 4, 6, 8 h 
 
 
37 
 
Caco-2 
 
CCD-841 
4 ITC SiNPs 
 
20 and 80 
 
6, 12, 24, 48 h 
 
37 
 
Caco-2 
4 ITC SiNPs 
 
80 
 
6, 12, 24 h 
 
4, 37 
 
Caco-2 
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2.4.4. ELISA Assay 
The enzyme-linked immunosorbent assay (ELISA) is a test that benefits using antibodies 
and colour change to identify an analyte, usually an antigen, in a sample.  
Antigens from the sample are attached to a surface. Then, a specific antibody is added to the 
surface so it can bind to the antigen. The secondary antibody, which is linked to an enzyme, is 
added and attach to the primary antibody. Finally, a substance containing the enzyme's 
substrate is added. The subsequent reaction produces detectable signal, most commonly as a 
colour change in the substrate, which correlates to the amount of analyte present in the original 
sample.32 
        
Figure 2.10. Schematic representation of an indirect ELISA assay. Unknown amount of antigen is 
coated to the well and it is incubated with dilutions of antibodies. The antigen bound antibody is then 
recognized by the secondary antibody linked to the enzyme. A colorimetric substrate is used to 
measure the level of antibody. 
 
Caco-2 cells were seeded on a 96 well plate at a seeding density of 5×104 cells per well and 
incubated overnight at 37 oC. Thiourea and amine capped SiNPs were added at a range of 
different concentrations from 10 to 100 µg/mL for 4 h. The media was then removed and 100 
µL of 4 % (v/v) PFA was added to each well for 15 minutes to fix the cells. Cells were washed 
twice with 100 µL tris-buffered saline (TBS). Permeabilization buffer (100 µL, 0.5 % Triton 
X) was added and incubated for 15 minutes at room temperature. Followed by another TBS 
washing, NH4Cl (100 µL) as the quenching solution was added. Then blocking buffer (10 % 
(v/v) FBS in PBS) was added and incubated for 30 minutes. The primary antibody (Anti-EGFR 
antibody, 0.2 mg/ml, 1:1000) was added to each well and incubated overnight at 4 oC. The day 
after, the primary antibody solution was removed and the plate was washed three times with 
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the wash buffer. The secondary antibody (anti-rabbit IgG, HRP-linked antibody, 2 mg/ml BSA, 
1:1000) was added and incubated for 30 minutes at room temperature. Finally 3,3’,5,5’-
Tetramethylbenzidine (TMB) substrate (100 µL per well) was added to each well and incubated 
at room temperature and protected from light. The TMB stop solution (100 µL per well) was 
added after 15 minutes when the blue colour was achieved and the absorbance was measured 
at 450 nm using a microplate reader (BMG Labtech Polar Star Optima) within 30 minutes of 
stopping the reaction.   
Before the whole cell staining, the plate was emptied and washed twice with ultrapure water. 
Janus Green Whole Stain (100 µL per well, 0.3%) was added to each well and incubated for 5 
minutes at room temperature. All excess stain was removed followed by 3-5 times washing 
with ultrapure water (200 µL per well). The Elution buffer (100 µL per well) was added and 
the absorbance was measured at 615 nm after 10 minutes incubation at room temperature. 
 
2.5. Synchrotron-based Fourier Transform Infrared Microspectroscopy 
Techniques  
A synchrotron is an electron storage ring that produces intense broadband light from X-rays 
through microwaves. Synchrotron radiation is the light emitted by relativistic electrons in high-
energy accelerators along a circular trajectory. Infrared beamlines collect synchrotron light 
from bending magnets in the electron storage ring. This light extends from X-rays down 
through the infrared spectral range, and acts as a source for a number of biologically relevant 
measurement techniques. This is particularly important for the infrared where the high source 
brightness enables microspectroscopy to be performed at the unprecedented resolution of just 
a few microns. This size scale is appropriate for investigating the variations in individual cells 
and therefore has a great advantage over other techniques since biological cells and tissues are 
extremely complex structures that vary widely in composition.33  
Infrared microspectroscopy is a quantitative analytical and non-destructive technique. The 
IR microscope beamlines are designed around an excitation system that collects ~40 mr from 
the storage ring. The extraction of the synchrotron light from the storage ring is commonly 
done with a combination of gold or aluminium coated plane and toroid/ellipsoid or spherical 
mirrors. The infrared light is focused through an infrared-transparent window, such as KBr and 
CaF2, which separates the ultrahigh vacuum (UHV) conditions of the storage ring and the rough 
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vacuum of the IR beamline. The IR transparent windows isolate the beamline vacuum from the 
ambient pressure of the microscope. The beam is then re-collimated and directed into the IR 
microscope. Although IR light passes easily through water vapour and carbon dioxide (CO2), 
it is highly absorbed by air, thus IR microscopes are typically purged with dry nitrogen or dry 
air.34, 35 
Synchrotron measurements in this work were performed at D7 beamline (MAX-IV 
laboratory, Lund, Sweden). 
 
2.5.1. Sample Preparation 
Free standing SiNPs were added on top of KBr substrates for analysis.  
Caco-2 and CCD-841 cell lines were used for synchrotron measurements. Cells were seeded 
on CaF2 IR optical substrates for the measurements, which were placed in 12 well plates, at a 
density 5×104 cells per well. All substrates were cleaned with 70% ethanol before being used 
for cell culture. After 24 h incubation, the media was removed and cells were washed three 
times with PBS. Then 50 µg/mL of ITC SiNPs were added to the cells and incubated for 6 h 
according to table 2.4. At the end of this time period, the growth medium was removed and 
cells were washed three times with PBS and then NaCl (0.9 %) and fixed with 4% PFA in PBS 
for 30 min. Then substrates were washed with distilled water and dried under ambient 
conditions. They were stored in the fridge before analysis under IR microscope.35  
 
2.5.2. Synchrotron FTIR Microspectroscopy 
The IR microspectroscopy measurements were performed on a Bruker IFS66V FTIR 
spectrometer coupled to a Hyperion 3000 infrared microscope using synchroton radiation at 
MAX-IV laboratory. The microscope was operated in transmission mode with a 10×10 µm2 
aperture using a ×15 objective and a condenser along with a single element, 100×100 µm2 
MCT detector. This arrangement gives a visible magnification of ×115 for the video camera in 
the microscope used to locate relevant structures in the samples. The data acquisition was 
performed using OPUS software (Bruker) version 7. The spectra selection for data treatment 
was based on eliminating those with very weak absorbance (poor S/N ratio). About 100 spectra 
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were analysed on each substrate for each cell line. Spectra were obtained by co-addition of 256 
scans at a spectral resolution of 4 cm−1. 
 
 
Figure 2.11. Schematic representation of a synchrotron FTIR microspectroscope reproduced from 
Bhargava.36 
 
 
2.5.3. FTIR Imaging Using Focal Plane Arrays Detector (FPA)   
A conventional globar was used as light source for the FTIR imaging spectra in transmission 
mode. Optical and FTIR images were performed with the same microscope and spectrometer 
and a 128 × 128 FPA detector with individual dimension of detectors 40 × 40 μm2; Bruker 
Optik, Ettlingen, Germany. In order to minimise the atmospheric variations and ensure 
optimum spectral acquisition, N2 was performed on both spectrometer and microscope. As the 
transmission mode uses a 15× objective this gives a sample area of 340 × 340 µm2 for each 
image. This enables the visualisation of the structure and quantitative spectral characterisation 
with the necessary signal to noise ratio. Spectral images were obtained by co-addition of 128 
scans at a spectral resolution of 8 cm−1. After recording the spectra, images were performed 
using the integrated intensities of selected spectral areas characteristic of either protein or 
phospholipid constituents and colour codes were used to determine the distribution of the 
examined constituent. 
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Figure 2.12. Photograph of the synchrotron FTIR microspectroscopy facility at MAX-IV 
laboratory, Lund. 
 
 
Table 2.4. List of different parameters examined in FTIR synchrotron microspectroscopy and imaging. 
 
NPs 
 
Concentration 
 
Incubation Time 
(h) 
 
Cell Line 
 
Substrate 
 
ITC SiNPs 
(P Br SiNPs) 
 
NH2 SiNPs 
 
 
50 µg/mL 
 
 
6 
 
Caco-2 
CCD-841 
 
CaF2 
 
ITC SiNPs 
(P Br SiNPs) 
 
ITC SiNPs 
(P NH2 SiNPs) 
 
Br SiNPs 
NH2 SiNPs 
 
 
 
5 mg 
 
 
 
_ 
 
Free 
standing 
material 
 
 
 
KBr 
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2.6. Statistics 
Statistical methods throughout this study are represented as mean ± SEM taken over a 
minimum of three independent experiments. Statistical significance was measured by two-
way-ANOVA followed by a Bonferroni post-test using GraphPad Prism version 5.03 for 
Windows, GraphPad Software, San Diego California, USA. 
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3.1. Overview 
Conventional cancer chemotherapies have been associated with serious systemic toxicities 
and dose-limiting side effects that restrict their clinical application.1 Targeted therapeutics on 
the other hand, by being more selective, can potentially minimise the side effects of these 
anticancer agents by avoiding healthy cells.2, 3 In efforts to develop targeted anticancer drugs, 
it is essential to consider many different aspects of molecular biology, such as the interactions 
with cell surface receptors.4, 5 RTKs have been identified as major contributors in numerous 
signal transduction pathways and are implicated in cell proliferation.6, 7 EGFR is one of the 
most important RTKs and plays a key role in a wide diversity of biological processes, including 
cell proliferation, metastasis, and angiogenesis.8-10 Although EGFR is involved in various 
physiological processes, and as such is expressed in non-malignant tissues, this tyrosine kinase 
has been shown to be over-expressed in tumours of epithelial origin such as colon, breast, 
ovarian, lung, and prostate cancer.11, 12 Consequently, EGFR overexpression in cancerous 
tissue presents an attractive target for compounds with inhibitory activity. 
Among the anticancer drugs discovered in recent years, thiourea compounds have shown 
potent anticancer properties owing to their strong inhibitory activity against RTKs, PTKs, and 
NADH oxidase, which are all active in the process of tumorigenesis.10, 11, 13 EGFR, as one of 
the important PTKs, is known to be overexpressed in many types of cancer cells. This receptor 
has also been identified as the prime target of thiourea based chemotherapeutics. 
In this chapter we report the synthesis of thiourea-functionalised SiNPs as a new 
multifunctional nanoscale system. By developing such hybrid nanoparticles, we can exploit the 
unique optical properties of SiNPs whilst introducing the functionalities of the thiourea ligand 
for diagnostic applications. We herein report the synthesis and in vitro evaluation of the toxicity 
and targeting activity of thiourea-functionalised SiNPs. This approach investigates the ability 
of thiourea to target EGFR overexpression in cancer cells whilst taking advantage of the 
intrinsic photoluminescence properties of SiNPs, without the need for any fluorescent tags.  
First, we demonstrate the synthesis and characterisation of amine-functionalised SiNPs 
produced by top down and bottom up techniques. The full detailed evaluation of the products 
obtained from each method will be discussed as well as the advantages and disadvantages of 
each technique.  Based on the data obtained and considering the strengths and weaknesses of 
each type, the top down NH2 SiNPs were chosen for the remainder of the project due to the 
Chapter 3                        Synthesis and Characterisation of Thiourea-functionalised Silicon Nanoparticles  
 
 
99 
higher level of purity they exhibited. These particles were used as control material in nanoscale 
within Chapter 3 and 4. In addition, amine functional group in these compounds can be used 
for further functionalisation to synthesise ITC SiNPs (Chapter 4).  
The rest of this chapter will focus on the synthesis and characterisation of thiourea-
functionalised SiNP. A thiourea ligand was synthesised followed by hydrosilylation to 
functionalise SiNPs with this specific functional group. The hydrogen terminated SiNPs were 
first prepared through the electrochemical etching of porous silicon and later functionalised by 
thiourea. These functionalised SiNPs were tested in terms of cytotoxicity to colorectal cancer 
and primary cells and active EGFR-mediated targeting. In several respects, these novel 
nanoparticles offer significant advantages compared to conventional therapeutics. These 
include the integration of the targeting moiety and therapeutic moiety in the same system, the 
use of inexpensive materials and more significantly the production of a highly stable 
nanosystem. 
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3.2. Synthesis of Hydrogen-terminated Silicon Nanoparticles 
Hydrogen terminated SiNPs were synthesised by galvanostatic anodization of porous 
Silicon layer (boron-doped p-Si (100) chip with 1.25 × 1.25 cm2 size) in a 1:1 v/v solution of 
48% aqueous HF and ethanol as described in Chapter 2 and reported previously.14 As these 
obtained SiNPs rapidly undergo oxidation in air, it is important to stabilise them using different 
surface functionalisation. 
 
3.3. Synthesis of Amine-functionalised Silicon Nanoparticles by Top Down 
Method 
One of the methods to functionalise SiNPs uses allylamine which can avoid oxidation on 
the nanoparticle surface, and also solubilise nanoparticles in polar solvents such as water and 
alcohol. Moreover, introducing the amine functional group can produce a platform as a 
common starting material ideally suited for further functionalisation, as this functional group 
is reactive and has the potential for further modification. These factors contribute to the 
development of a nanosystem with more specialised characteristics for biomedical 
applications.  
Amine-functionalised SiNPs were synthesised by reacting the hydrogen-terminated porous 
silicon with allylamine, in the presence of H2PtCl6 catalyst in isopropanol (Scheme 3.1). 
 
 
Scheme 3.1. Schematic illustration of the top down synthesis of NH2 SiNPs. 
 
 
Si
Si
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3.4. Synthesis of Amine-terminated Silicon Nanoparticles by Bottom Up 
Method 
There are several issues relating to the nanoparticles obtained from top down methods which 
limit their large scale industrial biomedical applications. Examples of these are the low quantity 
of materials obtained from each batch, and less control over the shape and size of 
nanoparticles.15 Therefore, it is important to investigate bottom up methods as an alternative, 
which may remedy some of these drawbacks. Here, an attempt to synthesise NH2 SiNPs by 
bottom up methods was undertaken in order to understand how such issues might be addressed.  
NH2 SiNPs were synthesised using a method outlined by Wang et al.
16 by adding APTES 
to an aqueous solution while stirring. Next, ascorbate sodium was added to the mixture 
followed by stirring for 20 min. This was a simple one-step reaction (Scheme 3.2). 
 
 
Scheme 3.2. Schematic illustration of the bottom up synthesis of NH2 SiNPs. 
  
3.5. Characterisation of Amine-terminated Silicon Nanoparticles 
In order to evaluate which group of NH2 SiNPs has potential to be used in this project, 
chemical and optical characterisation was performed on both products. This was followed by 
a cytotoxicity assay to determine the suitability of these nanoparticles for biomedical 
applications. 
 
3.5.1. Chemical Bonding by FTIR 
Using FTIR as a spectroscopic tool, NH2 SiNPs prepared by different methods, were 
analysed. The spectrum of top down NH2 SiNPs is shown in Figure 3.1 (a). The observed peaks 
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at 1260 and 1450 cm-1 are representative of Si-C symmetric bending and Si-CH2 scissoring 
modes respectively.17 The features at around 2800 to 2900 cm-1 are assigned to the C-H 
stretching of the alkane in the ligand. The N-H stretching of the amine functional group was 
observed around 3400 cm-1 in top down NH2 SiNPs as well as the bottom up product in 
spectrum (b).18  The N-H wagging and scissoring were observe at around 970 and 1590 cm-1 
respectively.14, 16 The combination of these features demonstrate the successful 
functionalisation of both synthetic procedures. Further oxidation was observed for the bottom 
up NPs with the wider signal observed at about 1000 cm-1 characteristic of Si-O bond.19 
 
 
Figure 3.1. FTIR spectra of NH2 SiNPs synthesised by top down (a) and bottom up method (b). 
 
3.5.2. Elemental Analysis EDX 
Elemental analysis of the NH2 SiNPs using energy-dispersive X-ray spectroscopy (EDS) 
analysis is shown in Figure 3.2 (a) and (b). Nanoparticles were coated with a layer of gold prior 
to the measurement. The analysis clearly indicated the presence of silicon and carbon in spectra 
and elements appeared in the expected ratios. However the ratio of oxygen to silicon appeared 
higher in the spectra of bottom up NH2 SiNPs compared to the top down NPs. This could be 
due to the presence of oxygen on saline compounds which are used as the starting material in 
the synthesis of bottom up nanoparticles. Moreover, there were impurities observed in the 
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bottom up samples which came from the reagent ascorbate sodium used in the synthesis of 
bottom up nanoparticles. It should be noted that although dialysis was undertaken for 24 and 
48 h to purify the bottom up nanoparticles, there was still signs of impurities after these 
purification steps. On the other hand, the level of oxide on NPs increased after the long term 
dialysis which might be due to the long exposure to the solvent.  
 
 
 
   Figure 3.2. EDX spectrum of NH2 SiNPs synthesised by top down (a) and bottom up (b) methods. 
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3.6. Size and Dispersity Measurement of Amine-functionalised SiNPs 
3.6.1. Visualisation and Size Measurement by TEM 
TEM images of NH2 SiNPs are shown in Figure 3.3 top down and Figure 3.4 bottom up. 
Part (c) each figure gives the size distribution of SiNPs with an average diameter of 5.02 nm 
for the top down and 1.46 nm for the bottom up nanoparticles. The lattice spacing values of 
0.31 and 0.29 nm are consistent with the Si (111) plane 20 (part (d) in each figure). 
 
  
 
 
Figure 3.3. TEM images of top down NH2 SiNPs (a) and (b) and the histogram showing the distribution 
of nanoparticle diameters (c) from 85 nanoparticles and the lattice spacing of Si (111) plane (d). 
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Figure 3.4. TEM images of bottom up NH2 SiNPs (a) and (b) and the histogram showing the distribution 
of nanoparticle diameters (c) from 100 nanoparticles and the lattice spacing of Si (111) plane (d). 
 
 
3.6.2. Hydrodynamic Size and Zeta Potential Measurement by DLS 
The hydrodynamic diameters of NH2 SiNPs in water were was measured by DLS. Top down 
nanoparticles had an average of 7.45 nm which was slightly larger than the core size obtained 
from TEM, as expected.21, 22 This could be due to the presence of the amine groups, which 
increase the hydrophilicity of SiNPs and form a hydration shell around the nanoparticles.23 The 
small size of bottom up nanoparticles was confirmed by DLS, measured as 4.05 nm in water 
(Figure 3.5). As particles smaller than 5 nm benefit the renal clearance in vivo, the smaller size 
of bottom up nanoparticles might offer the advantage of this method for biomedical 
applications.24    
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Figure 3.5. Hydrodynamic size of NH2 SiNPs synthesised by top down (a) and bottom up (b) 
methods dispersed in water measured by DLS. 
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nanoparticles is better than the top down nanoparticles. This is due to the use of saline at the 
beginning of the synthesis (for bottom up NPs), which already has NH2 with this compound. 
This fact can show a better colloidal dispersity of particle obtained from bottom up techniques 
due to the better surface coverage by the ligand. 
 
 
 
 
Figure 3.6. Zeta potential of NH2 SiNPs synthesised by top down (a) and bottom up (b) methods. 
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3.7. Optical Properties of Amine-functionalised SiNPs 
3.7.1. Absorption and Emission Spectra 
The absorption and emission spectra of NH2 SiNPs in water are presented in Figure 3.7 by 
top down (a) and bottom up (b) methods.  There was a gradual increase in absorbance with a 
decrease in the wavelength from the onset of 450 nm for both types of NH2 SiNPs. The 
emission spectrum of nanoparticles in water was centred at 440 nm for the top down and 460 
nm for the bottom up with a full width at half maximum height (FWHM) of 99 and 70 nm 
respectively (Excitations: 360 and 400 nm). 
 
 
Figure 3.7. Absorption and emission spectra of top down NH2 SiNPs (a) and bottom up NH2 SiNPs 
(b) dispersed in water (The excitation wavelength was set at 360 and 400 nm respectively). 
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3.8. Biomedical Studies of Amine-functionalised SiNPs 
3.8.1. In vitro Cytotoxicity Assay by MTT 
The purpose of using NH2 SiNPs in this project is firstly to use them as control samples for 
biological experiments in order to compare the efficiency of other types of nanoparticles 
(thiourea and ITC-functionalised SiNPs) with these non-toxic nanoparticles. In addition, they 
can be also exploited to be used as the starting material for further surface modifications. As a 
result, the toxicity should be measured and regulated if it is to be used as an appropriate control. 
MTT assay was performed on both types of NH2 SiNPs to assess the cell viabilities.  Caco-2 
cells were incubated with different concentrations of NH2 SiNPs for 24 and 48 h. As shown in 
Figure 3.8 (a), the cytotoxicity of top down nanoparticles was very low for both time points 
and even after 48 h incubation cells remained at 80% of their initial cell viability after 
incubation with 100 µg/mL nanoparticles. However, when the concentration of bottom up 
nanoparticle increases, a slight reduction in cell viability was observed. The loss of cell 
viability continued to ~ 60 % after 48 h incubation with 100 µg/mL NH2 SiNPs (Figure 3.8 
(b)). Using the bottom up approach to synthesise SiNPs often adds unwanted impurities,25, 26 
and so would cause the difference in toxic behaviour between the two types of NPs. This is 
confirmed by the EDX data (Figure 3.2). 
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(b) 
 
Figure 3.8. In vitro cytotoxicity of NH2 SiNPs synthesised by top down (a) and bottom up (b) by MTT 
after incubation with Caco-2 at 24 and 48 h. Statistical significance was determined by two-way-
ANOVA followed by a Bonferroni post-test (*P < 0.05).  Results are expressed as mean ± SEM (n =3). 
  
Consequently, by evaluating the chemical and physical characterisation data, the desired 
structure for NH2 SiNPs was obtained in both synthesis methods. The greater positive surface 
charge of bottom up nanoparticles suggests the higher stability of nanoparticle in biological 
environments due to the better surface coverage by the amine functional group.16 Although a 
bottom up approach offers a better chance to offer a more uniform size distribution (Figure 3.4 
(c)) and a larger scale production, it requires an extensive purification protocol which results 
in substantial residue oxidation on the nanoparticle surface (Figure 3.1(b)). The key 
disadvantage of the top down method, on the other hand, could be considered to be the 
scalability for the industrial quantities. However, there are some examples of this method being 
successfully applied beyond milligram scales. The British company pSiMedica and Japanese 
company Tokao Yonehara of Canon Inc.27 have developed functionalised porous silicon in 
large quantities. This can be done by directing the anodization of 10,000 silicon wafers per 
month. In this technique, layers of pure silicon are deposited onto the porous layer of a silicon 
wafer. Then, the wafer is bonded to another silicon wafer with an insulating silicon-oxide 
surface, in a way that the pure layer of silicon ends up sandwiched in the middle. The porous 
silicon is selectively dissolved away to leave the desired product which is silicon on top of an 
oxide layer on top of the silicon wafer. This technique can therefore scale up the 
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electrochemical etching to produce porous silicon and meet the requirements of manufacturing 
scale up.27  
As the top down approach synthesises a purer form of NH2 SiNPs, they are easily dispersed 
in aqueous solvents with no sign of aggregation as shown by Ahire at el.14 Noting that these 
nanoparticle are to be used as probes in bioassays in for this project, their lower cytotoxicity is 
prioritised over a larger quantity of production, and therefore the top down NH2 SiNPs were 
chosen for the rest of the project to act as control for biological experiments.  
 
3.9. Synthesis of Thiourea-functionalised Silicon Nanoparticles 
Conjugation of thiourea onto the SiNP surface has high potential for the active targeting of 
EGFR overexpressing cancer cells. This can therefore increase the stability of silicon, enhance 
the nanoparticle cell uptake and reduce the fast clearance of the nanoparticles from the body 
since the capping ligand renders hydrogen terminated SiNPs hydrophilic to provide stable 
dispersions. In order to evaluate the potential of such systems, a ligand containing a thiourea 
segment was synthesized via the reaction between sulforaphane and allylamine and 
subsequently used to functionalise the surface of hydrogen terminated SiNPs (Scheme 3.3). 
 
 
Scheme 3.3. Schematic illustration of (a) the chemical synthesis of thiourea ligand and (b) the 
conjugation of thiourea onto the surface of hydrogen capped silicon nanoparticles via hydrosilylation 
reaction. 
Si
 
Si
Chapter 3                        Synthesis and Characterisation of Thiourea-functionalised Silicon Nanoparticles  
 
112 
3.10. Chemical Characterisation of Thiourea-functionalised SiNPs 
3.10.1. Chemical Bonding by FTIR 
The FTIR spectra of Sulforaphane, thiourea and thiourea-functionalised SiNPs are presented 
in Figure 3.9. The absorption peak at 1012 represents S=O in the structure of Sulforaphane as 
the starting material. Vibrations related to C-N and C-S bonds can be seen at 1298 and 692 cm-
1 respectively.28, 29 The characteristic feature of the isothiocyanate functional group can be 
clearly observed as a prominent double peak at 2099 cm-1.30 These peaks disappeared after 
reacting with allylamine but the stretching frequencies related to N-C-N vibrations in thiourea 
group were found at 1545 cm-1. The band at 3279 cm-1 represent the stretching vibration of the 
N-H bond in the derivative thiourea.31 After surface functionalisation of SiNPs with thiourea, 
a peak at 1258 cm-1 can be seen which is a strong indicator of Si-C bonding.17 In addition, there 
was no evidence of Si-H stretching at 2100 cm-1.32 Therefore, the thiourea ligand with a 
terminal double bond reacted with the hydrogen terminated silicon surface via hydrosilylation 
in order to give a covalent Si-C linkage on the surface of the nanoparticles. 
 
 
Figure 3.9. FTIR spectra of (a) sulforaphane; (b) thiourea and (c) thiourea-functionalised SiNPs. 
The relevant features of each spectrum are highlighted. 
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3.10.2. Elemental Analysis by EDX 
EDX analysis was performed on thiourea-functionalised SiNPs coated with gold (Au) as the 
reference. A sharp signal was detected indicative of the silicon core and the surface of 
nanoparticles was shown to be coated with carbon, sulphur and oxygen atoms (Figure 3.10). 
 
 
Figure 3.10.  EDX spectra of thiourea-functionalised SiNPs. 
 
3.10.3. Elemental Analysis by XPS 
For further evidence of the nanoparticle structure, the surface chemical bonding was 
investigated using the full survey and high resolution XPS spectroscopy. Figure 3.11 shows 
the full survey of the photoelectron spectrum. The high resolution XPS spectra of Si2p, C1s, 
O1s and N1s regions taken on a thin film of thiourea-functionalised SiNPs are presented in 
Figures 3.12 to 3.15. 
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Figure 3.11. XPS full survey spectrum from thiourea-functionalised SiNPs deposited on a gold 
substrate. 
 
Figure 3.12 indicates that the Si2p spectrum is fitted with three components and a Shirley 
background. The three peaks are located at 101.95, 102.73 and 100.91 eV. The first peak is 
attributed to Si-C confirming the hydrogen on the surface of SiNPs is replaced with thiourea.33 
The second peak at binding energy 102.73 eV is related to Si-O due to partial surface oxidation 
under the ambient conditions.34 The third component at 100.91 eV is assigned to Si-Si within 
silicon core of NPs.35, 36 
 
 
Figure 3.12. High resolution XPS spectrum from thiourea-functionalised SiNPs showing Si2p region. 
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The C1s spectrum is fitted with three components and a Shirley background (see Figure 
3.13). The four peaks appeared at 284.65, 284.04, 285.50 and 286.72 eV. The first component 
at 284.65 eV is attributed to C-C bonding. The second peak at 284.04 eV relates to the existence 
of C-Si and finally the last two peaks at 285.50 and 286.72 eV are assigned to C-H and C-N 
respectively.37, 38           
 
 
Figure 3.13. High resolution XPS spectrum from thiourea-functionalised SiNPs showing C1s region. 
 
 
The O1s spectrum is presented in Figure 3.14 and fitted with three components and a Shirley 
background. The first peak is related to partial oxidation at 532.01 eV for Si-O. The second 
binding energy at 533.25 eV is attributed to some hydroxide O-H group. The last component 
of O1s spectrum is assigned to O-S at 531.10 eV.36   
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Figure 3.14. High resolution XPS spectrum from thiourea-functionalised SiNPs showing O1s region. 
 
The N1s spectrum is presented in Figure 3.15 and fitted with two components and a Shirley 
background. The peak at 399.58 eV is assigned to C-N bonding in the thiourea. The other peak 
at 398.67 eV is attributed to N-C=S.39  
 
Figure 3.15. High resolution XPS spectrum from thiourea-functionalised SiNPs showing N1s region. 
 
According to the surface chemistry data obtained from XPS the surface of SiNPs is fully 
capped with the ligand. A table with the quantification of XPS data can be seen in Table 3.1. 
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Table 3.1. XPS data with the detailed ratio of elements present on the surface of thiourea-functionalised 
SiNPs obtained by high resolution scans. 
Scans Positions Position (eV) FWHM Area % 
 
 
Si 2p 
Si-C 101.95 1.0320 11177.421 70.32 
Si-O 102.73 1.0369 3803.808 23.93 
Si-Si 100.91 1.0230 913.945 5.75 
 
 
C 1s 
C-C 284.65 1.0752 2304.59 51.23 
C-Si 284.04 1.0564 15674.85 34.82 
C-H 285.50 1.2336 5203.06 11.57 
C-N 286.72 1.1092 1057.05 2.23 
 
 
O 1s 
Si-O 532.01 1.1839 4278.528 86.96 
O-S 531.10 1.0372 4117.594 8.33 
O-H 533.25 1.1261 2461.856 4.33 
 
N 1s 
N-C 399.58 1.4741 1532.947 86.73 
N-C=S 398.67 1.237 234.52 13.27 
 
 
3.11. Size and Dispersity Measurement of Thiourea-functionalised SiNPs 
3.11.1. Visualisation and Size Measurement by TEM 
 Figure 3.16 (a) illustrates a TEM image of SiNPs on a carbon coated copper grid. A mean 
size and size distribution was found to be 4.5 nm after analysing approximately 100 SiNPs 
from different regions of the grid (Figure. 3.16 (b)). The insert figure shows the crystalline 
structure of the individual NPs. The measured lattice spacing in these crystalline particles is 
0.31 nm, corresponding to the (111) interplanar spacing of the diamond cubic structure of 
silicon.20  
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Figure 3.16. TEM image of thiourea-functionalised silicon nanoparticles (a). The insert shows an 
enlarge view of the high resolution image of the crystalline structure. The corresponding histogram of 
nanoparticle size distribution after analysing 88 particles (b). 
 
3.11.2. Hydrodynamic Size Measurement by DLS 
The size of nanoparticle plays a critical role in the efficiency of cellular uptake as it can 
determine the mechanism and uptake rate.40 The investigation of particle size therefore will 
impact on the application of nanoparticles in biomedicine.41  
The mean hydrodynamic diameters of thiourea-functionalised SiNPs are represented in 
Figure 3.17 and Table 3.2 in different solvents: water, PBS and the cell culture media RPMI 
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and RPMI/10% FBS.  The observed hydrodynamic diameters are slightly larger than those 
observed in the corresponding TEM images; understandably, as hydrodynamic diameters are 
generally larger than the core particle sizes obtained by TEM. According to the data, SiNPs 
show almost the same average diameters in all solvents. This is more than double than the core 
size of SiNPs due to the formation of an outer shell after the interaction between the capping 
ligand and the surrounding environment.42 However, the average diameter and the PdI are 
slightly increased for NPs in the RPMI containing 10% FBS, suggesting the expected 
adsorption of serum proteins on the surface of positively-charged SiNPs. This is because of the 
small size of SiNPs and their large surface area lead to partial aggregation in the biological 
media, and therefore the presence of proteins reduces the surface energy. Nevertheless, the 
aggregation was not significant as the main population of SiNPs was still observed around the 
expected sizes similar to other solvents less than 20 nm.  
 
 
Figure 3.17. Hydrodynamic diameter of thiourea-functionalised SiNPs in different dispersing 
solvents. 
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Table 3.2. Mean hydrodynamic diameters and polydispersity index of thiourea-functionalised SiNPs 
measured by DLS in different media. 
Solvent Mean Particle Size (nm) ± SD Polydispersity Index ± SD 
Water 11.32 ± 0.05 0.16 ±0.05 
PBS 12.20 ±1.05 0.22 ± 0.05 
RPMI 12.50 ± 1.26 0.20 ± 0.10 
RPMI/10%FBS 16.70 ± 4.80 0.33 ± 0.04 
 
 
3.12. Zeta Potential and Stability of Thiourea-functionalised SiNPs in 
Human Plasma 
The nanoparticles, especially if made in aqueous solution, have a surface charge to stabilise 
them against aggregation, which can happen via electrostatic repulsion. The magnitude of the 
zeta potential gives an indication of the potential stability of the colloidal system. Nanoparticles 
with a zeta potential between −10 and +10 mV are considered approximately neutral, while 
nanoparticles with zeta potentials values of greater than +30 mV or less than −30 mV are 
considered strongly cationic and anionic, respectively and therefore more stable.43 If 
nanoparticles in a suspension have a large negative or positive zeta potential, they will tend to 
repel each other and therefore there will be no tendency for the particles to come together and 
aggregate. If the nanoparticles have low zeta potential, there will be no force to prevent the 
particles coming together and flocculating. Thiourea-functionalised SiNPs were centrifuged 
and re-suspended in Milli-Q water at a final concentration of 25 μg/mL prior to the 
measurement. The zeta potential was found to be 21 ± 0.80 mV.  
The cellular growth media contains several components such as essential amino acids, 
serum proteins, vitamins, etc. These chemicals could interact with nanoparticles and change 
their physiochemical properties such as size, surface charge, surface chemistry and aggregation 
state.44 The presence of electrolytes and high ionic strength of the biological media can cause 
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nanoparticle aggregation via electrostatic screening.45 This aggregation can interfere with the 
ability of nanoparticles to interact with cells and therefore influence the cell internalisation. 
This would eventually add complexity to the system. As a result, if the aggregation state of 
SiNPs is not considered, difficulties arise when interpreting the data from uptake studies and 
nanoparticle biodistribution.46 
When nanoparticles are introduced into the growth media or plasma, they adsorb plasma 
proteins and adopt the corresponding physiochemical properties of the protein shell which is 
called protein corona.47 The protein adsorption can change the nanoparticle charge immediately 
to a similarly negative value as the serum proteins in the media.48 As a result, nanoparticles 
with originally positive charge upon preparation are no longer cationic in the cellular plasma. 
This is significant in terms of the cytotoxicity and cellular uptake of NPs and is a counterpoint 
against the common concept in the literature that cationic nanoparticles disrupt the negatively 
charged membrane of cells by electrostatic interactions. The protein adsorption on NPs can 
mediate the uptake mechanism via receptor mediated endocytosis.49 As a result, media with 
different protein compositions could lead to various levels of toxicity and uptake efficiency. 
This is important when comparing the results from different experimental parameters 
addressing the uptake and cytotoxicity of NPs.  
The surface charge of thiourea-functionalised SiNPs was tested in human plasma to 
investigate the effect of protein adsorption on zeta potential values of NPs. The stability of NPs 
was tested in human plasma at different time points (Figure 3.18). Ideally, in order to avoid the 
rapid clearance of NPs from the body, nanoparticles should minimally interact with plasma 
proteins. Therefore the influence of the NP interactions with the plasma protein adsorption was 
tested by reacting at 37 oC for different time points. The rate of zeta potential decrease of 
thiourea-functionalised SiNPs was rapid for the first hour of the exposure, indicating an 
expected adsorption of plasma proteins. Thereafter, the rate of decrease slowed substantially. 
This suggests that the protein coating by itself may increase the stability of system. 
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Figure 3.18. Zeta potential of thiourea SiNPs in human plasma at different time points. 
 
3.13. Optical Properties of Thiourea-functionalised SiNPs 
3.13.1. Absorption and Emission Spectra 
Absorption and emission spectra of thiourea-functionalised SiNPs are presented in Figure 
3.19. The inset photograph is the sample under UV illumination at 254 nm. NPs were dispersed 
in EtOH prior to the measurement as this improved the solubility of the sample. The gradual 
increase in the absorbance with decreasing excitation wavelength from the onset wavelength 
of 430 nm. The solid line shows the photoluminescence spectrum of thiourea-functionalised 
SiNPs with the maximum emission peak centre at approximately 420 nm and a full width at 
half-maximum height (FWHM) of 79 nm under an excitation wavelength of 340 nm. 
Unlike direct bandgap semiconductors, there are still many uncertainties in the relationship 
between nanoparticle surface configuration and PL properties. Contrary to silicon wafers, the 
surface structure of SiNPs is inhomogeneous and therefore is far more complex. Among all the 
emissions from SiNPs, the mechanism of the blue emission is much more controversial and 
still unclear.32, 50 Surface oxide might be one of the reasons which determines the emission 
photon energy. This blueshift is explained as a result of the size reduction of the core with 
oxidation (loss of surface atoms due to oxidation) according to the quantum confinement 
effect.50 On the other hand, Kang et al.51 confirmed the blue emission in 3 nm SiNPs originated 
from the silicon core and not from oxidation after examining the controlled oxidation on SiNPs. 
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This is because of the stable and efficient blue emission observed even after etching by HF. 
Chen et al.52 has also suggested that the silicon oxide is not responsible for the blue shift in 
porous silicon. They explain that by observing a change in the peak position of the blue band 
after varying the excitation wavelengths. Considering these previous observations, and the fact 
that FTIR and XPS data did not show high levels of oxidation-induced defects on the silicon 
surface, the likelihood of hydrosilylation causing the blueshift is stronger.53  
 
 
Figure 3.19. Absorption and emission spectra of thiourea-functionalised SiNPs at excitation at 340 
nm. The inset image shows the fluorescence from a vial of sample in EtOH when excited with a UV 
lamp. 
 
More importantly, a reasonable explanation of the origin of blue PL, found in this case, is 
provided by Veinot et al,32 who confirmed that SiNPs obtained from the nitrogen containing 
reagents could provide a short-lived excited state that gives rise to the blue emission of SiNPs. 
They applied controlled experimental conditions on SiNPs exposed to nitrogen containing 
reagents in the absence of air and observed no blue PL. SiNPs were also exposed to air in the 
absence of nitrogen compounds in order to oxidise the surface and again no blue PL was 
observed. Finally, they tested SiNPs exposed to both air and nitrogen compounds and observed 
the appearance of blue PL. Therefore, the presence of nitrogen in the structure of thiourea 
ligand with the possibility of partial oxidation occurred during the synthesis is most likely the 
reason for the blue PL of thiourea-functionalised SiNPs.  
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3.13.2. Quantum Yield Measurement 
A fluorescence quantum yield of thiourea-functionalised SiNPs was measured in EtOH by 
a comparative method described by Williams et al.54 with a reference to quinine sulphate when 
dissolved in 0.1 M H2SO4. Five solutions with absorbance within 0.1 and 0.01 were prepared 
(Figure 3.20). The gradients were obtained from the plot of integrated fluorescence intensity 
vs. absorbance for the SiNPs and reference (Figure 3.22). The quantum yield of thiourea-
functionalised SiNPs was calculated using by: 
 
                                              𝑸 =  𝑸𝑹𝒆𝒇 (
𝑮𝒓𝒂𝒅𝑺𝒊𝑵𝑷𝒔
𝑮𝒓𝒂𝒅𝑹𝒆𝒇
)(
𝜼𝑬𝒕𝒐𝑯
𝟐
𝜼𝑹𝒆𝒇
𝟐 )                              (Equation 3.1) 
 
Where 𝑸 is the quantum is yield of the sample and 𝑸𝑹𝒆𝒇 is the reference quantum yield of 
quinine sulphate in 0.1 M H2SO4 and is equal to 54.6%.55 The gradient of quinine sulphate and 
thiourea-functionalized SiNPs were 851171 and 158767 respectively according to the plots of 
integrated fluorescence intensity vs. absorbance. The refractive index of both solvents were 
known (𝜼𝐸𝑡𝑂𝐻=1.33 and 𝜼𝑅𝑒𝑓= 1.346), thus the sample quantum yield can be calculated as 
follows:                            
                
                                 𝑸 = 𝟓𝟒. 𝟔% (
𝟏𝟓𝟖𝟕𝟔𝟕
𝟖𝟓𝟏𝟏𝟕𝟏
) (
𝟏.𝟑𝟑𝟐
𝟏.𝟑𝟒𝟔𝟐
) = 𝟗. 𝟗𝟒%              (Equation 3.2) 
 
A quantum yield of 9.94% was calculated which is close to the previously reported quantum 
yields for SiNPs normally between 4 to 25%.17, 33, 56  
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Figure 3.20. UV/Vis spectra at different dilutions of thiourea-functionalised SiNPs in EtOH. 
 
 
Figure 3.21. Emission spectra of thiourea-functionalised SiNPs at varying concentration in EtOH. 
(Excitation: 340 nm) 
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Figure 3.22. Plotted integrated intensity of emission against absorbance for both thiourea-
functionalised SiNPs in EtOH and quinine sulphate in 0.1 M H2SO4. 
 
3.13.3. Long-term PL Stability 
In order to have a more efficient system in terms of biomedical applications, it is important 
to obtain NPs with suitable PL stability. The long-term stability of the synthesised SiNPs in 
EtOH was tested over a month and it was found that NPs can maintain about 80% of their initial 
PL after 30 days (Figure 3.23). The stabilisation of the PL by the coating ligand is attributed to 
the covalent passivation of the surface by the thiourea which can prevent the oxidation of the 
NP surface.  
 
Figure 3.23. Long term PL stability of thiourea-functionalised SiNPs stored in EtOH. 
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3.13.4. Effect of pH on Photoluminescence stability 
A successful surface functionalisation increases the stability and dispersity of SiNPs in 
various solvents. As a result, this will form SiNPs with high brightness/photoluminescence and 
stability through a wide range of pH values. The pH is a fundamental parameter for biomedical 
uses, and thus the PL stability of thiourea-functionalised SiNPs was tested over a range of 
different pH values. Figure 3.24 represents the changes in the intensity and peak wavelength 
of SiNPs of pH values from 4 to 9. Based on the data obtained, the photoluminescence intensity 
was stable over a range of physiologically relevant pH environments. Additionally, for pH 
levels 4-8 the peak position of the maximum PL emission remained unchanged, however for 
the most alkali pH 9 this shifted slightly to a lower wavelength. Taken overall, these results 
indicate that the inorganic capping ligand successfully isolates the silicon core from the 
surrounding environment and therefore makes SiNPs suitable for further biomedical 
investigations. 
 
 
Figure 3.24. PL stability of thiourea-functionalised SiNPs in buffers of different pH values. 
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3.14. In vitro Biomedical Studies of Thiourea-functionalised SiNPs 
3.14.1. Cytotoxicity Assay by MTT 
Modifying the surface chemistry of NPs, given their large surface area, alters the toxicity 
and biological characteristics which can be beneficial for biomedical applications. In this study, 
the cytotoxicity of thiourea-functionalised SiNPs in colon cancer cells and their equivalent 
non-cancerous cell line is evaluated by MTT assay. Amine-functionalised SiNPs, which have 
been identified as a non-toxic biomaterial,14 were used in this project as a control compound. 
Cells were exposed to increasing concentrations ranging from 5 to 1500 µg/mL thiourea and 
amine-functionalised SiNPs.  After 24 h incubation, MTT assay was carried out in Caco-2 and 
CCD-841 cells and the absorbance values were normalised to the untreated cells. The results 
indicate that for the NPs used in the current study, concentrations up to 1500 µg/mL did not 
show any significant toxicity after 24 h incubation (Figure 3.25 (a) and (b)). For this time point, 
both thiourea and amine functionalised SiNPs reduced CCD-841 and Caco-2 cell viability by 
approximately 20-25%, which indicates that the anticancer activity of thiourea did not develop 
in this short incubation time.  
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Figure 3.25. In vitro cytotoxicity of thiourea and amine capped SiNPs by MTT after incubation 
with Caco-2 (a) and CCD-841 (b) for 24 h incubation at 37 oC. (The results were normalised to 
non-stimulated cells.) Statistical significance was determined by two-way-ANOVA followed by 
a Bonferroni post-test (*P < 0.05 and ns statistically not significant).  Results are expressed as 
mean ± SEM (n =3). 
 
In Caco-2 cells, thiourea-functionalised SiNPs had a slightly larger effect than amine-
functionalised SiNPs for concentrations around 50 µg/mL. For the longer 72 h exposure 
(Figure 3.26 (a) and (b)), the Caco-2 cell viability dropped by 60% for concentrations above 
100 µg/mL, a result that was not reproduced by amine-functionalised SiNPs which had 
negligible effect beyond 24 hours. Lower cell viability was observed at lower concentrations 
of thiourea-functionalised SiNPs in Caco-2 cells than in CCD-841, which is important if the 
treatment is to be effective whilst having a less impactful effect on normal cells. In CCD-841 
cells the behaviour was similar for both thiourea and amine-functionalised SiNPs.  
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Figure 3.26. In vitro cytotoxicity of thiourea and amine capped SiNPs by MTT after incubation 
with Caco-2 (a) and CCD-841 (b) for 72 h incubation at 37 oC. (The results were normalised to 
non-stimulated cells.) Statistical significance was determined by two-way-ANOVA followed by 
a Bonferroni post-test (***P < 0.001 and ns statistically not significant).  Results are expressed 
as mean ± SEM (n =3). 
 
For the high dosage of nanoparticles to be effective in this case may not seem to be 
appropriate (1500 µg/mL), however, it should be mentioned that the concentration used for the 
MTT assay is calculated with the whole entity of functionalised SiNPs, i.e. drug with the 
covalently bonded silicon core and thus for thiourea-functionalised SiNPs to be more effective 
in terms of the cytotoxic effects, a higher dose of nanoparticles needed (more than 100 µg/mL). 
In addition, considering the naturally low toxicity of silicon nanoparticles, this would make 
the application of nanoparticles at such high dosage appropriate as there would be little concern 
regarding the safety of silicon used in these multifunctional nanomaterials. 
10 100 1000
0
20
40
60
80
100
120
Thiourea SiNPs
C
e
ll
 V
ia
b
il
it
y
 (
%
)
  
  
  
C
a
c
o
-2
(a)
Amine SiNPs
***
ns
Concentration (g/mL)
10 100 1000
0
20
40
60
80
100
120
Amine SiNPs
Thiourea SiNPs
C
e
ll
 V
ia
b
il
it
y
 (
%
)
  
  
  
 C
C
D
(b)
ns
ns
*
Concentration (g/mL)
Chapter 3                        Synthesis and Characterisation of Thiourea-functionalised Silicon Nanoparticles  
 
 
131 
3.14.2. Cellular Uptake Studies 
3.14.2.1. Confocal Microscopy 
In order to understand the uptake behaviour of thiourea-functionalised SiNPs at the cellular 
level, the cellular internalisation and intercellular distribution of NPs were evaluated by 
confocal imaging. Figure 3.27 shows the bright field confocal images of Caco-2 cells without 
any nanoparticle treatments and Figure 3.28 demonstrates the cells incubated with 100 µg/mL 
of thiourea-functionalised SiNPs for 2 h at 37 oC. Cells were later treated with longer incubation 
time (4 h) as shown in Figure 3.29. As can be seen, the uptake was shown to be time dependent 
as the signal become more apparent for longer incubation time point. 
In addition, cell staining was performed in Figures 3.30 and 3.31 for the control and Figures 
3.32 and 3.33 for the treated cells. In order to make sure there was no interference in the 
fluorescence of nanoparticles by actin staining, Figure 3.33 was collected only from the cells 
with nuclei staining and treated with thiourea-functionalised SiNPs. Based on the images 
obtained, thiourea-functionalised SiNPs were successfully internalised within the cell 
cytoplasm as shown by the green fluorescence. 
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Bright Field SiNPs 
  
Merged 
 
Figure 3.27. Bright field confocal fluorescence images of Caco-2 cells without thiourea-
functionalised SiNPs (control). 
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Bright Field SiNPs 
  
Merged 
 
Figure 3.28. Bright field confocal fluorescence images of Caco-2 cells incubated with thiourea-
functionalised SiNPs for 2 h. Green fluorescence from thiourea capped SiNPs. 
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Bright Field SiNPs 
  
Merged 
 
Figure 3.29. Bright field confocal fluorescence images of Caco-2 cells incubated with thiourea-
functionalised SiNPs for 4 h. Green fluorescence from thiourea capped SiNPs. 
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Nuclei Actin 
  
SiNPs Merged 
  
Figure 3.30. Confocal fluorescence images of Caco-2 control (untreated) cells. Blue from Hoechst for 
nuclei, red from Phalloidin for actin staining. 
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Nuclei Actin 
  
SiNPs Merged 
  
Figure 3.31. Confocal fluorescence images of Caco-2 control (untreated) cells. Blue from Hoechst for 
nuclei, red from Phalloidin for actin staining. 
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Nuclei Actin 
  
SiNPs Merged 
  
Figure 3.32. Confocal fluorescence images of Caco-2 cells incubated with thiourea capped SiNPs for 
4 h. Blue from Hoechst for nuclei, red from Phalloidin for actin staining and green fluorescence from 
thiourea capped SiNPs. 
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Nuclei  SiNPs 
  
Merged 
 
Figure 3.33. Confocal fluorescence images of Caco-2 cells incubated with thiourea capped SiNPs for 
4 h. Blue from Hoechst for nuclei and green fluorescence from thiourea capped SiNPs. 
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For further evidence, the internal distribution of SiNPs was examined by a set of Z-stack 
images. Thiourea-functionalised SiNPs were taken up into Caco-2 cells as demonstrated in 
Figure 3.34 Nanoparticles were not only on the external cellular membrane, they were also 
observed throughout the cytoplasm inside the cells. 
 
 
Figure 3.34. Confocal fluorescence images of Caco-2 cells incubated with thiourea capped SiNPs for 
4 h. Blue from Hoechst for nuclei, red from Phalloidin for actin staining and green fluorescence from 
thiourea capped SiNPs. 
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3.14.2.2. Flow Cytometry 
For additional SiNP uptake evidence, flow cytometry was used in both cancer and normal 
cells to semi-quantitatively measure cellular uptake of the NPs. 
The two well-known cell lines, Caco-2 and CCD-841, were chosen because of their different 
expression of EGFR. Caco-2 cells have been shown to overexpress the EGFR mRNA by almost 
five times when normalised to the CCD-841 cells as control. In addition, CCD-841 cells did 
not show EGFR overexpression and lacked observable EGFR phosphorylation.57  
Caco-2 cells were first incubated with various concentrations of thiourea and amine 
functionalised SiNPs (from 10 to 100 µg/mL) for 30 min (Figure 3.35). As can be seen the 
uptake was concentration dependent for both nanoparticles. There was not a significant 
difference in the uptake of two NPs for the concentrations from 10 to 50 µg/mL.  However, 
there was a much higher level of uptake for thiourea-functionalised SiNPs at the highest 
concentration with showing almost twice as much as amine-functionalised SiNPs at 100 
µg/mL. Higher concentrations were not considered here, as that would cause greater toxicity 
to the cells, as observed by MTT results, and therefore a fewer number of cells would be 
available to be detected. The same experiment was performed on Caco-2 cells with longer 
incubation time (4h) (Figure 3.36). A higher level of fluorescence was detected from the cells 
at this time point for both types of nanoparticles and for the last two high concentrations at 50 
and 100 µg/mL; cells internalised significantly more thiourea SiNPs than amine SiNPs. As a 
higher level of uptake was observed at 100 µg/mL of thiourea SiNPs, it was decided to take 
this concentration and test various time points to evaluate which time point gives the optimal 
uptake rate thereafter use these parameters with the normal cell line.  
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Figure 3.35. Uptake efficiency of thiourea-functionalised SiNPs (a) and amine-functionalised SiNPs 
(b) in Caco-2 cells with various concentrations from 10 to 100 µg/mL after 30 min incubation. 
Collective flow cytometric analysis results (c) which are presented as fluorescence median of cells after 
nanoparticle uptake. Statistical significance was determined by two-way-ANOVA followed by a 
Bonferroni post-test (***P < 0.001 and ns statistically not significant).  Results are expressed as mean 
± SEM (n =3). 
 
(a)
Control
10 µg/mL
20 µg/mL
50 µg/mL
100 µg/mL
(b)
Control
10 µg/mL
20 µg/mL
50 µg/mL
100 µg/mL
10 20 50 100
0
1
2
3
4
Amine SiNPs
Thiourea SiNPs
M
e
d
ia
n
 (
F
L
-1
)
ns
nsns
***
(c)
Concentration (g/mL)
Chapter 3                        Synthesis and Characterisation of Thiourea-functionalised Silicon Nanoparticles  
 
142 
 
 
 
 
 
Figure 3.36. Uptake efficiency of thiourea-functionalised SiNPs (a) and amine-functionalised SiNPs 
(b) in Caco-2 cells with various concentrations from 10 to 100 µg/mL after 4 h incubation. Collective 
flow cytometric analysis results (c) which are presented as fluorescence median of cells after 
nanoparticle uptake. Statistical significance was determined by two-way-ANOVA followed by a 
Bonferroni post-test (***P < 0.001, **P < 0.01 and ns statistically not significant).  Results are 
expressed as mean ± SEM (n =3). 
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Next, thiourea and amine functionalised SiNPs (each 100 µg/mL) were incubated with both 
cells (Caco-2 and CCD-841) for five different time periods (from 30 min to 8 h). Median 
fluorescence values demonstrate that cell uptake of thiourea and amine functionalised SiNPs. 
The data confirmed considerably more uptake of thiourea-functionalised SiNPs in Caco-2 cells 
compared to amine-functionalised SiNPs for all time points (Figure 3.37). Moreover, the 
fluorescent signal of thiourea-functionalised SiNPs increased gradually between 30 min and 4 
h. At 4 h exposure the maximal thiourea-functionalised SiNP uptake was observed, whereas 
longer times (6 and 8 h) did not increase the cellular uptake. This suggests that thiourea-
functionalised SiNPs reached an uptake saturation level, whereas the non-specific cellular 
uptake of amine-functionalised SiNPs increased over time. A plausible explanation for this 
result, consistent with previous known characteristics of thiourea-functionalised SiNPs, is that 
the thiourea-functionalised SiNP can inhibit the EGFR receptor activity.58 Amine-
functionalised SiNPs on the other hand have no known similar interaction, and thus the lower 
levels of internalisation are likely reached through passive targeting. Since a saturation level 
was reached for thiourea-functionalised SiNPs, it is more likely that EGFR are transported to 
endosome/lysosome for degradation rather than the possibility of the receptor recycling 
process, which would lead to the increase of uptake over time.59 The introduction of thiourea-
functionalised SiNPs in cancer cells can therefore potentially manage the multiple cellular 
processes in which EGFR is a key player and thus an inhibit tumour growth. However, the level 
of thiourea-functionalised SiNP uptake in CCD-841 cells seemed to be much lower (Figure 
3.38). A higher florescence was observed at the shorter time point of 1 h incubation. For longer 
incaution times, up to 8 h exposure, the uptake decreased. One possible explanation for this 
behaviour could be that the presence of the ligand caused some steric alteration which reduced 
the uptake of thiourea-SiNPs for longer exposure. This may be compounded by the fact that 
expression of EGFR in primary epithelial colon cells is less than cancer cells.60   
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Figure 3.37. Uptake efficiency of thiourea-functionalised SiNPs (a) and amine-functionalised SiNPs 
(b) in Caco-2 cells with 100 µg/mL after various incubation time points from 30 min to 8 h. Collective 
flow cytometric analysis results (c) which are presented as fluorescence median of cells after 
nanoparticle uptake. Statistical significance was determined by two-way-ANOVA followed by a 
Bonferroni post-test (***P < 0.001 and ns statistically not significant).  Results are expressed as mean 
± SEM (n =3). 
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Figure 3.38. Uptake efficiency of thiourea-functionalised SiNPs (a) and amine-functionalised SiNPs 
(b) in CCD-841 cells with 100 µg/mL after various incubation time points from 30 min to 8 h. 
Collective flow cytometric analysis results (c) which are presented as fluorescence median of cells after 
nanoparticle uptake. Statistical significance was determined by two-way-ANOVA followed by a 
Bonferroni post-test (***P < 0.001 and ns statistically not significant).  Results are expressed as mean 
± SEM (n =3). 
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The hypothesis for the interaction between thiourea-functionalised SiNPs and ATP binding 
site of intracellular domain in EGFR receptors is depicted in Scheme 3.4. 
 
              
Scheme 3.4. Schematic illustration of the interaction between thiourea SiNPs and ATP binding site of 
intracellular domain in EGFR receptors. 
 
 
3.14.3. ELISA Assay 
The activity of thiourea-functionalised SiNPs towards EGFR was tested using Elisa assay. 
Figure 3.39 shows the different behaviour of thiourea and amine-functionalised SiNPs with 
different concentrations when antibodies, known to bind to EGFR, are introduced to Caco-2 
cells. As can be seen, the normalised absorbance of thiourea-functionalised SiNPs was lower 
than amine-functionalised SiNPs due to the interaction of thiourea-functionalised SiNPs with 
EGFR which made the receptors unavailable for binding with antibodies. This behavior was 
concentration dependent and lower absorbance was detected from the cells treated with higher 
concentrations of thiourea-functionalised SiNPs. The positive control shows the cells treated 
with only primary antibody. 
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Figure 3.39. Normalised absorbance data of the ELISA test performed using the classical ELISA 
procedure, without targeted SiNPs (with amine-functionalised SiNPs) and the ELISA procedure using 
the thiourea-functionalised SiNPs in Caco-2 cells. Statistical significance was determined by two-way-
ANOVA followed by a Bonferroni post-test (***P < 0.001 and ns statistically not significant).  Results 
are expressed as mean ± SEM (n =3). 
 
 
3.15. Summary and Conclusions 
The fabrication of nanoparticles through chemical synthesis routes normally leaves 
impurities from various starting materials and reagents in the final product which is not ideal 
for biomedical applications. These impurities affect the stability of functionalised SiNPs in 
solvents and cause agglomeration. On the other hand, top down synthesis methods offer higher 
quality of nanoparticle with less by-products and impurities. These NPs are widely anticipated 
to be used in a growing number of applications and as it has been reported previously the issue 
regarding the scalability of top down techniques can be overcome by using large-scale Teflon 
cells as demonstrated by UK and Japanese companies.27 As a result, for the purpose of 
developing a nanosytem suitable for biomedical applications, after analysing two well 
developed synthesis approaches of top down and bottom up for the synthesis of NH2 SiNPs, it 
was decided to use the top down nanoparticles with higher purity for the continuation of the 
project. These NH2 NPs are non-toxic and water soluble, making them ideal for use as control 
and starting material for further modification in this work.   
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We report here the synthesis of thiourea-functionalised SiNPs as a novel nanodelivery 
system, which can interact with cancer cells that overexpress EGFR.  This approach makes use 
of the physiochemical and biological properties of both components of the nanosystem, in 
particular the photoluminescence of SiNPs and the anticancer activity of thiourea. According 
to the FTIR and elemental analysis, SiNPs are fully capped with the thiourea ligand. The 
stability of SiNPs in different biological media, as a result of the covalent conjugation of the 
ligand on the surface of nanoparticles, was shown by DLS. This result has addressed the 
challenges regarding the long term stability of nanoparticles for similar biomedical 
applications. The in vitro toxicity of the novel nanoparticles was evaluated by MTT assay in 
colorectal cancer and normal cells. The thiourea-functionalised SiNPs caused a loss of cell 
viability after 72 h exposure to the cancer cells. Considering the data obtained from uptake 
studies in both Caco-2 and CCD-841 cells, thiourea functionalised SiNPs were distributed 
within the cytoplasm, as visualised in confocal images. The uptake of thiourea-functionalised 
SiNPs was time dependent. As the fluorescent signal increased gradually between 30 min and 
4 h. The saturation uptake level suggested that the ligand binds with the receptor and therefore 
the degradation of EGFR after 4 hours is likely to occur. This is significant in term of the 
development of future diagnostic tools for drug delivery systems. Overall, the nanodelivery 
system developed herein presents an encouraging platform for drug delivery, particularly 
aiming for the inhibiting of EGFR overexpression in cancer cells. 
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4.1. Overview 
Isothiocyanates (ITCs) are known to induce phase II enzymes, related to the detoxification 
process of chemical carcinogens, and thus can prevent the start of carcinogenesis and act as 
chemo-preventive functional groups.1 Although many studies have investigated the effect of 
ITCs on phase II enzymes,2, 3 few have looked at their effects when it comes to nanoscale 
systems in specific conjugation with nanoparticles.  
In the following chapter, isothiocyanate-functionalised SiNPs (ITC SiNPs) were 
synthesised using two different methods which were initiated from two different types of SiNPs 
as starting materials. The surface chemistry of these particles were characterised and their 
optical properties and long term stability examined to assess the advantages and disadvantages 
of each type of synthesis approach. NH2 SiNPs obtained from the top down synthesis route 
(discussed in Chapter 3 (Section 3.3)), were used as one of the precursors and another type of 
SiNPs covered by the allyl bromide functional group were used as a precursor for the other 
synthesis route. Thermal hydrosilylation was run to produce bromine-functionalised SiNPs (Br 
SiNPs) and their chemical and optical properties were characterised.  
Characterisation showed the successful synthesis of ITC SiNPs by both methods. However, 
the samples produced from the precursor Br SiNPs (ITC SiNPs (P Br SiNPs) exhibited strong 
photoluminescence whereas the second route using NH2 SiNPs as precursor (ITC SiNPs (P 
NH2 SiNPs)) produced nanoparticles with weak quantum yield and therefore lower optical 
efficiency. As a result, only ITC SiNPs (P Br SiNPs) were used for uptake studies in this 
chapter. 
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4.2. Synthesis of Bromine Capped Silicon Nanoparticles  
Several attempts were made to synthesise Br SiNPs using the microwave method and 
thermally induced hydrosilylation reaction by refluxing.  
First, the H-terminated SiNPs were reacted with allyl bromide using a microwave in a 1% 
volumetric ratio. The reaction was attempted in various solvents such as DCM, THF and 
toluene. The obtained solution was filtered and the solvent was removed under vacuum. The 
resulting powder was characterised by FTIR after filtering the silicon chips and removing the 
solvent. The spectra did not show any Si-C bonding on the surface of SiNPs. The length of the 
reaction was increased from 30 min to 1 h but there was no significant improvement. 
Following this, the thermal hydrosilylation reaction was attempted and tested under various 
experimental parameters. Table 4.1 shows the different parameters examined in this synthesis 
to achieve the desired product. The hydrosilylation reaction in dry toluene at 65 oC with 2 mL 
of the allyl bromide (which was run overnight) gave the greatest yield out of all the methods 
(Table 4.1). The FTIR spectrum of this product confirmed the formation of bromine-
functionalised SiNPs (Figure 4.1) and will be discussed in the following section. In all of these 
experiments the H-terminated SiNPs, which were used as the starting point, were obtained from 
the etching of four silicon chips and the reaction was followed in 10 mL of each solvent. 
As a result of this analysis to determine the optimal experimental parameters providing the 
greatest yield (Table 4.1), Br SiNPs were synthesised using the thermal hydrosilylation reaction 
of H-terminated SiNPs with allyl bromide in dry toluene and left at reflux overnight (Scheme 
4.1). The residual allyl bromide was removed by heating under reduced pressure and 
centrifugation. This synthetic procedure gave a yield of approximately 25 mg of powder like 
material. The yield was consistent over several reactions.  
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Table 4.1. Synthesis of bromine-functionalised SiNPs under various reaction parameters.  
            
Parameters 
  Solvent 
 
Allyl bromide 
(mL) 
 
Time  
(h) 
 
Temperature 
 ( oC) 
 
Product 
Weight 
(mg) 
 
 
 
Dry DCM 
 
1  
 
12 
 
24 
 
 
 
35 
 
10 
 
10 
 
2  
 
12 
 
24 
 
13 
 
15 
 
4  
 
12 
 
24 
 
15 
 
17 
 
 
 
Dry Toluene 
 
1  
 
12 
 
24 
 
 
 
 
65 
 
15 
 
15 
 
2  
 
12 
 
24 
 
20 
 
25 
 
4  
 
12 
 
24 
 
15 
 
18 
 
 
 
Dry THF 
 
1  
 
12 
 
24 
 
 
 
60 
 
17 
 
18 
 
2  
 
12 
 
24 
 
18 
 
20 
 
4  
 
12 
 
24 
 
20 
 
20 
 
 
 
Scheme 4.1 Schematic illustration of the synthesis of Br SiNPs. 
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In order to evaluate if these synthesised SiNPs can be used as precursor to produce the 
desired ITC functional group, the initial characterisation was performed on the samples. 
 
4.3. Chemical Characterisation of Bromine-functionalised SiNPs 
4.3.1. Chemical bonding by FTIR 
To confirm the existence of the covalent Si-C bond on the surface of SiNPs, FTIR was 
performed on a dry powder of Br SiNPs obtained from each synthesis method outlined in Table 
4.1. Figure 4.1 shows the FTIR spectra of allyl bromide ligand (Figure 4.1 (a)) compared to the 
product after the microwave hydrosilylation (Figure 4.1 (b)). Due to the large amount of oxide, 
which occurs under the microwave condition, many signals were not detectable. Although there 
was a small peak at 1261 cm-1 which could be related to the formation of Si-C bond in this 
product,4 the existence of the Si-H peak at 2100 cm-1 shows the unsuccessful synthesis in the 
case.5 This could therefore show the poor surface coverage by the ligand as well as high level 
of oxide layer on the surface of SiNPs. Table 4.2 shows the relevant vibrations observed for 
this batch.  
 
Figure 4.1. FTIR spectra of allyl bromide (a), bromine-functionalised SiNPs obtained from the 
microwave method (b) and from the thermal hydrosilylation method (c). 
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Given that microwave hydrosilylation was unsuccessful, thermal hydrosilylation was 
considered as an alternative method. The IR spectra of the product produced from thermal 
hydrosilylation is shown in Figure 4.1 (c). The spectrum displayed no bands characteristic to 
Si-H stretching around 2100 to 2200 cm-1.5  Moreover, the covalent Si-C bond was confirmed 
with the relative signals at 1269 and 1461 cm-1 for the Si-C symmetric bending and Si-CH2 
scissoring vibrations respectively.4 This combined with the absence of a peak at 1637 cm-1 
which would correspond to C=C bond in allyl bromide, suggests that the ligand was attached 
to the SiNPs.6 Therefore, this method almost certainly produces the required fully capped 
bromine-functionalised SiNPs (see Table 4.2). 
 
Table 4.2. Molecular vibrational information of allyl bromide (a), Br SiNPs obtained by microwave 
method (b), Br SiNPs obtained by thermal hydrosilylation (c).   
 
Wavenumber (cm-1) 
 
Vibrational Motion 
 
Structural Feature 
 
Spectrum 
 
687 
 
stretching 
 
C-Br 
 
 
 
 
 
 
(a) 
 
Allyl Bromide 
 
921 
 
=C-H bending 
 
C-H 
 
1205 
 
stretching 
 
C-C 
 
1410, 1440 
 
CH2 scissoring  
 
C-H 
 
1637 
 
stretching 
 
C=C 
 
2967, 3091 
 
=C-H stretching 
 
C-H 
 
690 
 
stretching 
 
C-Br 
 
 
 
 
 
 
(b) 
 
Bromide SiNPs 
 
1036 
 
stretching 
 
Si-O 
 
1261 
 
symmetric bending 
 
Si-C 
 
 
1455 
 
scissoring  
stretching 
 
Si-CH2 
C-C 
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2109 
 
stretching 
 
Si-H 
 
2936, 3116 
 
stretching 
 
C-H 
 
696 
 
stretching 
 
C-Br 
 
 
(c) 
 
Bromide SiNPs 
 
1269 
 
symmetric bending 
 
Si-C 
 
 
1461 
 
scissoring  
stretching 
 
Si-CH2 
C-C 
 
 
4.3.2. Elemental Analysis by EDX 
The Br SiNPs are rich in silicon and carbon. This can be confirmed from the EDX spectrum 
of samples which obtained from a number of spots on the material. The elemental components 
of the material were observed to be silicon, carbon, oxygen and bromine (Figure 4.2).  
 
 
   Figure 4.2. EDX spectrum of bromine-functionalised SiNPs. 
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4.3.3. Elemental Analysis by XPS 
Chemical bonding of SiNPs with the allyl bromide ligand was also investigated by XPS 
analysis through both wide (Figure 4.3) and high resolution scans over Si2p, C1s, O1s and 
Br3d regions of the SiNPs (Figures 4.4 to 4.7). The wide scan spectrum was dominated by 
signals attributed to Si2p, Si2s, C1s, O1s and Br3d.  
XPS provided information on the elements present on the surface and indicated the 
environment in which these elements exist.  
 
Figure 4.3. XPS full survey spectrum from Br SiNPs deposited on a gold substrate. 
 
The Si2p spectrum was curve-fitted into three peak components against a Shirley 
background (Figure 4.4). The first component at 103.67 eV is attributed to Si-C bonding.7 The 
second at 103.06 eV is assigned to Si-O from SiO2 at the surface of SiNPs 
8 and the third at 
102.15 eV is for Si-Si within the silicon core of the SiNPs.9 The presence of Si-C component 
in the Si2p region suggests that the surface silicon atoms change from Si-H to Si-C bonding. 
By the fitting performed almost 72% of the silicon surface was estimated to bind by Si-C bonds 
to the allyl bromide capping layer and 10% to the Si-Si bonding (Table 4.3). The remaining 
17% was related to the oxidised Si on the surface on NPs. The degree of oxidation is a 
qualitative estimation based on the structure and chemical makeup of these type of NPs. An 
estimated 80% of the available surface has undergone ligand capping. These results are 
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consistent with previous studies which found that H-terminated silicon surfaces bound to 
organic monolayers with normally 50% surface coverage.10, 11  
 
 
Figure 4.4.  High resolution XPS spectrum from Br SiNPs showing Si2p region. 
 
 
The C1s spectrum was also fitted with three components and a Shirley background. They 
appeared at 284.92, 284.10 and 286.46 eV (Figure 4.5). The first peak at binding energy 284.92 
eV is attributed to C-C bonds and the second component, at binding energy 284.10 eV, is 
related to C-Si bonds, covering almost 22% of the spectrum area (Table 4.3).12 The final 
binding energy at 286.46 eV is characteristic of C-Br bonds.13  
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Figure 4.5. High resolution XPS spectrum from Br SiNPs showing C1s region. 
 
The O1s spectrum of Br SiNPs fitted with two components and a Shirley background can 
be seen in Figure 4.6. The fittings appeared at 532.45 and 534.44 eV (Figure 4.6). The peak at 
532.45 eV corresponds to Si-O covering almost 97% of the spectrum (Table 4.3). This is most 
likely as a result of the chemical oxidation in part due to X-ray induced oxidation.9  
 
 
Figure 4.6.  High resolution XPS spectrum from Br SiNPs showing O1s region. 
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The Br3d spectrum is shown in Figure 4.7 and fitted with one peak at 69.20 eV. This is a 
peak representative of C-Br.14, 15 However, this signal was lower than would be expected, likely 
due to the shallow penetration depth of this technique and the gap between the bromine atom 
and the surface of SiNPs. 
 
 
Figure 4.7.  High resolution XPS spectrum from Br SiNPs showing Br3d region. 
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Table 4.3. XPS data with the detailed ratio of elements present on the surface of Br SiNPs obtained by 
high resolution scans. 
 
Scans 
 
Positions 
 
Position (eV) 
 
FWHM 
 
Area 
 
% 
 
 
 
Si 2p 
 
Si-C 
  
103.6720 
 
1.6227 
 
13706.611 
 
 71.81 
 
Si-O 
 
103.0601 
 
0.9355 
 
3338.186 
 
17.49 
 
Si-Si 
 
102.1563 
 
0.9366 
 
2041.875 
 
10.70 
 
 
 
C 1s 
 
C-C 
 
284.92 
 
1.9377 
 
21467.324 
 
75.30 
 
C-Si 
 
284.10 
 
1.4277 
 
8471.041 
 
22.61 
 
C-Br 
 
286.46 
 
4.1114 
 
7525.297 
 
20.08 
 
 
O 1s 
 
Si-O 
 
532.45 
 
1.526 
 
35976.84 
 
97.28 
 
O-H 
 
534.44 
 
1.263 
 
1006.98 
 
2.72 
 
Br 3d 
 
Br-C 
 
69.20 
 
3.3389 
 
4462.412 
 
100 
 
 
4.4. Size and Dispersity Measurement of Bromine-functionalised SiNPs 
4.4.1. Visualisation and Size Measurement by TEM 
The TEM micrographs confirm that Br SiNPs have been successfully synthesised (Figure 
4.8). The distribution of SiNPs diameters was 2-10 nm. The mean nanoparticle diameter was 
6.02 nm, calculated from the average of 100 particles obtained from different regions of the 
grid. The diameter which occurred most frequently was 5 nm which is 1 nm lower than the 
mean diameter, indicating a slightly skewed distribution. 
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Figure 4.8. TEM images of Br SiNPs (a) and (b) and the histogram showing the distribution of Br 
SiNPs diameters (c). 
 
4.4.2. Hydrodynamic Size Measurement by DLS 
DLS measured the hydrodynamic diameter of Br SiNPs in toluene. The size was 7.46 ± 0.05 
nm in toluene (Figure 4.9). DLS demonstrated a very close size to that obtained from the TEM. 
The presence of anything attracted to the surface of SiNPs, such as a surrounding layer or 
capping ligands, can increase SiNP diameter size in toluene, and produced a well dispersed 
solution of nanoparticles without any sign of aggregation. 
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Figure 4.9. Hydrodynamic size of Br SiNPs dispersed in toluene measured by DLS. 
 
 
4.5. Optical properties of Bromine-functionalised SiNPs 
4.5.1. Absorption and Emission Spectra 
The emission and absorption spectra of Br SiNPs in toluene are presented in Figure 4.10. A 
gradual increase in the absorbance was observed with a decreasing wavelength. For 
wavelengths below than 475 nm the absorbance increased at a greater rate. The solid line shows 
the PL spectrum of Br SiNPs in toluene at room temperature. The maximum emission peak 
was observed at 400 nm with a full width at a half maximum height (FWHM) of 150 nm under 
an excitation wavelength of 310 nm.     
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Figure 4.10.  Absorption (dotted line) and emission (solid line) spectra of bromine-functionalised 
SiNPs dispersed in toluene (The excitation wavelength was set at 310 nm). 
 
Considering the data obtained from the characterisation of Br SiNPs, the desired structure 
was achieved and nanoparticles showed acceptable optical properties. Therefore, they could be 
used for further synthesis to obtain the ITC functional group on the surface of SiNPs.  
 
4.6. Synthesis of Isothiocyanate-functionalised Silicon Nanoparticles 
Two different approaches have been investigated to synthesise isothiocyanate-
functionalised SiNPs. The first attempt involved using the allyl isothiocyanate directly in order 
to introduce this functional group to the surface of H-terminated SiNPs via hydrosilylation 
(Scheme 4.2). The refluxing was performed in dry toluene initially for 5 h, then for another 
seven hours (to 12 h), and finally to 24 h. Despite the extended refluxing time, the IR spectra 
of the products did not show any evidence of the presence of ITC group. This could be due to 
the high reactivity of the ITC which is more reactive compared to the C=C bond in the structure 
of ITC and therefore precluded hydrosilylation.  
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Scheme 4.2 Schematic illustration of the synthesis of ITC SiNPs using AITC. 
 
Since this attempt at did not succeed, the experimental plan was altered to use other types 
of nanoparticles as precursors including the Br SiNPs and NH2 SiNPs and then later synthesise 
the ITC group from Br and NH2 functionalities which are already present on the surface.  Thus, 
a detailed spectroscopic study was required for each synthesis to evaluate which group had the 
potential to be used as a multifunctional compound for further investigation. 
 
4.6.1. The Use of Bromine-functionalised Silicon Nanoparticles Precursors 
The bright ITC SiNPs were produced by reacting the mixture of bromine-functionalised 
SiNPs with KSCN in dry ethanol and refluxing overnight (Scheme 4.3). On completion of the 
reaction, the mixture was allowed to cool and then the solvent was removed under the reduced 
pressure. The residual starting material and by products were removed after washing with water 
and extraction of ITC SiNPs into diethyl ether. Approximately 25 mg of the desired NPs were 
obtained as an orange powder after removing the solvent. 
 
Scheme 4.3. Schematic illustration of the synthesis of ITC SiNPs (P Br SiNPs). 
 
Si
Si
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4.6.2. The Use of Amine-functionalised Silicon Nanoparticles Precursors 
Through the second method amine capped SiNPs produced from the top down approach as 
described in Chapter 3 (Section 3.3) and reacted with CS2 in an ice bath. After 3 h stirring, 
dicyandiamide was added followed by 3 drops of triethylamine (Scheme 4.4). The reaction was 
stirred for extra 3 hours. The desired SiNPs were extracted in ethyl acetate and impurities were 
washed by distilled water. Via this procedure, approximately 28 mg ITC SiNPs were obtained 
from each batch. 
 
Scheme 4.4. Schematic illustration of the synthesis of ITC SiNPs (P NH2 SiNPs). 
 
4.7. Chemical Characterisation of ITC SiNPs 
4.7.1. Chemical bonding by FTIR 
Figure 4.11 shows the FTIR spectra of ITC SiNPs, produced from Br SiNPs (a), after 6 h 
(b), 12 h (c) and 24 h (d) refluxing at 65 oC. After 6 hours of reflux, the characteristic double 
bond featuring the ITC functional group had not developed yet. The growth was clear after 
longer time periods; after 12 hours refluxing at 65 oC, the double peak was observed clearly at 
2039 cm-1 and finally reached to the maximum intensity after 24 h.16 This result conforms the 
formation of the ITC group on the surface of SiNPs. The final spectrum shows a peak at 1269 
cm-1 representing C-Si bonds,4 and an absence of signal at 695 cm-1 indicative of the C-Br 
bond,17 which was still present at 12 h. The C-H rocking of the alkane in the product appeared 
at 746 cm-1 (spectra (c) and (d)).17 The ITC coated SiNPs displayed features from Si-O bonds 
at around 1015 cm-1.18 These features indicate the presence of only a very small number of Si-
O bonds per nanoparticle, as they are easily visible due to the polarity of the Si-O bond.19  
Si
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Figure 4.11. FTIR analysis for ITC SiNPs (P Br SiNPs) after 6 h (b), 12 h (c) and 24 h (d) refluxing 
compared to the spectrum of Br SiNPs (a). 
 
For comparison, the ITC SiNPs (P NH2 SiNPs) were also characterised by ATR analysis. 
Figure 4.12 (b) showed a clear double bond at around 2100 to 2200 cm-1 indicating the 
synthesis of ITC functional group.16 Scissoring and stretching vibration bands of Si-CH2 and 
Si-C bonds (at about 1450 and 1260 cm-1, respectively) also show the covalent attachment of 
the ligand molecules in both nanoparticles to the surface of the H-terminated SiNPs.4 After the 
synthesis, in spectrum (b) in Figure 4.12, there was no sign of N-H wagging and stretching at 
790 and 3600 cm-1 respectively which were assigned to the amine functional group in the 
starting material (a).20 Stretching signals with symmetric and asymmetric C-H stretching 
vibrations at 2800 and 2900 cm-1 respectively were observed in the FTIR spectra of both 
samples.6 
Based on the IR data collected from both types of ITC SiNPs, the synthesis methods were 
successful. Both compounds represented the ITC functional group after the synthesis and the 
other differences in their spectra are attributed to the differences in reaction conditions in 
addition to the different staring materials.  
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Figure 4.12. FTIR analysis for ITC SiNPs (P NH2 SiNPs) (b) and NH2 SiNPs as the precursor (a). 
 
 
4.7.2. Elemental Analysis by EDX 
The elemental composition was investigated using EDX. The EDX spectrum of ITC SiNPs 
(P Br SiNPs) (Figure 4.13) shows the presence of silicon, oxygen, and sulphur indicating a 
favourable elemental composition.  
Nitrogen is often impossible to be detected by EDX as the nitrogen fingerprint closely 
resembles that of heavier chemical elements in the EDX spectrum. Such overlap can lead to 
misidentification of nitrogen by other elements.21 
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Figure 4.13.  EDX spectra of ITC SiNPs (P Br SiNPs). 
 
Silicon, carbon, oxygen and sulphur were also identified in the EDX spectrum of ITC SiNPs 
(P NH2 SiNPs) (Figure 4.14). However, there were some partial amounts of platinum catalyst 
which were used in the synthesis of NH2 SiNPs.  
EDX is dependent on the atomic mass of the elements being analysed which means the 
lower the atomic mass (and number) the harder they are to detect. Therefore, when a sample of 
mixed elements, with a wide range of atomic numbers is being analysed, the detector peak sizes 
are not representative of the exact atomic ratios of the elements present.22 As a result, EDX has 
predominantly been used to identify the existence of elements in nanoparticles and not to obtain 
the accurate elemental ratios, whereas the XPS method is used to provide more comprehensive 
information.  
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Figure 4.14. EDX spectra of ITC SiNPs (P NH2 SiNPs). 
 
4.7.3. Elemental Analysis by XPS 
The detailed XPS was collected from ITC SiNPs synthesised by both methods to 
characterise the surface chemistry of these materials. 
Figure 4.15 shows the full survey spectrum of ITC SiNPs (P Br SiNPs). From this spectrum, 
Si2p, Si2p, C1s, O1s and N1s peaks can be observed. The peaks not assigned on Figure 4.15 
were for the Au substrate where nanoparticles where deposited on top. All spectra were 
calibrated to the Au4f peak. The oxygen level observed in XPS is typical of the X-ray induced 
oxidation of SiNPs during the measurement. 
The high resolution XPS spectra are shown in the following Figures to confirm the surface 
chemical bonding.  
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Figure 4.15. XPS full survey spectrum from ITC SiNPs (P Br SiNPs) deposited on a gold substrate. 
 
The Si2p spectrum, shown in Figure 4.16, was fitted with three components and a Shirley 
background. The first peak appeared at 102.28 eV is attributed to Si-C bonding.23 This peak 
covered approximately 62% of the spectrum (Table 4.4) which indicates the surface of SiNPs 
is terminated by the ligand. 27% was assigned to Si-O appearing at 102.91 eV and the smallest 
peak was at 101.62 eV is attributed to Si-Si bond within the nanoparticle core.9, 24, 25 
 
Figure 4.16.  High resolution XPS spectrum from ITC SiNPs (P Br SiNPs) showing Si2p region. 
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The C1s spectrum was fitted with 4 components (Figure 4.17). The largest area covering 
51% was for the peak appeared at 285.04 eV attributed to C-C.12 The peak appeared at 284.60 
is assigned to C-Si with approximately 26%. There was evidence for C-N bonding at 286.44 
eV and a very low amount of C-O bond at 289.00 eV (~ 3%).26  
 
Figure 4.17.  High resolution XPS spectrum from ITC SiNPs (P Br SiNPs) showing C1s region. 
 
In Figure 4.18, the O1s spectrum is fitted with one component which makes up 100% of the 
spectrum. This peak appeared at 532.19 eV representative of Si-O bonding due to the oxidation 
caused by the X-ray beam.9  
 
Figure 4.18.  High resolution XPS spectrum from ITC SiNPs (P Br SiNPs) showing O1s region. 
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The N1s spectrum is fitted with two peaks and Shirley background (Figure 4.19). The main 
peak at 400.06 eV is assigned to the C-N bonding of the ITC ligand and the second peak at 
398.34 eV is for N=C=S.26 The existence of the second component confirms the presence of 
isothiocyanate functional group.  
 
 
Figure 4.19.  High resolution XPS spectrum from ITC SiNPs (P Br SiNPs) showing N1s region. 
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Table 4.4. XPS data with the detailed ratio of elements present on the surface of ITC SiNPs (P Br 
SiNPs) obtained by high resolution scans. 
 
Scans 
 
Positions 
 
Position (eV) 
 
FWHM 
 
Area 
 
% 
 
 
 
Si 2p 
 
Si-C 
 
102.28 
 
0.894 
 
7085.34 
 
61.82 
 
Si-O 
 
102.91 
 
1.001 
 
3132.30 
 
27.33 
 
Si-Si 
 
101.62 
 
0.708 
 
1243.85 
 
10.85 
 
 
 
 
C 1s 
 
C-C 
 
285.0467 
 
1.4363 
 
31007.285 
 
51.37 
 
C-Si 
 
284.6036 
 
1.1629 
 
16086.168 
 
26.65 
 
C-N 
 
286.4418 
 
2.5780 
 
11493.093 
 
19.04 
 
C-O 
 
289.0017 
 
1.7998 
 
1772.406 
 
2.94 
 
O 1s 
 
Si-O 
 
532.19 
 
1.422 
 
63074.47 
 
100 
 
 
N 1s 
 
N-C 
 
400.0649 
 
1.9383 
 
5859.794 
 
88.24 
 
N=C=S 
 
398.3493 
 
1.4366 
 
780.779 
 
11.76 
 
 
Next, the chemical bonding of ITC SiNPs (P NH2 SiNPs) was also investigated with both 
full survey (Figure 4.20) and high resolution scans over Si2p, C1s, O1s and N1s regions 
(Figures 4.21 to 4.24). 
Chapter 4                        Synthesis and Characterisation of Isothiocyanate-functionalised Silicon Nanoparticles  
 
180 
 
Figure 4.20. XPS full survey spectrum from ITC SiNPs (P NH2 SiNPs) deposited on a gold substrate. 
 
The Si2p spectrum was fitted with three components and a Shirley background (Figure 
4.21). The first component at 102.08 eV is assigned to Si-C and this covered about 56% of the 
spectrum area (Table 4.5).23 Two peaks at 102.77 and 101.39 as indicative of Si-O and Si-Si 
respectively.9  
  
 
Figure 4.21.  High resolution XPS spectrum from ITC SiNPs (P NH2 SiNPs) showing Si 2p region. 
 
800 700 600 500 400 300 200 100 0
N1s
Si2p
Si2s
C1s
O1s
 
 
In
te
n
s
it
y
 (
a
rb
.u
n
it
s
)
Binding energy (e.V)
106 105 104 103 102 101 100 99
Si-Si
Si-O
Si-C
 
 
In
te
n
s
it
y
 (
a
rb
.u
n
it
s
)
Binding energy (e.V)
Chapter 4                        Synthesis and Characterisation of Isothiocyanate-functionalised Silicon Nanoparticles  
 
181 
The C1s spectrum of ITC SiNPs (P NH2 SiNPs) presented in Figure 4.22 is fitted with peaks 
at 285.01, 286.45, 286.64 and 288.73 eV. C-C bonding with 43% and C-Si bonding with about 
29% conformed to the expected bonding ratios. The last two peaks related to the C-N and C-O 
bonding had almost 16% and 12% of the C1s spectrum respectively (Table 4.5).12  
 
Figure 4.22.  High resolution XPS spectrum from ITC SiNPs (P NH2 SiNPs) showing C1s region. 
 
About 95% of the Si2p spectrum is assigned to Si-O with a peak at 531.89 eV and the 
remaining 5% is assigned to O-H bonding (Figure 4.23 and Table 4.5).9 
 
Figure 4.23.  High resolution XPS spectrum from ITC SiNPs (P NH2 SiNPs) showing O1s region. 
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The N1s spectrum was fitted with two components and a Shirley background. The peaks 
appeared at 400.15 and 398.53 eV representative of N-C (~92%) and N=C=S (~7%) 
respectively (Figure 4.24 and Table 4.5).26 
 
Figure 4.24. High resolution XPS spectrum from ITC SiNPs (P NH2 SiNPs) showing N1s region. 
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Table 4.5. XPS data with the detailed ratio of elements present on the surface of ITC SiNPs (P NH2 
SiNPs) obtained by high resolution scans. 
 
Scans 
 
Positions 
 
Position (eV) 
 
FWHM 
 
Area 
 
% 
 
 
 
Si 2p 
 
Si-C 
 
102.08 
 
0.928 
 
7733.79 
 
58.79 
 
Si-O 
 
102.77 
 
1.033 
 
4526.98 
 
34.41 
 
Si-Si 
 
101.39 
 
0.658 
 
894.83 
 
6.80 
 
 
 
 
C 1s 
 
C-C 
 
285.0133 
 
1.4089 
 
38090.087 
 
43.22 
 
C-Si 
 
286.4565 
 
2.0528 
 
25369.816 
 
28.78 
 
C-N 
 
286.6482 
 
1.6723 
 
14152.366 
 
16.06 
 
C-O 
 
288.7319 
 
2.3009 
 
10524.785 
 
11.94 
 
 
 
O 1s 
 
Si-O 
 
531.89 
 
1.542 
 
48936.71 
 
95.36 
 
O-H 
 
535.14 
 
1.793 
 
2382.82 
 
4.64 
 
 
N 1s 
 
N-C 
 
400.1580 
 
2.3633 
 
10331.406 
 
92.95 
 
N=C=S 
 
398.5392 
 
1.6816 
 
784.072 
 
7.05 
 
XPS data confirmed the presence of the expected atoms in both types of ITC SiNPs. 
However, the degree of oxidised atoms in ITC SiNPs (P Br SiNPs) seemed to be lower than 
ITC SiNPs (P NH2 SiNPs) as there was only 3% of the C1s attributed to the C-O in in ITC 
SiNPs (P Br SiNPs) whereas 12% of the spectrum in ITC SiNPs (P NH2 SiNPs) is attributed to 
this oxide (see Tables 4.4 and 4.5). This variation in oxidation levels might be attributed to 
differences in synthesis method, as these introduce dissimilar oxygen amounts into the 
nanosystem. 
The Si/C ratio of 1:6 was obtained for ITC SiNPs (P Br SiNPs) and ratio of 1:8 for ITC 
SiNPs (P NH2 SiNPs). Considering the expected ratio should be close to 1:4 in ITC SiNPs, the 
possibility of some unbound carbon impurities in ITC SiNPs (P NH2 SiNPs) is higher than ITC 
SiNPs (P Br SiNPs). 
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4.8. Size, Dispersity and Surface Charge of ITC SiNPs 
4.8.1. Visualisation and Size Measurement by TEM 
Figure 4.25 shows the TEM images of ITC SiNPs (P Br SiNPs) with different 
magnifications. The size of approximately 100 chosen NPs was measured by transmission 
electron microscopy. These NPs have a mean diameter of 4.01 nm (Figure 4.26). It should be 
noticed that the observed dispersity of these particles corresponds very closely to the lattice 
spacing in silicon crystals confirming the high definition of these NPs. Given the electron 
density of the ITC chain, it is likely that only silicon core of the NPs is visible by TEM. The 
lattice spacing of 0.31 nm is consistent with the Si (111) plane.27 
  
  
Figure 4.25. TEM images of ITC SiNPs (P Br SiNPs). The scale bars show 2 nm in (a), 5 nm in (b), 
10 nm in (c) and 20 nm in (d). 
(b)
(c) (d)
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Figure 4.26. ITC SiNPs (P Br SiNPs) diameter histogram (a) and the lattice spacing the Si (111) 
plane (b). 
 
 
TEM micrographs of ITC SiNPs (P NH2 SiNPs) are also shown in Figure 4.27. The average 
size for these NPs, which is coming from the NH2 SiNPs as the basis, was 4.21 nm which 
obtained after analysing 100 nanoparticles (Figure 4.28). 
 
 
Figure 4.27. TEM images of ITC SiNPs (P NH2 SiNPs). 
 
5 nm
(b)
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Figure 4.28. ITC SiNPs (P NH2 SiNPs) diameter histogram. 
 
 
4.8.2. Hydrodynamic Size Measurement by DLS 
As mentioned previously in Chapter 1, the DLS measures the hydrodynamic diameter of 
SiNPs and is dependent on the interaction between the surrounding environment and the 
functionality present on the surface of SiNPs.28 The DLS results of ITC SiNPs (P Br SiNPs) 
are shown in Figure 4.29. The nanoparticle diameter in RPMI containing the serum and DMSO 
was slightly larger than the diameters measured in the organic solvent (toluene), DMSO and 
RPMI without any supplements (Table 4.6). This could be due to either some partial 
aggregation in the media containing the serum or the formation of protein corona around the 
nanoparticles.  
Protein adsorption on the nanoparticle surface can mediate the uptake of nanoparticles.  
Therefore, each media type with different protein compositions could result in various toxicity 
and uptake patterns. As a result, it is important to evaluate the size of NPs in the specific media 
they are going to be used for biological studies.29, 30 
PdI, which is an indicator of the particle size distribution, was equal or less than 0.1 in 
toluene, DMSO and RPMI demonstrating the high monodispersibility of the prepared 
nanoparticle suspensions. The normal centrifugation before the measurement promoted the 
limited aggregation leading to the formation of ITC SiNPs with lower PdI. 
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Figure 4.29. Hydrodynamic diameter of ITC SiNPs (P Br SiNPs) in different dispersing solvents. 
 
Table 4.6. Mean hydrodynamic diameters and polydispersity index of ITC SiNPs (P Br SiNPs) 
measured by DLS in different media. 
 
Solvent 
 
Mean particle Size (nm) ± SD 
 
Polydispersity Index ± SD 
 
Toluene 
 
11.85 ± 0.05 
 
0.08 ± 0.02 
 
DMSO 
 
21.22 ± 1.20 
 
0.10 ± 0.02 
 
 
RPMI 
 
22.70 ± 0.50 
 
0.10 ± 0.13 
 
RPMI/10% 
DMSO+10%FBS 
 
33.01 ± 0.24 
 
0.20 ± 0.08 
 
The average size of the 18.24 nm was obtained for ITC SiNPs (P NH2 SiNPs) in toluene 
(Figure 4.30). Further information about the size of these nanoparticles in various media is 
presented in Table 4.7. The synthesised nanoparticles were found to be rather monodispersed 
without any significant sign of aggregation and thus suitable for further experiments, although 
the PdI was more than what obtained for ITC SiNPs (P Br SiNPs).  
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It should be also noted in general the PdI for the nanoparticles obtained from the top down 
approaches such as ITC SiNPs are slightly larger than for those obtained from the bottom up 
techniques, and this is because they are typically not very narrow distributed.  
 
Figure 4.30. Hydrodynamic diameter of ITC SiNPs (P NH2 SiNPs) in different dispersing solvents. 
 
Table 4.7. Mean hydrodynamic diameters and polydispersity index of ITC SiNPs (P NH2 SiNPs) 
measured by DLS in various media. 
 
Solvent 
 
Mean particle Size (nm) ± SD 
 
Polydispersity Index ± SD 
 
Toluene 
 
18.24 ± 2.50 
 
0.11 ± 0.05 
 
DMSO 
 
23.84 ± 1.15 
 
0.14 ± 0.11 
 
RPMI 
 
19.68 ± 1.03 
 
0.30 ± 0.04 
 
RPMI/10% 
DMSO+10%FBS 
 
29.05 ± 1.27 
 
0.42 ± 0.12 
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4.9. Optical Properties of ITC SiNPs 
4.9.1. Absorption and Emission Spectra 
The surface composition and termination play a dominant role in determining the optical 
properties and stability of nanoparticles.31 To evaluate the potential of ITC SiNPs and the 
validity of each synthesis route, the UV-Vis and PL measurements were performed on 
nanoparticles.  
The UV/Vis absorption and emission spectra of these ITC SiNPs (P Br SiNPs) at room 
temperature can be seen in Figure 4.31 (a). Nanoparticles displayed an optical transition in the 
300-360 nm range. The solid line is the PL spectrum of nanoparticles in toluene at room 
temperature. The PL showed a maximum emission in the blue region with a maximum at 450 
nm when excited at the optimum wavelength of 360 nm with a full width at a half maximum 
height (FWHM) of 95 nm. 
The UV-Vis spectrum of ITC SiNPs (P NH2 SiNPs) showed a gradual increase from high to 
low wavelengths (Figure 4.31 (b)). The maximum emission was found at 410 nm with a full 
width at a half maximum height (FWHM) of 110 nm under an excitation wavelength of 360 
nm.  
The origin of the photoluminescence in ITC SiNPs is the product of the combination of both 
direct and indirect band gaps in SiNPs. Some theoretical evidence suggests that 1-2 nm SiNPs 
with carbon terminated surfaces show direct band gap optical transitions, leading to the 
photoluminescence in the blue region.32-34 However, considering the size distribution of ITC 
SiNPs, these particles are too big to display blue PL by the quantum confinement effect. The 
possibility of the presence of nitrogen containing ligand caused the blue PL is higher as shown 
previously by Veinot et al. The presence of nitrogen atom in the structure of isothiocyanate 
functional group provided the mechanism of blue emission.5 
The spectra were collected from the nanoparticles dispersed in toluene. The PL spectra for 
both types of ITC SiNPs showed that the strongest PL emission appeared in toluene suspension. 
This could be explained by the fact that the HOMO/LUMO gap in toluene is low, leading to a 
fast electron transfer between the NPs and the surface bonding structure with the solvent 
molecules.35 Therefore, this could be utilised to improve the luminescence efficiency of the 
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composite of toluene and silicon. As a result, toluene was used for the optical characterisation 
of ITC SiNPs in this work. 
 
 
Figure 4.31. Absorption and emission spectra of ITC SiNPs (P Br SiNPs) (a) and ITC SiNPs (P NH2 
SiNPs) (b) at excitation at 360 nm in toluene. 
 
Interestingly, the difference in synthesis methods did not greatly affect the size and optical 
properties of the SiNPs. Each group of ITC SiNPs show similar UV-Vis absorption peak and 
in each case the PL emission showed emission in blue region between 410 and 450 nm under 
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excitation at 360 nm. This is due to the similar nature of the nanoparticle core and the attached 
functional group. 
 
4.9.2. Quantum Yield Measurement 
The fluorescence quantum yield (QY) of a fluorophore is an important characteristic of 
molecules which shows the ratio of fluorescence photons emitted to photons absorbed by the 
sample. Here, the quantum yield is measured by a comparative method described by Williams 
et al.36 Quinine sulphate was selected as standard because of the similar absorbance range to 
the SiNPs samples.  
Figures 4.32 and 4.33 show the UV-Vis and PL spectra of ITC SiNPs (P Br SiNPs) at five 
different concentrations, respectively. The integrated intensity is plotted against the absorbance 
for nanoparticles and the quinine sulphate reference using all spectra where the absorbance (or 
optical density) at 360 nm is greater than 0.01 and less than 0.1. (Figure 4.34) 
The quantum yield is calculated using the gradient shown in Figure 3.34 from the following 
equation: 
                                    𝑸 =  𝑸𝑹𝒆𝒇 (
𝑮𝒓𝒂𝒅𝑺𝒊𝑵𝑷𝒔
𝑮𝒓𝒂𝒅𝑹𝒆𝒇
)(
𝜼𝑻𝒐𝒍𝒖𝒆𝒏𝒆
𝟐
𝜼𝑹𝒆𝒇
𝟐 )                        (Equation 4.1) 
 
Where QRef is the quantum yield of the standard quinine sulphate and was considered to be 
54.6% when dissolved in 0.5M H2SO4. ηToluene is the refractive index of the solvent = 1.497 
and ηRef is the refractive index of the reference = 1.346.  
A quantum yield of 12.55% was calculated which is in agreement with the previously 
reported quantum yields for SiNPs which typically lie between 2% and 25%.4, 23, 37 
These calculated quantum yields are bright enough for biological applications, however they 
may vary with different excitation wavelengths. 
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Figure 4.32. UV/Vis spectra at different dilutions of ITC SiNPs (P Br SiNPs) in toluene. 
 
                   
Figure 4.33. Emission spectra of ITC SiNPs (P Br SiNPs) at varying concentration in toluene 
(Excitation: 360 nm). 
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Figure 4.34. Plotted integrated intensity of emission against absorbance for both ITC SiNPs (P Br 
SiNPs) in toluene and quinine sulphate in 0.1 M H2SO4. 
 
Figures 4.35 and 4.36 show the UV-Vis and PL spectra of ITC SiNPs (P NH2 SiNPs) at five 
different concentrations, respectively. Following the same procedure the integrated intensity 
has been plotted against the absorbance for nanoparticles and the reference (Figure 4.37). 
Using equation 4.1, the quantum yield of 2.61% was calculated for ITC SiNPs (P NH2 
SiNPs). The reasons for the low quantum yield of ITC SiNPs (P NH2 SiNPs) could be the 
presence of more oxide layer on the surface of ITC SiNPs (P NH2 SiNPs) compared to ITC 
SiNPs (P Br SiNPs), which can be explained by the formation of lower-energy mid gap states 
induced by newly formed defects, thus quenching the quantum yield of nanoparticles.38 This 
quenching might be a result of differences in the synthesis method of each of type of ITC 
SiNPs. Therefore, reduction of ITC SiNPs (P NH2 SiNPs) surface defects, in order to achieve 
brighter quantum yield, must be addressed.  
As a result, for further bioimaging experiments they may not be strong enough to be detected 
by the microscope and therefore only ITC SiNPs (P Br SiNPs) will be used later to investigate 
the bioimaging applications of nanoparticles.  
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Figure 4.35. UV/Vis spectra at different dilutions of ITC SiNPs (P NH2 SiNPs) in toluene. 
 
 
Figure 4.36. Emission spectra of ITC SiNPs (P NH2 SiNPs) at varying concentration in toluene 
(Excitation: 360 nm). 
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Figure 4.37. Plotted integrated intensity of emission against absorbance for both ITC SiNPs (P 
NH2 SiNPs) in toluene and quinine sulphate in 0.1 M H2SO4. 
 
4.9.3. Long Term PL Stability 
The PL stability of ITC SiNPs was measured over 30 days. This is important due to the lack 
of PL stability of nanostructured silicon which limits their commercial viability in a wide range 
of biomedical applications. The photoluminescence intensity of samples was monitored over a 
month using an excitation wavelength at 360 nm (Figure 4.38). The results show that after 30 
days, about 70% of the intensity was maintained which confirms the high stability of the 
samples.   
Similar characteristics were observed for ITC SiNPs (P NH2 SiNPs) as they were 
moderately stable over a month. The decrease in PL intensity was negligible over time and the 
overall intensity was still more than 80% of the initial PL (Figure 4.39). 
Even though the monolayers formed on single crystal silicon surfaces are robust to oxidation 
over long periods it is likely that these monolayers contain some defects over time and therefore 
the solvent they are dispersed in can penetrate to the underlying silicon atom layers.  
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Figure 4.38. Long term PL stability of ITC SiNPs (P Br SiNPs) (a) and PL intensity of ITC SiNPs (P 
Br SiNPs) over 30 days (b). 
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Figure 4.39.  Long term PL stability of ITC SiNPs (P NH2 SiNPs) (a) and PL intensity of ITC SiNPs 
(P NH2 SiNPs) over 30 days (b). 
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4.9.4. Solvent Effect on Optical Properties of Silicon Nanoparticles 
Four groups of ITC SiNPs suspensions were prepared to explore the influence of solvent 
polarity on the emission of nanoparticles. Hexane, toluene, dichloromethane and chloroform 
were selected as four solvents representative of a wide range of polarity indexes.  
The experimental results demonstrate that solvent polarity has a large effect on the light –
emitting properties of ITC SiNPs. A positive correlation was identified between the solvent 
polarity of both types of ITC SiNPs and the redshift of the PL peak (Figure 4.40). A possible 
mechanism for this phenomenon is suggested through consideration of SiNPs and the 
neighbouring solvent as a composite.35 To begin with, the dipole moment of organic molecules 
in the excited state is normally different from that in ground state. When the molecules of the 
solvent rapidly absorb photons, electrons in the solvent will redistribute and thus alter the 
dipole moment.39 When the sample is excited, the solvent undergoes a relaxation with a 
minimum free energy for the relaxed state. The higher the polarity of the solvent, the lower the 
energy of the relaxed state providing the larger red shift in the emission spectrum of the 
solvent.35 The same mechanism applies in the case of the composition of nanoparticles and 
dispersing solvent. The energies of the excited state will decrease under illumination due to the 
influence of the polarity of the solvent. Therefore, the PL spectrum will show a red shift.  
In this experiment, chloroform had the highest polarity index and showed the largest red 
shift for ITC SiNPs (both types). This is explained by the effect of the nanoparticle/solvent 
composite’s electronic state.   
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Figure 4.40.  Effect of solvent polarity on PL stability of ITC SiNPs (P Br SiNPs) (a) and ITC 
SiNPs (P NH2 SiNPs) (b). 
 
4.10. TGA Analysis and Estimation of the Ligand on the Surface 
TGA measurements were used to estimate the quantity of ligands on the surface of SiNPs. 
This is essential for biomedical applications as this amount needs to be known to compare the 
behaviour of these nanoparticles with an equivalent known control (drug).  
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As seen in the data, it was observed that the weight on the TGA trace starts to decrease due 
to the heat flow into the sample (Figure 4.41). This happened relatively rapidly which suggests 
the degradation of the capping ligand. The completion of the initial degradation happened at 
about 210 oC. Above 320 oC, the heat flow into the sample increases again and the weight 
continued to decrease in the TGA trace. A higher rate of weight loss was observed for this 
second stage of degradation as depicted by the derivative. The completion of the second 
degradation was observed at about 350 oC as there was only a small decrease in the weight.  
The TGA measurement was performed after heating in an inert atmosphere, and the overall 
percentage weight loss from the initial temperature to 1000 oC was 64%. This reduction could 
have several causes such as the evaporation of the functionalised SiNPs or the degradation of 
the functional ligand.14, 40 In this experiment, considering that the silicon core maintains 
stability even at higher temperatures,41 the weight loss is better explained through the second 
process. Two derivative peaks were observed which could be attributed to the removal of bound 
functional groups (ITCs) from the silicon first and then decomposition of the Si-C from the 
nanoparticle surface. Thus, the estimation of the weight attributed to the ligand is 
approximately 60% of the total nanoparticle weight, with the remaining 40% the silicon core.  
 
 
Figure 4.41. TGA and derivative of ITC SiNPs (P Br SiNPs). 
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Similar behaviour was observed for ITC SiNPs (P NH2 SiNPs) after an identical TGA 
analysis. It is henceforth considered that this ligand weight estimate holds for both types of 
ITC SiNPs. Therefore, for the following biological assay 60% of each batch was taken to be 
ITC ligand.  
 
 
4.11. In Vitro Biomedical Studies 
4.11.1. Cytotoxicity Assays by MTT 
The physiochemical properties of SiNPs determine the degree of toxicity in biological 
environments. In order to evaluate the cytotoxicity of the synthesised SiNPs, an MTT assay 
was performed to determine the loss of cell viability. Caco-2 and CCD-841 cells were seeded 
on a 96-well plate and incubated at 37 oC for 24 h. Next, the cells were treated with various 
concentrations of ITC SiNPs from 5 to 70 µg/mL for a period of 24 and 48 h. After this time 
the media was removed and cells were washed by PBS and the MTT protocol was performed 
as previously described in Chapter 2 (Section 2.4.2). The absorbance was recorded on a 
microplate reader at the wavelength of 570 nm and the percentage of the viable cells was 
calculated by comparison against untreated control cells. All experiments were repeated on 
three different occasions. In order to have a better understanding of the effect of nanoparticles 
on cells, two different graphs are provided for each experiment to make the comparison more 
straightforward. This is since the concentration needed to compare the nanoparticle effect, with 
the drug as control, needs to be shown as µM (group (a) in each graph). When NH2 SiNPs is 
used as the control, on the other hand, the unit for nanoparticles is µg/mL (group (b) in each 
graph). As 60% of ITC nanoparticles is considered consists of the ligand, the following 
concentrations were used for the MTT assays: 
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Table 4.8. Concentrations of nanoparticles and AITC in MTT experiments.  
µg/mL (ITC SiNPs) 5 10 15 20 30 50 70 
60% of the weight 
(ligand) 
3 6 9 12 18 30 38 
µM (AITC) 30 60 90 120 181 302 380 
 
NH2 SiNPs have shown previously to act as a non-toxic material
42 and therefore are used 
here to evaluate the therapeutic properties of ITC SiNPs with another material at nanoscale.  
Figure 4.42 (a), shows the cytotoxicity of ITC SiNPs in Caco-2 cells compared to the 
original drug, allyl isothiocyanate (AITC). As indicated, the change in cell viability was not 
statistically significant up to 120 µM, where nanoparticles started to decrease the viability to 
approximately 70%. At 181 µM, there was a large difference in terms of the effectiveness of 
nanoparticles compared to the drug as control which reduced the viability of cells to 40%. The 
highest concentration at 380 µM ITC SiNPs (P Br SiNPs) had a cytotoxic effect of 
approximately 58% viability after 24 h, while ITC SiNPs (P NH2 SiNPs) showed a very similar 
effect to the AITC drug with the remaining cell viability of less than 40%.  
Figure 4.42 (b) shows the results from the same experiment when compared to NH2 SiNPs 
as non-toxic nanomaterials. For the highest concentration at 70 µg/mL, NH2 SiNPs did not 
have any effect on cell viability with almost 90% of cells still alive in contrast with both groups 
of ITC SiNPs.  
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Figure 4.42. In vitro cytotoxicity of ITC SiNPs (P Br SiNPs) and ITC SiNPs (P NH2 SiNPs) by MTT 
after incubation with Caco-2 at 24 h compared to AITC as control (a) and NH2 SiNPs (b) as control. 
Statistical significance was determined by two-way-ANOVA followed by a Bonferroni post-test (***P 
< 0.001, **P < 0.01 and *P < 0.05). Results are expressed as mean ± SEM (n =3). 
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 For longer incubation time points, such as after 48 h, (Figures 4.43 (a) and (b)) SiNPs did 
not show any statistically significant effect on cell viability at low concentrations, whereas the 
AITC reduced the cell viability from when they were first introduced to almost 70% for this 
low concentration. This might be attributed to the errors in the estimation of the ligand on the 
surface which may not be exactly equal to the amount of the AITC used as control for low 
concentrations, as this is a rough estimation for this measurement. However, at 181 µM, 
nanoparticles and AITC reduced the cell viability to less than 40%, and continued to become 
more cytotoxic at the highest concentration 380 µM which showed only about 20% cell 
viability. It should be noted for most concentrations, ITC SiNPs (P NH2 SiNPs) seemed to be 
more cytotoxic than ITC SiNPs (P Br SiNPs), and presented closer behaviour to AITC as 
control.  
In Figure 4.43 (b) it is observed that statistically significant differences between NH2 SiNPs 
and ITC SiNPs occur for all concentrations for this 48 h incubation time, the magnitude of 
which becomes very large for the highest concentrations. ITC SiNPs, based on these results, 
are more effective in terms of their increased cytotoxicity for all concentrations. This is 
attributed to the capping functional ligand, as a similar effect was not observed for NH2 SiNPs, 
with approximately 70% cell viability for the highest concentration after 48 h incubation.  
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Figure 4.43. In vitro cytotoxicity of ITC SiNPs (P Br SiNPs) and ITC SiNPs (P NH2 SiNPs) by MTT 
after incubation with Caco-2 at 48 h compared to AITC as control (a) and NH2 SiNPs (b) as control. 
Statistical significance was determined by two-way-ANOVA followed by a Bonferroni post-test (***P 
< 0.001, **P < 0.01 and *P < 0.05). Results are expressed as mean ± SEM (n =3). 
 
Figure 4.44 shows the overall comparison between two different time points for ITC SiNPs 
(P Br SiNPs) (a) and in ITC SiNPs (P NH2 SiNPs) (b). It is clear that both types of nanoparticles 
need longer time periods, such as 48 h, to be effective. In addition, even though both 
nanoparticles seem to follow similar trends, the ITC SiNPs (P NH2 SiNPs) appear to be slightly 
more cytotoxic, which could be related to the difference in the synthesis methods leading to a 
change in the purity level for each type of SiNPs. Moreover, the exact amount of the ITC on 
the surface of each type of SiNPs could be slightly different which would be due to the 
limitations related to the top down synthesis method. This would in turn make the active sites 
on the surface of H-terminated SiNPs inconsistent and therefore batch dependant.  
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Figure 4.44. MTT of ITC SiNPs (P Br SiNPs) at 24 and 48 h (a) and ITC SiNPs (P NH2 SiNPs) at 24 
and 48 h (b) after incubation with Caco-2 cells. Statistical significance was determined by two-way-
ANOVA followed by a Bonferroni post-test (***P < 0.001 and **P < 0.01). Results are expressed as 
mean ± SEM (n =3). 
 
Figure 4.45 (a) shows the MTT results in CCD-841 cells after 24 hours incubation with the 
SiNPs and AITC. It was concluded that ITC SiNPs (P NH2 SiNPs) reduced the toxicity to 80% 
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concentrations at 90 µM. For the 120 to 380 µM concentrations, the cell viability for both types 
of nanoparticles and the drug was moderately stable at around 60%. Finally, the highest dose 
of ITC SiNPs (P NH2 SiNPs) were the most cytotoxic, decreasing cell viability by nearly 60%, 
while ITC SiNPs (P Br SiNPs) and AITC caused ~40 % loss of cell viability. 
In Figure 4.45 (b), the actual effect of ITC SiNPs becomes clearer by comparing their effect 
with that of NH2 SiNPs at 20 µg/mL concentration. At this level, they both reduced the cell 
viability to almost 60% vs 90% of the control cell viability respectively, which was independent 
of the concentration level above 20 µg/mL.  
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Figure 4.45. In vitro cytotoxicity of ITC SiNPs (P Br SiNPs) and ITC SiNPs (P NH2 SiNPs) by MTT 
after incubation with CCD-841 at 24 h compared to AITC as control (a) and NH2 SiNPs (b) as control. 
Statistical significance was determined by two-way-ANOVA followed by a Bonferroni post-test (***P 
< 0.001, **P < 0.01 and *P < 0.05). Results are expressed as mean ± SEM (n =3). 
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SiNPs was stronger specifically at concentrations above 120 µM. A minimum level of cell 
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SiNPs) and ITC SiNPs (P NH2 SiNPs) at 380 µM respectively. These cell viabilities were 
slightly higher than that of AITC (~ 13 %) and much lower than that of NH2 SiNPs (~ 75%) 
for the equivalent concentration at 70 µg/mL (Figure 4.46 (b)).  
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Figure 4.46. In vitro cytotoxicity of ITC SiNPs (P Br SiNPs) and ITC SiNPs (P NH2 SiNPs) by MTT 
after incubation with CCD-841 at 48 h compared to AITC as control (a) and NH2 SiNPs (b) as control. 
Statistical significance was determined by two-way-ANOVA followed by a Bonferroni post-test (***P 
< 0.001, **P < 0.01 and *P < 0.05). Results are expressed as mean ± SEM (n =3). 
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Figures 4.47 shows a comparison of the behaviour of ITC SiNPs (P Br SiNPs) (a) and that 
of ITC SiNPs (P NH2 SiNPs) (b), at both time points (24 an 48 h) in CCD-841 cells. It is 
concluded that the fourth concentration used in the treatment of the CCD-841 cells (20 µg/mL) 
was of significance, since at this amount and above it, the cell viability changed dramatically 
for both types of ITC SiNPs. Overall, ITC SiNPs (P NH2 SiNPs) were more cytotoxic in CCD-
841 cells than Caco-2.  
It should be noted that the cytotoxic effect of ITC SiNPs on CCD-841 cells is very dependent 
on the cell line sensitivity which leads to lower cell viability when exposed to any sort of 
foreign material.43, 44 Thus, in order to have an appropriate comparison to the results obtained 
by the MTT assay, it is important to evaluate the behavioural differences between the ITC 
SiNPs and the controls of AITC and NH2 SiNPs within the same cell line.  
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Figure 4.47. MTT of of ITC SiNPs (P Br SiNPs) at 24 and 48 h (a) and ITC SiNPs (P NH2 SiNPs) at 
24 and 24 h (b) after incubation with CCD-841 cells. Statistical significance was determined by two-
way-ANOVA followed by a Bonferroni post-test (***P < 0.001, **P < 0.01 and ns not statistically 
significant). Results are expressed as mean ± SEM (n =3). 
 
In conclusion, ITC SiNPs (P NH2 SiNPs) where slightly more cytotoxic than ITC SiNPs (P 
Br SiNPs) in MTT experiments. This might be due to the better surface coverage of SiNPs by 
the ITC ligand. However, the possibility of impurities originating from the synthesis method, 
leading to more cytotoxic effects, should be taken into the consideration in future work. In 
general, since the difference in the behaviour of these two types of SiNPs was negligible, for 
the further uptake studies only ITC SiNPs (P Br SiNPs) were selected. This choice was based 
on the better optical properties of these nanoparticles and their higher quantum yield.  The low 
quantum yield of ITC SiNPs (P NH2 SiNPs), on the other hand, would be a significant 
impediment for uptake studies, specifically imaging and flow cytometry. More specifically, for 
these latter two assays, the fluorescence of nanoparticles is more important than the 
cytotoxicity for therapeutic applications.  
 
4.11.2. Cellular Uptake Studies 
The ability of SiNPs to become internalised by cells is dependent on several factors, 
including the type of NP, the type of cell line and uptake mechanism.45, 46 In order to understand 
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and the intracellular distribution of both the nanoparticles were evaluated by flow cytometry 
and confocal imaging. 
 
4.11.2.1. Confocal Microscopy 
In this experiment, colon cancer cells (Caco-2) were incubated with a concentration of 50 
μg/mL of ITC SiNPs (P Br SiNPs) for 6 and 12 h at 37 ºC. 
Figures 4.48 to 4.49 show the confocal images of control Caco-2 cells without any 
nanoparticle treatment, followed by Figures 4.50 to 4.53 showing cells after the nanoparticle 
treatments. The cells were stained with Phalloidin for actin staining. It was clearly observed 
that SiNPs (green) were localised in the cells.  
The internalisation was obviously time dependant as more ITC SiNPs were detected after 
12 h incubation (Figures 4.52 and 4.53) compared to the samples after 6 h treatment (Figures 
4.50 and 4.51). 
For further evidence, Z-stack imaging was performed to examine the spread of ITC SiNPs 
within the cells. The images were collected at 0.37 μm intervals. As can be seen in Figure 4.54, 
SiNPs were evenly distributed within the cytoplasm rather than only being attached to the 
external surface of the cells. 
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(a) (b) 
  
(c) 
 
Figure 4.48. Confocal fluorescence images of control (untreated) Caco-2 cells. Red channel (a), green 
channel (b), merged (c). Red from Phalloidin for actin staining. 
 
 
 
Chapter 4                        Synthesis and Characterisation of Isothiocyanate-functionalised Silicon Nanoparticles  
 
214 
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Figure 4.49. Confocal fluorescence images of control (untreated) Caco-2 cells. Red channel (a), green 
channel (b), merged (c). Red from Phalloidin for actin staining. 
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 (a) (b) 
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Figure 4.50. Confocal fluorescence images of Caco-2 cells incubated with ITC SiNPs (P Br SiNPs) 
for 6 h incubation. Red channel (a), green channel (b), merged (c). Red from Phalloidin for actin 
staining and green fluorescence from nanoparticles. 
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(a) (b) 
  
(c) 
 
Figure 4.51. Confocal fluorescence images of Caco-2 cells incubated with ITC SiNPs (P Br 
SiNPs) for 6 h incubation. Red channel (a), green channel (b), merged (c). Red from Phalloidin for 
actin staining and green fluorescence from nanoparticles. 
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(a) (b) 
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Figure 4.52. Confocal fluorescence images of Caco-2 cells incubated with ITC SiNPs (P Br SiNPs) 
for 12 h incubation. Red channel (a), green channel (b), merged (c). Red from Phalloidin for actin 
staining and green fluorescence from nanoparticles. 
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(a) (b) 
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Figure 4.53. Confocal fluorescence images of Caco-2 cells incubated with ITC SiNPs (P Br SiNPs) 
for 12 h incubation. Red channel (a), green channel (b), merged (c). Red from Phalloidin for actin 
staining and green fluorescence from nanoparticles. 
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Figure 4.54. Z-stack confocal images of Caco-2 cells incubated with ITC SiNPs (P Br SiNPs) for 12 h 
incubation, collected at 0.37μm intervals. Red from Phalloidin for actin staining and green fluorescence 
from nanoparticles. The first row shows the bottom layer and the last row shows the top layer (The 
order is from left to right). 
Chapter 4                        Synthesis and Characterisation of Isothiocyanate-functionalised Silicon Nanoparticles  
 
220 
4.11.2.2. Flow Cytometry 
To further investigate cell uptake, flow cytometry was undertaken using ITC SiNPs with 
Caco-2 cells. The total fluorescence intensity of particles was measured in 10,000 cells. Figures 
4.55 and 4.56 show the uptake efficiency of ITC SiNPs (P Br SiNPs) using FL1 channel 
detector. 
Cells were treated with two different concentrations of nanoparticles (20 and 70 µg/mL) for 
various time points (6 to 48 h). As can be seen in Figure 4.55 (a), the fluorescence detected 
from the cells when treated with 20 µg/mL of ITC SiNPs was very low and changed just slightly 
over time. On the other hand, by increasing the nanoparticle concentration to 70 µg/mL (Figure 
4.55 (b)), the time dependant behaviour of ITC SiNPs, in addition to the higher uptake level 
for this concentration, was clear.  
The overall median of the fluorescence for both concentrations is shown in Figure 4.56, 
after 6 and 12 h incubation. It was observed that the difference between the two different 
concentrations was not statically significant. However, it became significant for the 24 and 48 
h time periods.  
This relationship suggest that the amount of nanoparticle inside the cells is dependent on the 
dose applied to treat the cells, in addition to the specific time point for each treatment. The flow 
cytometric data in general confirmed the uptake of ITC SiNPs in Caco-2 cells in a similar time 
and dose dependant manner.  
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(a) 
 
              
(b) 
 
             
Figure 4.55. Uptake efficiency of ITC SiNPs (P Br SiNPs) in Caco-2 cells with various incubation 
times from 6 to 24 h. Cells were exposed to two nanoparticle concentrations of 20 μg/mL (a) and 70 
μg/mL (b). 
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Figure 4.56. Collective flow cytometric analysis results, which are presented as fluorescence median 
of cells after nanoparticle uptake showing the time dependent behaviour of uptake. Statistical 
significance was determined by two-way-ANOVA followed by a Bonferroni post-test (***P < 0.001, 
**P < 0.01 and ns not statistically significant). Results are expressed as mean ± SEM (n =3). 
  
To study further, the internalisation mechanism of ITC SiNPs was investigated. It has been 
shown previously that diffusion and active transport of molecules across the cell membrane are 
temperature dependant.47 The transport activity is significantly less at low temperatures and 
therefore the uptake of molecules could be considered as non-specific diffusional entry. Even 
though the ligands have been shown to attach to the cell membrane, the internalisation can be 
affected at low temperatures.46 Low temperatures can affect the binding of the ligands to 
specific receptors, and moreover the mobility of the ligand-receptor complex could be 
interfered as well.48 It has furthermore been shown that the transport of the endocytosed 
material from endosomes to lysosomes can be interfered with at low temperatures.45  
Small particles are beneficial to enter the cells more rapidly.46 Endocytosis is known as the 
main mechanism of cellular internalisation for many nanoparticles.49 However, if the 
nanoparticle diameter is smaller than 5 nm, it is more likely they enter the cells by other 
pathways such as translocation.49 Particles with the size of ~25 nm were shown to have a higher 
rate of uptake by endocyosis.46 This size is close to the hydrodynamic size of ITC SiNPs in 
biological media (Tables 4.6 and 4.7). The efficiency of endocytosis is dependent on the 
physiochemical properties of nanoparticles such as surface chemistry, size, shape and the cell 
type being exposed to NPs.50 In the endocytotic process, the size of the vesicles containing 
6 h 12 h 24 h 48 h
0
10
20
30
40
50
20 µg/mL
70 µg/mL
ns ns
 **
***
***
**
Time
M
e
d
ia
n
 (
F
L
1
-H
)
Chapter 4                        Synthesis and Characterisation of Isothiocyanate-functionalised Silicon Nanoparticles  
 
223 
nanoparticles varies based on the specific pathway. The nanoparticle size is a crucial parameter 
in determining which pathway will be taken.51  
Since ITC SiNPs could be effectively internalised into Caco-2 cells, different temperatures 
(4 oC and 37 oC) for the cell incubation were used to investigate the underlying uptake 
mechanism. Cells were treated with 70 µg/mL ITC SiNPs at 4 oC for various time points 
(Figure 4.57) and the data was compared to that obtained from the treated cells at normal 
physiological temperature (37 oC) (Figure 4.58). ITC SiNPs uptake was impeded when 
incubated at 4 oC while the internalisation was confirmed through fluorescence observations at 
37 oC. As a result, flow cytometry data indicated that the uptake of ITC SiNPs is most likely 
energy-dependant. 
 
 
 
Figure 4.57. Uptake efficiency of ITC SiNPs (P Br SiNPs) in Caco-2 cells when incubated at 4 oC. 
 
Figure 4.58. Collective flow cytometric analysis results after Caco-2 cells were incubated with ITC 
SiNPs (P Br SiNPs) at 37 oC and 4 oC. Statistical significance was determined by two-way-ANOVA 
followed by a Bonferroni post-test. (***P < 0.001 and **P < 0.01). Results are expressed as mean ± 
SEM (n =3). 
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4.12. Summary and Conclusions 
For many applications, it is desirable to prepare SiNPs with functional groups which can 
facilitate their conjugation to other molecules. It has been shown that NH2 SiNPs and Br SiNPs 
can be used as starting material to achieve nanoparticles with the ITC functional group.  
The successful synthesis of ITC SiNPs using two different approaches shows both types of 
nanoparticle are fully capped by the ITC group. Although using different starting materials and 
reagents, the final products behaved similarly when characterised by various physiochemical 
techniques. Both SiNPs types have been shown to be rich in silicon and with crystalline 
structures.  
ITC SiNPs obtained from Br SiNPs show higher levels of purity since the only reagent used 
is the synthesis method was a salt (KSCN) which was easily separated by washing and 
separation in non-miscible solvents. On the other hand, ITC SiNPs obtained from NH2 SiNPs 
as the starting material, showed the presence of impurities (by-products) even after several 
attempts of purification. Therefore, the higher toxicity of ITC SiNPs (P NH2 SiNPs) may not 
attributed to the therapeutic effects of the ITC functional group with confidence. 
It was shown that ITC SiNPs (P Br SiNPs) have a higher quantum yield than ITC SiNPs (P 
NH2 SiNPs), and were bright enough to be clearly detected by the confocal microscope and 
flow cytometer for uptake studies.  
The internalisation of ITC SiNPs (P Br SiNPs) was confirmed and it is most likely to be 
based on the receptor mediated endocytosis mechanism since the temperature behaviour was 
observed in the uptake process of SiNPs.    
Even though ITC SiNPs are not soluble in aqueous media, this is not a major concern for 
biomedical applications since they can be dispersed as lyophobic aqueous sols. This can be 
achieved by first dissolving the nanoparticles in small amounts of suitable organic solvents and 
later diluting them in polar solvents.  
In summary, this chapter has demonstrated the development and assessment of a novel, 
promising multifunctional nanosystem, which can be used for bioimaging applications, with 
the inherited therapeutic properties of the functional ligand. Furthermore, these nanoparticles 
are indeed compatible with cells, and can be exploited as potential probes in bioimaging assays 
and in further investigations.  
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5.1. Overview  
Biological tissues and cells are extremely complex structures that vary widely in 
composition. Different cellular components such as proteins, lipids, nucleic acids, and 
carbohydrates have unique IR spectra. Therefore, variations in their content or structure, can 
provide important information about the chemistry of cells and tissue states.1  
Conventional IR microspectroscopy has proven extremely valuable for resolving the 
chemical components in biological samples, however, the long wavelengths of IR radiation 
limit the spatial resolution which can be achieved. The resolution of traditional FTIR 
microspectroscopy is limited to approximately to 75 μm.  As individual biological cells are 
typically between 5 to 30 μm in diameter, they are too small to probe with a conventional 
thermal (globar) IR source.1  
Synchrotron-based Fourier Transform Infrared (SR-FTIR) microspectroscopy is a crucial 
technique that provides fingerprint-like information and is capable of characterising distinct 
tissue structures. The high brightness of the synchrotron source, which is defined as the photon 
flux or power emitted per source area and solid angle, allows smaller regions to be probed with 
an acceptable (S/N).2, 3 The spatial resolution of a synchrotron IR source is <10 μm (depending 
on the wavelength) and allows the chemical mapping of single living cells for the first time.4 
In addition, the high brightness of the synchrotron IR source is several hundred times higher 
than the conventional IR microspectroscopy and has opened the door to cellular and sub-
cellular chemical imaging of living cells for further investigation of various components.1  
In this chapter, SR-FTIR was used to study Caco-2 and CCD-841 cells and to determine the 
effect of ITC SiNPs on these cells. This method has been used to analyse the internalisation of 
ITC SiNPs, synthesised as described in Chapter 4, into the cells and to examine how they can 
affect the cells. First, the measurements were performed on free-standing materials to confirm 
the expected absorption signals for the relevant functionalities by a synchrotron source. As 
desired, the spectra obtained from the synchrotron facility showed similar peaks with more 
details and higher intensity than the normal FTIR facility.  
In order to evaluate the effect of ITC SiNPs on cells after uptake, the experiments were 
carried out by spectral comparison of cells treated by ITC SiNPs and control cells. Individual 
spectra were collected from both nuclei and cytoplasm of cells and the variations in the protein 
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and phospholipid contents of the treated cells confirmed the effect of nanoparticle 
internalisation in the treated cells. The results show that it is possible to establish the vibrational 
frequencies, corresponding to the specific functional group of cell components, to quantify the 
changes in cell composition in response to nanoparticle internalisation. 
The response of cells to changes in their chemical environment can be evaluated using FPA 
detector, which provides infrared chemical images. These changes were evaluated via the 
variations in the distribution of mid-infrared band intensities, and in doing so gives a profile of 
the biomolecular domains within cells before and after treatment with SiNPs. Such potential 
changes are due to several factors, including variations in density of various cellular 
components such as the proteins and phospholipids. This capability will be useful for the study 
of biological cells, as part of this project to identify and understand the interaction between 
synchrotron radiation and different cells before and after the nanoparticle internalisation. 
 
5.2. Synchrotron Measurement Studies    
5.2.1. Synchroton FTIR Spectroscopy of Free-standing SiNPs 
Before analysis, the quality of ITC SiNPs (discussed in Chapter 4) and their precursors was 
further checked with SR-FTIR. The higher resolution of synchrotron facilitated improved 
observations of signals related to the expected bonding frequencies occurring in nanoparticles.  
Figures 5.1 and 5.2 show the spectra of ITC SiNPs (a) and the starting materials (Br SiNPs 
and NH2 SiNPs) used for their synthesis (b). Signals representing the expected functional 
groups appeared at the anticipated wavenumbers.  The C-Si symmetric bending at about 1260 
cm-1 was clearer compared to that obtained in Chapter 3 by conventional FTIR. The double 
bond at around 2100 cm-1 for both types of ITC SiNPs confirmed the successful synthesis of 
the isothiocyanate functional group. The overall bonding features obtained by the synchrotron 
source appeared very sharp and clear compared to the standard laboratory source. 
Initially it was decided to use both types of ITC SiNPs for synchrotron studies. This was 
due to the fact that the double bond was detected in ITC SiNPs (NH2 SiNPs) with much higher 
intensity. It was anticipated that detection of these functional groups in cells after nanoparticle 
internalisation should be possible but, as the peaks related to cellular components were 
dominant, this double bond was much weaker and not found. Taking this finding in 
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combination with previous results obtained in Chapter 4, as ITC SiNPs (P Br SiNPs) showed 
better optical properties, it was decided to use only this type of ITC SiNPs for the biological 
synchrotron studies.  
 
Figure 5.1. SR-FTIR analysis for ITC SiNPs (P Br SiNPs) (a) and Br SiNPs as the precursor (b). 
 
 
Figure 5.2. SR-FTIR analysis for ITC SiNPs (P NH2 SiNPs) (a) and NH2 SiNPs as the precursor (b). 
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5.2.2. FTIR Spectral Comparison and Analysis of Individual Cells  
Figures 5.3 to 5.6 show the visual micrographs of Caco-2 and CCD-841 cells before and 
after treatment with ITC SiNPs. The presented spectra in the following sections were obtained 
from these figures. 
 
Figure 5.3. Photomicrographs of Caco-2 control cells. 
 
 
Figure 5.4. Photomicrographs of Caco-2 cells treated with ITC SiNPs. 
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Figure 5.5. Photomicrographs of CCD-841 control cells. 
 
 
Figure 5.6. Photomicrographs of CCD-841 cells treated with ITC SiNPs. 
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The ability of IR spectroscopy to distinguish and map various cells and tissues has helped 
to address the question about the origin of spectral differences between normal and cancer cells. 
Considering the size of human cells (~5-30 μm), IR microspectroscopy is an ideal method to 
investigate individual cells. In this project, the differences in spectral quality between the non-
treated individual cells and those treated with SiNPs were monitored using IR 
microspectroscopy.5 NH2 SiNPs were used as another type of control material to confirm if the 
observed effect originates from the isothiocyanate ligand on the surface of NPs being studied. 
The spatial resolution of IR microspectroscopy measurements is normally limited by the 
size of the aperture used, which in turn determines the projected image onto the detector. As a 
result, to obtain higher quality data in order to resolve individual cells or various components 
within the cells, apertures as 3-6 μm2 are desirable.5 However, in this work we compare spectral 
data collected at an aperture of 10 μm2 and it was possible to monitor the differences.  
Point spectroscopy gives highly specific data about the material present in cells. Figures 5.7 
to 5.12 show a micrograph (a), a chemical map (b) and a number of representative spectra (c) 
acquired from the positions along a trace shown in sub-figure (a) starting from near the 
end/edge of cells, going to the cytoplasm, passing the nucleus and then continuing the other 
side of the cell based on IR characteristics of Caco-2 and CCD-841cells. The image shown in 
sub-figure (b) was assembled using the integrated absorbance of the amide I band between 
1614 cm-1 and 1702 cm-1 which is contributed to the map showing the protein distribution in 
the cell.  
Both types of cells were treated with 50 μg/mL of ITC SiNPs and NH2 SiNPs as control for 
6 h. The IR spectra were acquired along a line to monitor the nuclei and cytosol IR 
characteristics of both untreated and treated cells. Each spectrum in sub-figure (c) is an average 
spectrum obtained from 20 individual cells. Substantial changes were observed in the finger 
print region (900-1800 cm-1) when comparing treated and control cells.  
The most prominent differences were found between the spectra from nuclei and cytosol of 
both types of cells treated with ITC SiNPs, specifically in ~1653 cm-1 which is an important 
feature of biological IR spectra for the amide I region. Figure 5.7 (c) shows the spectra of non-
treated Caco-2 cells, the intensity of signal at 1600 cm-1 remained unchanged for the spectra 
obtained from the cytoplasm and nucleus. However, Caco-2 cells treated with ITC SiNPs 
(Figure 5.8) showed the largest signal for the amide I region in the nucleus, indicating 
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considerable protein conformational changes in the nuclei of treated cells with ITC SiNPs. This 
is in agreement with the hypothesis of the suggested enzymatic process in which 
isothiocyanates are involved. ITCs are known to induce phase II enzymes. The expression of 
most phase II genes is mediated through the antioxidant response element (ARE). Nrf2 is a 
powerful protein and is kept in the cytoplasm under normal conditions. Following the exposure 
to the oxidative stress such as isothiocyanates, Nrf2 translocates to the nucleus and binds to the 
DNA at the location of ARE to initiate the transcription of antioxidative genes and their 
proteins.6 This will result in the transcriptional activation of a battery of detoxification and 
antioxidant proteins.7 Therefore, the increased concentration of proteins in nuclei on cells 
treated with ITC SiNPs and a higher intensity of the amide I peak is consistent with this.  
Similar behaviour was observed in CCD-841cells too; in the spectra of ITC SiNPs treated 
CCD-841cells, these bands in the amide I region are more pronounced for the nuclei of treated 
cells (Figure 5.11 (c)). In addition, the spectra obtained from treated cells revealed higher 
absorption in cytoplasm for C-H stretching region at 2800-3050 cm-1 and also a signal at 1737 
cm-1 which appeared as a small peak on the high frequency side of the amine I band (Figures 
5.8 and 5.11). This is related to the non-hydrogen bonded ester carbonyl C=O stretching mode 
of phospholipids.8 These differences attributed to variations of phospholipid content, are 
coming from the cellular membrane. The increased absorption of phospholipids has been 
previously reported after treatment with various apoptosis inducers which lead to the 
phospholipid alterations in cellular membrane.9, 10 This is in agreement with the fact that a large 
number of isothiocyanates have been shown to induce apoptosis in cells.11 The fact that both 
treated cells showed the higher concentration of phospholipids shows this originates from ITC 
SiNPs because the cells treated with NH2 SiNPs (Figures 5.9 and 5.12) did not show any 
increased phospholipid absorbance. This confirms that NH2 SiNPs are non-toxic control 
nanoparticles able to be used without inducing significant cytotoxic cellular effects. 
A comparison of the spectra of the two cell lines revealed significant spectral differences 
which indicate that IR spectroscopy can successfully monitor overall cell activity. These 
spectra display subtle differences between the treated and non-treated cells, and between the 
nuclei and the cytosol, which is in agreement with the behaviour of ITCs in cells related to the 
induction of phase II enzymes and apoptotic responses. 
Chapter 5                                             Synchrotron-based Fourier Transform Infrared Microspectroscopy 
 
237 
 
Figure 5.7. Synchrotron infrared imaging of a control Caco-2 cell showing the visual image (a), protein 
infrared image (b) and representative infrared spectra (c) acquired along the line in image (a). 
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Figure 5.8. Synchrotron infrared imaging of a Caco-2 cell treated with ITC SiNPs showing the visual 
image (a), protein infrared image (b) and representative infrared spectra (c) acquired along the line in 
image (a). 
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Figure 5.9. Synchrotron infrared imaging of a Caco-2 cell treated with NH2 SiNPs showing the visual 
image (a), protein infrared image (b) and representative infrared spectra (c) acquired along the line in 
image (a). 
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Figure 5.10. Synchrotron infrared imaging of a control CCD-841 cell showing the visual image (a), 
protein infrared image (b) and representative infrared spectra (c) acquired along the line in image (a). 
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Figure 5.11. Synchrotron infrared imaging of a CCD-841 cell treated with ITC SiNPs showing the 
visual image (a), protein infrared image (b) and representative infrared spectra (c) acquired along the 
line in image (a). 
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Figure 5.12. Synchrotron infrared imaging of a CCD-841 cell treated with NH2 SiNPs showing the 
visual image (a), protein infrared image (b) and representative infrared spectra (c) acquired along the 
line in image (a). 
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5.2.3. FTIR Mapping and Chemical Imaging Using Focal Plane Arrays Detector (FPA) 
Specific information regarding the spatial distribution of cell components can be obtained 
by using the approach of functional group mapping. This enables plotting of the absolute 
intensity of one absorption band within the map. By comparing the maps of different functional 
groups or their ratios, the information related to relative distribution of different components 
in the sample can be obtained.12  
The chemical changes associated with either the treated or control cells were evaluated using 
FPA mapping. IR imaging was used to evaluate the effect of nanoparticle internalisation on 
cells and visualise the chemical mapping information from different samples. If nanoparticles 
are internalised and introduce cytotoxicity or induce apoptosis to the cells, the pattern of 
chemical absorbance in cells will be different in control and treated cells.  Figures 5.13 to 5.18 
show the data obtained from FPA analysis, (a) visual micrograph, (b) 2D and (c) 3D chemical 
imaging of control and treated cells. The images shown in sub-figures (b) and (c) were 
assembled using the integrated absorbance between 2800 and 3000 cm-1 and thus were 
correlated to the phospholipid distribution of cells. All processed results are displayed on the 
same false-colour scale showing red (high) through to blue (low) for the given feature.   
The data from control cells (Figures 5.13 and 5.16) demonstrated less absorbance when 
integrated in the same region, which is related to the phospholipid features of cells. The 
chemical imaging of both Caco-2 (Figure 5.14) and CCD-841 (Figure 5.17) cells when treated 
with 50 μg/mL ITC SiNPs after 6 h incubation demonstrated considerably higher intensity at 
this location. This confirms that the spectral data obtained from the individual cells gives a 
higher distribution of phospholipids for the treated cells, which possibly is as a result of the 
apoptotic process occurring in the cells due to the effect of isothiocyanate functionality on 
SiNPs.  
The chemical image of cells treated with NH2 SiNPs was similar to the control cells with no 
clear observation of phospholipid signal and very low absorption after the integration in the 
similar region (Figures 5.15 and 5.18). This is in agreement with the MTT data, obtained in 
Chapter 3, and confirmed that amine-functionalised SiNPs do not change the cell viability at 
this concentration.  
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(a) 
 
                   (b)                                             (c) 
   
Figure 5.13. Visible and FTIR images of control Caco-2 cells a microscope image (a), 2D (b) and the 
3D (c) chemical images of cells (phospholipid profile). The colour bar indicates low (blue) to high (red) 
for component imaged. 
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 (a) 
 
       (b)                                         (c)  
  
 
Figure 5.14. Visible and FTIR images of Caco-2 cells treated with ITC SiNPs showing a microscope 
image (a), 2D (b) and the 3D (c) chemical images of cells (phospholipid profile). The colour bar 
indicates low (blue) to high (red) for component imaged. 
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 (a) 
 
       (b)                                         (c)  
 
  
Figure 5.15. Visible and FTIR images of Caco-2 cells treated with NH2 SiNPs showing a microscope 
image (a), 2D (b) and the 3D (c) chemical images of cells (phospholipid profile). The colour bar 
indicates low (blue) to high (red) for component imaged.  
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 (a) 
 
       (b)                                               (c)  
   
Figure 5.16. Visible and FTIR images of control CCD-841 cells a microscope image (a), 2D (b) and 
the 3D (c) chemical images of cells (phospholipid profile). The colour bar indicates low (blue) to high 
(red) for component imaged.   
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 (a) 
 
              (b)                                              (c)  
   
Figure 5.17. Visible and FTIR images of CCD-841 cells treated with ITC SiNPs showing a microscope 
image (a), 2D (b) and the 3D (c) chemical images of cells (phospholipid profile). The colour bar 
indicates low (blue) to high (red) for component imaged.   
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 (a) 
 
                  (b)                                           (c)  
 
  
Figure 5.18. Visible and FTIR images of CCD-841 cells treated with NH2 SiNPs showing a microscope 
image (a), 2D (b) and the 3D (c) chemical images of cells (phospholipid profile). The colour bar 
indicates low (blue) to high (red) for component imaged.    
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5.3. Summary and Conclusions 
ITC SiNPs can be successfully internalised into the cells and thus is a promising candidate 
for further investigation. FTIR microspectroscopy was used as a novel method to investigate 
the cellular uptake of nanoparticles. This helped in developing an understanding of the effect 
of these nanoparticles on cells and further investigate the mechanism of their function. This 
technique also enabled the visualisation of cells and to choose the specific regions to get the 
spectral data for analysis. 2D and 3D chemical maps were obtained using the FPA detector and 
revealed the chemical composition of biological cells by raster scanning the sample.  
Clear changes were observed in the spectral regions corresponding to the nuclei of cells 
treated with ITC SiNPs correlated to the protein content and also for the cytoplasm of the 
treated cells correlated to the phospholipid contents. It is suggested that both of these spectral 
changes are associated to the mechanism of isothiocyanate when enter cells; they increase the 
protein level in the nuclei after the migration of enzymes from cytoplasm to the nuclei. ITC 
SiNPs also increase the chance of apoptosis in the cells which lead to the increase level of 
phospholipids in the treated cells compared to the non-treated cells and those treated with NH2 
SiNPs as control.  
The IR microspectroscopy was capable of monitoring the level of cell activity in detail, and 
the major advantage of this method over microscopic methods, in the visible/UV spectral 
region, is its ability to monitor the chemical composition of the sample using the inherent 
spectral properties of the components. Cells demonstrated large signals for the chemical 
composition of treated cells when integrated in the phospholipid region.  
Although the micron-scale resolution of SR-FITR microspectroscopy may not be the 
ultimate goal, this technique has significantly improved the resolution compared to alternative 
conventional sources, which allowed the analysis of various cell components before and after 
nanoparticle internalisation in this project. 
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6.1. Summary and Conclusions 
The development of novel new nanotechnologies for biomedical applications, commonly 
referred to collectively as nanomedicine, has great potential to improve diagnosis and 
therapeutic methods and thus the overall prognosis for a wide range of diseases. In recent 
decades, the advancement in nanotechnology and material science has resulted in an increasing 
number inorganic nanomaterials which have been studied as potential drug delivery carriers, 
due to their versatile physicochemical properties. SiNPs, in particular, exhibit several unique 
properties, including conjugation versatility, suitable biocompatibility and very low 
cytotoxicity levels and therefore offers an excellent drug delivery platform candidate.  
 Although significant advances have been made in nanomedicine, the largest challenge 
remains the targeted delivery to a specific cell. The difficulty lies in the recognition of 
cancerous cells amongst thousands of normal healthy cells as well as providing a suitably 
stabile nanodelivery system. To date, research efforts have mainly focused on the delivery 
efficiency in one cell line. However, the cellular delivery system to target specific cell lines in 
an extremely diverse environment of cell types is required and is not addressed in the majority 
of studies. SiNPs with multipurpose surface functionalities to target specific receptors with 
high transfection efficiency are key areas for further development in the next decade, which 
might lead to breakthroughs for cellular delivery systems.  
The work highlighted in this thesis has focused primarily on the synthesis and 
characterisation of functionalised SiNPs for biomedical applications. Compounds with 
anticancer properties, such as thiourea and isothiocyanate, were used as capping ligands. These 
multifunctional systems benefit both from the optical properties of SiNPs for bioimaging 
purposes and the targeting and therapeutic properties of the conjugate for drug delivery 
purposes.  
The primary objective of the thesis is to develop nanomaterial candidates which are non-
toxic, economical with efficient synthesis, for use in biomedical applications. There are three 
key challenges to realising the potential of such a system: 
 A nanodelivery system which exhibits long-term stability. 
 The development of a diagnostic approach with efficient targeting of cancer cells. 
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 Maximally exploiting the therapeutic properties of biomolecules when conjugated 
on NPs 
The first of these three challenges was tackled by utilising a nanosystem which benefits 
from the central role of the covalent surface Si-C bond, which is inherently stable. For efficient 
targeting of cancerous cells, the overexpression of EGFR in several common types of cancer 
was exploited, by using thiourea derivates as the conjugate.  On the final challenge, AITC, 
known as an economical and highly effective anticancer biomolecule, was applied in 
conjugation with SiNPs for the first time.  
In Chapter 1, a short history and general introduction to nanomaterials is provided. The 
properties of semiconductor QDs and in particular SiNPs are discussed, highlighting the origin 
of SiNP luminescence and influence of the quantum confinement effect in detail. Later, an 
overview of different methods for synthesis and functionalisation of SiNPs is given with a 
discussion of the advantages and disadvantages of each method. The possible biomedical 
applications of SiNPs are also mentioned in addition to the importance of cytotoxicity in the 
biomedical applications of NPs. The chapter continues by underlining different types of 
thiourea derivatives as potential inhibitors of EGFR overexpression in cancer cells. Finally, the 
use of isothiocyanate compounds as potential chemopreventive properties is discussed.  
The work in Chapter 2 describes the general procedures and detailed methods used to 
synthesise porous SiNPs from electrochemical etching. This is followed by the 
functionalisation of porous silicon to produce amine-functionalised SiNPs, thiourea-
functionalised SiNPs, bromine-functionalised SiNPs, isothiocyanate-functionalised SiNPs in 
addition to bottom up amine-functionalised SiNPs. Later in this chapter, various apparatus and 
research techniques used for the physiochemical characterisation of synthesised SiNPs are 
explained. Finally, biological assays and the synchrotron FTIR microscopy measurements, 
used in this thesis, are discussed.  
In Chapter 3, a method for functionalising SiNPs with a thiourea layer over the NP surface 
is presented. These novel resultant SiNPs offer significant advantages compared to 
conventional therapeutics. These include the integration of the targeting moiety and therapeutic 
moiety in the same system, the use of inexpensive materials, and more importantly the 
production of a highly stable nanosystem.  
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The synthesised NPs were characterised with a wide selection of techniques such as FTIR, 
EDX, XPS, TEM, DLS, UV-vis and PL spectroscopy which allowed the chemical composition 
and physiochemical properties of the materials to be determined. It is shown that the SiNPs 
produced by this method are silicon rich, crystalline, luminescent, and functionalised with 
thiourea chains. A quantum yield of approximately 10% was achieved. The PL stability both 
in the long-term and for a range of different pH values (4-9) confirmed the suitability of these 
particles for a variety of possible biomedical applications.  
The product was examined for in vitro cytotoxicity in Caco-2 and CCD-841 cells. The 
results showed significant toxicity of thiourea SiNPs after 72 h of incubation in Caco-2 cancer 
cell line, and the toxicity was concentration dependent and became saturated for concentrations 
above 100 μg/mL. Confocal microscopy confirmed the cell internalisation of SiNPs and flow 
cytometry data indicated receptor-mediated targeting in cancer cells. Finally, in order to 
confirm the interaction between the thiourea on the surface of SiNPs and EGFR, Elisa assay 
was performed on cells.  
This nanocomposite takes advantage of the EGFR active targeting of the ligand in addition 
to the photoluminescence properties of SiNPs for bioimaging purposes. 
The work in Chapter 4 explored the first synthesis and characterisation of SiNPs 
functionalised with isothiocyanate. This was accomplished by using two different methods 
with two types of precursors, amine and bromine-functionalised SiNPs. The materials 
produced in this approach were similar in terms of the chemical characterisation. The surface 
functionalisation was analysed by FTIR, EDX and XPS studies. However, the optical 
properties of NPs obtained from the corresponding bromine-functionalised SiNPs as precursor 
were stronger with a quantum yield of 12.55% which made them more suitable candidates for 
bioimaging and uptake studies. The highly crystalline structure of NPs was shown by TEM 
images and DLS measured the hydrodynamic size which was slightly larger than the core size. 
The in vitro toxicity was verified by MTT assay in both cancer and non-cancer cell lines. The 
synthesised SiNPs were found to reduce the viability of Caco-2 cells to approximately 50% 
after 24 h treatment with 70 μg/mL NPs. Visualisation imaging of NPs in Caco-2 colorectal 
cancer cells showed the internal distribution of NPs in the cells. The internalisation of ITC 
SiNPs (P Br SiNPs) was confirmed by flow cytometry and it is most likely to be based on the 
receptor mediated endocytosis mechanism since the temperature behaviour was observed in 
the uptake process of SiNPs.    
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Finally, a novel approach for investigating the NP cell internalisation is introduced in 
Chapter 5. Synchrotron-based FTIR microspectroscopy was used to determine the effect of 
isothiocyanate-functionalised SiNPs after the cell internalisation. Individual spectra were 
collected from both nuclei and cytoplasm of treated and control cells. Spectral comparison of 
cells treated by NPs and control cells revealed the variations in the protein and phospholipid 
contents of the treated cells as a result of the effect of NP internalisation. The increased 
concentration of proteins in the nuclei of treated cells resulted in a higher intensity of the amide 
I peak, which indicated considerable protein conformational changes in the nuclei. In addition, 
the spectra obtained from treated cells revealed higher absorption for C-H stretching in the 
cytoplasm, due to variations of phospholipid content of the cellular membrane. This is assumed 
to be the result of the apoptosis effect from the isothiocyanate functional group on the treated 
cells leading to the phospholipid alterations in cellular membrane. 
 
6.2. Discussions and Future Prospects 
The methods described in the previous chapters are demonstrated to provide a sound 
approach to synthesise stable SiNPs, which shows great promise for applications in bioimaging 
and biomedical fields. They also represent a solid basis with which to develop a further 
understanding of SiNP properties. However, there are several significant concerns that must be 
addressed before SiNPs become widely used in the biomedical field.  
Despite the fact that there are already numerous researchers working with SiNPs, the nature 
of certain properties is still unclear. Thus, further investigations are necessary to determine 
whether the current theories of SiNP optical properties, as explained by quantum confinement 
and oxide-related defects, are sufficient to fully describe the full range of observed 
phenomena.1-3 An example of this issue is in the understanding of photoluminescence 
quenching when sensing certain chemical molecules, as the competing theories of this are 
incompatible.  
More generally, other possible research avenues include improvements in synthetic 
strategies to produce stable SiNPs dispersed in a wide range of solvents instead of the given 
one, and to consistently fabricate controlled particles with an appropriate size and biochemical 
functional groups for more widespread applications.  
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It is already established that silicon has a low intrinsic toxicity in cells, in contrast to Cd, for 
example, which is a significant advantage of SiNPs when considering their biomedical 
applications. As the number and type of SiNPs in this field continues to increase, studies to 
characterise their effects after exposure and to address their potential toxicity are relatively 
few. Therefore, a systematic approach to obtain accurate information on the cytotoxicity of 
SiNPs (with various additional functionalities) is necessary. It is essential to understand the 
extent to which NPs impact the specific system or cell line under study. In addition, the in vivo 
cytotoxicity and behaviour of NPs could be completely different as a result of the presence of 
plasma proteins and the formation of protein corona, which all need to be considered before 
any wider NP use. 
In regard to the two approaches used for the synthesis of amine-functionalised SiNPs, top 
down methods produce purer and better dispersed NPs in aqueous solvents with no sign of 
aggregation. The electrochemical etching in general is a straightforward, cost-effective and 
rapid method. The synthesised particles by this method showed lower cytotoxicity towards 
cells which indicates that they are more suitable for biomedical applications. However, the 
resultant SiNPs show a broader size distribution and varied shape compared to the bottom up 
products. Control of NP size and shape is essential for several reasons, the size of the NPs 
affects their movement in and out of the vasculature, whereas the margination of particles to 
vessel wall is impacted by their shape. But most importantly this factor can determine which 
specific cell uptake mechanism is followed. As a result, utilising batches of NPs with a wide 
range of sizes will weaken the conclusions of cell internalisation studies, since each size group 
of NP within a batch will follow different uptake pathways. In addition, Another drawback of 
top down method, harsh conditions need to be applied for the synthesis; with regard to 
electrochemical etching, the toxicity of reagents such as hydrofluoric acid used for the 
preparation of SiNPs.  
The key disadvantage of top down methods for the synthesis of SiNPs is scalability. 
However, there are several examples of such methods being applied on industrial scales, 
producing particles beyond milligram scales. For instance, the British company, pSiMedica, 
and a Japanese company, Tokao Yonehara of Canon Inc., have been successful in meeting this 
challenge by optimising the synthesis of functionalised porous silicon in large quantities 
leading to the anodization of 10,000 silicon wafers per month. In this technique, layers of pure 
silicon are deposited onto the porous layer of a silicon wafer. Then, the wafer is bonded to 
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another silicon wafer with an insulating silicon-oxide surface, in a way that the pure layer of 
silicon ends up sandwiched in the middle. The porous silicon is selectively dissolved away to 
leave the desired product which is silicon on top of an oxide layer on top of the silicon wafer.4 
The bottom up approach offers a better chance to obtain more homogeneous chemical 
compositions for nanoparticles. In addition, it is low-cost and offers the use of a wide variety 
of available precursors to synthesise SiNPs. Uniform size distribution and the ability to produce 
large amounts of material can be considered as the major advantages of this technique. 
However, the resulting NPs in this method are sometimes less dispersible, possibly due to the 
high coverage of the particles by the specific functional ligands as they are most of the time 
originally attached to the core from the beginning in the starting material. In addition, as a 
result of the solution based synthesis in this approach, the presence of unwanted impurities in 
the product is normally the drawback of this method which typically requires an extensive 
purification protocol to be removed. This sometimes leads to a significant degree of oxidation, 
which subsequently can result in red-tailed broad emission features in the PL spectrum and in 
some cases causes cytotoxicity in the biological environment.  
One of the significant factors when considering the use of NPs more generally, is the high 
tendency of NPs to form aggregates and their resulting long term stability in specific biological 
media. Therefore, before any further research applying NPs in biological environments it is 
crucial to produce well-dispersed and stable batches. The aggregation limits the contact 
between the NPs and cells, thus reducing the transfection efficiency. Another possible 
consequence of not having stable NPs is the excretion of NPs and their accumulation in the cell 
which can harm the cell growth. However, due to the chemical stability of SiNPs, these samples 
cannot be dissolved easily in the cell, and it is difficult for them to leave cells like ions. 
Exocytosis can occur due to the osmotic pressure, but this likey has very low rate because their 
concentration in cells are quite low. 
With respect to the synthesis of the thiourea-functionalised SiNPs, the resultant particles 
showed no obvious sign of agglomeration and NPs were dispersible in a wide range of different 
solvents. However, a systematic study focusing on the interaction of these particles in vivo is 
still required to predict and avoid any undesired interactions and possibly minimise them by 
further modification of the particle surface. It would be extremely beneficial to extend the 
techniques, applied in this thesis, for larger scale production of SiNPs of a wide range of sizes 
with different photoluminescence colours. Efforts also need to be directed towards improving 
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the purity of the final product by reducing the use of toxic chemicals such as HF used in 
electrochemical etching. 
The inorganic NPs functionalised with biomolecules are thought to be internalised through 
the endocytosis process since the particle size is normally less than 500 nm. Although the 
detailed mechanism of endocytosis has not been well understood, microscopic observations 
indicate the changes in cell morphology and cytoskeleton structure while endocytosis happens. 
The endocytosis may be a receptor-mediated, or non-receptor-mediated process.5 Although 
considerable advances in the development of SiNPs conjugated with biologically active ligands 
such as thiourea have been made in this project, with respect to the area of EGFR inhibiting 
effects of NPs to confirm the receptor mediated endocytosis, there are still significant factors 
that could be further developed and understood. This project was focused on two cell lines 
(normal and cancerous) with different levels of receptor expression in order to evaluate any 
possible interaction between the thiourea-functionalised SiNPs and EGFR. In order to establish 
the potential of these particles in these regards, and to optimise transfection efficiency of 
particles, an objective approach is required to cover various types of cell lines with different 
levels of receptor expression. Obviously this level could vary depending on the passage number 
of cells and the culture conditions which might affect the exact amount of the EGFR receptor. 
Therefore, western blotting to determine the accurate level of the EGFR for specific cells before 
doing any flow cytometry or Elisa test would be highly beneficial, and lead to more robust 
data. Another possible alternative in this case could be the use of well-known and conventional 
EGFR inhibitors before any treatment with thiourea-functionalised SiNPs. By following this 
approach, the fluorescence measured by flow cytometry or the absorbance measured by Elisa 
test could provide a proper comparison. This would enable the evaluation of whether this 
inhibition is actually related to the thiourea ligand, and if there is any difference between non-
treated or NP treated cells, and those treated first with the inhibitor and then later with the NPs. 
This would provide a much improved understanding of NP-receptor interactions, and the 
driving forces in the transfection process which ultimately lead to better cell specific target 
delivery with high efficiency. 
The final precondition for successful treatment of diseases with SiNPs requires an effective 
bioconjugate. Currently, in this project it was not possible to accurately determine the amount 
of the therapeutic ligand on the surface of SiNPs obtained by top down approach. This is due 
to the batch dependent property of the obtained particles which affects the availability and 
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consistency of active sites on the surface of hydrogen-terminated SiNPs after each synthesis. 
Any evaluation of therapeutic properties needs to be compared with a control drug of 
equivalent amount with known properties to determine the drug load in the system under study. 
Modification of the system towards the synthesis of more homogeneous particles from the top 
down method in the future could address this issue.  
A comparison between the confocal images obtained from the cells treated with ITC SiNPs 
and those obtained from thiourea SiNPs (Chapter 3, section 3.14.2.1) indicated a clear 
difference in terms of the internal localisation of these two types of SiNPs. The intensity of 
thiourea-functionalised SiNPs detected in the cells was brighter than ITC SiNPs and they were 
mostly distributed within the cytoplasm, whereas ITC SiNPs showed lower brightness with 
some NPs distributed in different parts of cytoplasm as well as the nuclei. Even though the 
reason in this regard is not exactly clear, there are several possibilities which may attribute for 
this different behaviour. First of all, due to the lower viability of cells treated with ITC SiNPs 
at high concentrations, the amount of SiNPs used for the treatment of cells before imaging was 
almost half of those used for the thiourea SiNPs (50 µg/mL ITC SiNPs vs 100 µg/mL thiourea 
SiNPs). This concentration level was optimised to this amount as it was not possible to get 
enough number of cells for imaging analysis after the treatment with higher concentrations of 
ITC SiNPs. In addition, those cells which survived and were detected by the microscope did 
not show any uptake. Therefore, it can be concluded that cell viability correlates with the lack 
of uptake in the cells and thus lower concentrations of NPs were used for the imaging analysis. 
In addition, the different ratio of silicon to ligand in these two types of NPs may have led to 
different proportions of silicon core entering the cells, and therefore may have led to different 
levels of signal from the particles detected by the confocal microscope. Moreover, size 
uniformity of NPs should be considered when their interactions with biological systems are 
examined. Thus, another important factor which may be responsible for this behaviour is the 
possibility of having more than one endocytosis mechanism in cells treated with ITC SiNPs 
which would lead to the accumulation of them in different parts of the cells. For example, if 
particles follow marcrocytosis or clathrine-dependent endocytosis, it is possible that they are 
sent to lysosomes for degradation6, 7 whereas if caveolae-dependent endocytosis is the major 
route of NP endocytosis, it is likely they accumulate in endoplasmic reticulum or nuclear 
envelope.8, 9 In addition, clathrin- and caveolae-independent endocytosis which relies on 
cholesterol and specific lipid compositions, can bypasse the classical endocytic organelles and 
deliver the NPs via nonendosomal, cytosolic organelles to the endoplasmic reticulum.10 
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In biological solutions such as cell culture media, the surface chemistry of NPs plays a 
crucial factor in their localisation. Therefore, the higher chemical activity of isothiocyanate 
functional group could possibly have led to stronger interactions between NPs and various 
serum proteins in the biological media, causing partial agglomeration. If the NPs are already 
aggregated or agglomerated prior to binding to the cell membrane, their endocytosis patterns 
would differ from that of individual NPs.11 
It should be mentioned that all these parameters need to be well determined and optimised                                 
for a better understanding of the behaviour behind the internal localisation of NPs, as it is 
critical to their intended therapeutic function. Due to the position and amount of NPs within a 
cell, identification of any degradation of the NPs within intracellular compartments and its 
impact on cell viability needs to be further addressed. Modifying the loading time and 
concentration of NPs can promote cell visibility for imaging applications. 
Nontoxic SiNPs have created a new chapter in the field of nanoscience. This thesis has 
demonstrated that it is possible to synthesise SiNPs with high stability, targeted delivery and 
incorporating the therapeutic properties of conjugated biomolecules. In the future, properly 
designed materials may expand the use of QDs for biomedical applications, which have been 
disadvantaged by the presence of toxic elements in many semiconductor QD systems. It is 
highly likely that interest and research into the field of SiNPs will increase in the coming 
decades, and it is hoped that a wide range of diseases with a currently poor prognosis will 
eventually be effectively diagnosed and treated with negligible side-effects. Such 
developments in the field of nanomedicine will certainly have an immeasurably positive 
influence on future society. 
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